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ABSTRACT 
 
Quorum sensing (QS) is a phenomenon that allows bacteria to communicate with each 
other. Small molecules known as autoinducers are synthesized and released by 
bacteria, and once enough members of the community are around to ensure survival, 
i.e. quorum, a phenotype, e.g. bioluminescence, is expressed. There are two types of 
QS molecules, intra- and inter-species.  
 
S-4,5-Dihydroxy-2,3-pentanedione (DPD) is a byproduct of the activated methyl cycle 
which recycles methionine. This has led to the discussion as to whether DPD is a 
metabolic byproduct or is the interspecies signal as proposed previously. The detection 
and quantitation of DPD however, has not been incredibly efficient. We have designed 
and synthesized a derivatizing agent to detect DPD using SRM based mass 
spectrometry. Using this technology combined with a previously synthesized isotope 
version of DPD, we were able to derivatize and quantitate DPD. 
 
Acylhomoserine lactones (AHLs) are a type of intra-species QS molecules in which the 
acyl chain can be differentiated among species. Previously there has been no easy way 
to quantitate these molecules despite their ease of detection through mass 
spectrometry. Herein we have designed an internal standard that incorporates two 
deuteriums into the conserved portion of the lactone and designed a convergent 
synthesis that uses D2-Fmoc-Methionine as a common intermediate to make a range of 
AHLs standards. 
 
Using these technologies for isotope-dilution mass-spectrometry (MS) we were able to 
quantitate both DPD and AHLs from cultures of Escherichia coli, Vibrio harveyi, and 
Vibrio fischeri. From these measurements we learned the E. coli does not use DPD as a 
cell density regulator while V. harveyi does. Using SRM based MS we discovered a new 
AHL produced by V. fischeri and showed a temporal pattern in synthesis that could be 
used to determine the phase of growth in this organism.  
 
Lastly, the metabolic effects of DPD and AHLs on lab and mixed microbial cultures from 
the Atlantic Ocean were studied. Each autoinducer showed opposing effects on the 
metabolism of these cultures showing that QS has the ability to alter the physiology of 
these organisms and potentially effecting dissolved organic matter in the ocean. 
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INTRODUCTION 
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Understanding quorum sensing in bacteria would allow open questions about the 
phenotypes controlled by these systems to be answered.  We sought to create 
measurement technology to detect and quantitate these quorum sensing signals in order 
to understand their biosynthesis. After determining that we can measure these signals 
successfully, we turned our attention to probe the metabolic effect these molecules have 
on marine populations since signaling has an established biosynthetic link to 
metabolism. 
 
Bacteria are able to communicate using small molecules. These molecules were originally 
termed autoinducers as they were thought to upregulate their own synthesis.  Autoinducers, or 
signaling molecules, exist in two main classes, inter- and intra-species. The proposed 
interspecies molecule is (S)-2,3-dihydroxy-4,5-pentanedione (DPD), because it’s synthase, 
LuxS, is found in > 50% of all sequenced bacteria. 3-7 The intra-species signals can be put into 
two broad categories; acylhomoserine lactones8-10 (AHLs) are found in Gram-negative bacteria, 
while autoinducing peptides11-13 are used in Gram-positive species. These groups have the 
ability to be chemically differentiated and therefore can create a species specific signal to have 
more “private conversations.” There have also been other species specific signals identified that 
do not fit into either of these two categories. Collectively, quorum sensing signals allow bacteria 
to act as pseudomulticellular organisms that can determine if enough members are around to 
ensure success of the community. At this point, a quorum is reached, and a phenotype is 
expressed.3-4,13-55 Examples of phenotypic behaviors include bioluminescence, biofilm formation, 
and virulence. Originally quorum sensing was thought to only signal for cell density, but this has 
come into question recently. The syntheses of DPD and AHLs from the activated methyl cycle 
provide the link between quorum sensing and metabolism.8,56-59 DPD is a metabolic byproduct of 
methionine salvage via the luxS enzyme.59 This enzyme is responsible for the cleavage of S-
ribosylhomocysteine to cysteine during the activated methyl cycle and is responsible for the 
recycling of methionine. The lactone ring of AHLs is synthesized with LuxI from S-
adenosylmethionine where the acyl chain can vary based on the organism and is thought to 
come from lipid biosynthesis. Being able to both measure and quantitate these signaling 
molecules as well as measure their metabolic effects in bacteria will help determine the role of 
these molecules in nature. 
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Collectively, the techniques used to holistically measure metabolism are termed metabolomics. 
Metabolomics uses a variety of techniques including liquid chromatography-tandem mass 
spectrometry (LC-MS/MS) to measure relative concentrations of metabolites from cells.60-61 By 
quenching the metabolism quickly a global picture of the current state of the system can be 
measured. At this point a variety of techniques can be used to measure metabolic differences. 
One of those techniques uses a separation by liquid chromatography followed by an 
introduction into a triple quadrupole mass spectrometer via an electrospray ionization source.61 
Selected reaction monitoring (SRM) technology is then used to measure a unique parent mass-
to-charge (m/z) – fragment m/z pair for each metabolite.61 This technology can easily measure 
relative concentration changes between cultures grown over time or under different conditions. 
 
The SRM technique can also be used to measure both DPD and AHL concentrations from a 
sample by using isotope dilution mass spectrometry. This allows for absolute quantitation of 
these quorum sensing signals by using a stable isotope labeled version of the molecule of 
interest as an internal standard. Previous methods3,62-65 used to measure these compounds 
relied on bioassays and bioreporters that suffered mainly from their inability to or unreliable 
quantitation. In the case of AHLs, other LC-MS(/MS) methods29,67-71 have also been reported, 
however these are long and to make them shorter irregular additives are used. 
 
Once the ability to measure and quantitate these quorum sensing signals is accomplished, 
understanding their effect on their surrounding environments becomes of interest. The link 
between metabolism and QS can be observed in marine nutrient cycling. The dissolved organic 
matter (DOM) in the ocean can consist of excreted secondary metabolites including QS 
molecules and unwanted metabolic byproducts. The effect that these molecules have on the 
surrounding cultures is of much interest due to the roles that marine bacteria play in carbon, 
nitrogen, and phosphorus cycling in the ocean.72-74 
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CHAPTER I 
DETECTION AND QUANTITATION OF DPD AND AHLS 
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A version of this chapter was originally published by  Shawn R. Campagna, Jessica R. Gooding 
and Amanda L. May: 
Reproduced with permission from Shawn R. Campagna*, Jessica R. Gooding, and Amanda L. 
May. Direct Quantitation of the Quorum Sensing Signal, Autoinducer-2, in Clinically Relevant 
Samples by Liquid Chromatography−Tandem Mass Spectrometry. Analytical Chemistry 2009, 
81(15), 6374-6381; doi 10.1021/ac900824j. Copyright 2009 American Chemical Society. 
 
A version of this chapter was originally published by Amanda L. May, Mary E. Eisenhauer, 
Kristen S. Coulston, and Shawn R. Campagna: 
Reproduced with permission from Amanda L. May, Mary E. Eisenhauer, Kristen S. Coulston, 
and Shawn R. Campagna*. Detection and Quantitation of Bacterial Acylhomoserine Lactone 
Quorum Sensing Molecules via Liquid Chromatography–Isotope Dilution Tandem Mass 
Spectrometry. Analytical Chemistry 2012, 84(3), 1243-1252; doi 10.1021/ac202636d. Copyright 
2012 American Chemical Society. 
 
The articles listed were combined and kept as originally submitted with minor adaptations. JRG 
performed mass spectrometric and biological experiments for DPD analysis. MEE and KSC 
helped with the synthesis of (D2)AHLs. Raw Data Tables can be found in the publications. 
 
1.1 Abstract  
 
Quorum Sensing is a type of bacterial cell-to-cell signaling that allows for cell density dependent 
regulation of gene expression.  Many of the behaviors mediated by quorum sensing are critical 
for bacterial colonization or infection, and autoinducer-2 has been proposed as a universal 
interspecies signaling molecule that allows multi-species colonies of bacteria, e.g. biofilms or 
dental plaque, to behave as pseudo-multicellular organisms. However, the direct detection of 
autoinducer-2 has been difficult, leaving the in vivo relevance of this signal in question. Herein 
we report a liquid chromatography ─ tandem mass spectrometric technique that enables 
reproducible, quantitative, and sensitive measurement of the concentration of autoinducer-2 
from a variety of sources. This technique was applied to the detection of autoinducer-2 from 
Escherichia coli and Vibrio harveyi in proof-of-concept studies and was then used to directly 
measure the concentration of the signal produced by oral bacteria in human saliva.  
 
A second set of molecules known as acylhomoserine lactones (AHLs) are used as intraspecies 
quorum sensing signals by Gram negative bacteria, and the detection and quantitation of these 
molecules is of interest. This manuscript reports a liquid chromatographic–isotope dilution 
tandem mass spectrometric method for the quantitation of these molecules. A divergent solid 
phase synthesis of stable isotope labeled AHLs suitable for use as an internal standard is 
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reported. This route relies on the biomimetic conversion of a dideuterated methionine 
equivalent, N-Fmoc-(4,4-2H2)methionine, to the desired labeled AHL, and a representative 
series of eight of these molecules was produced in >95% purity and yields up to ~50%. The 
representative AHL internal standards were then used to develop an optimized liquid 
chromatography─tandem mass spectrometric (LC-MS/MS) separation and detection protocol 
for these molecules, which relies on a high efficiency C18 core-shell column to minimize the 
time necessary for separation. The addition of internal standards at different points during 
sampling was also found to affect the analysis for hydrophobic AHLs with addition prior to cell 
removal giving the most accurate results. Taken together, the use of the internal standards and 
separation method reported herein provide a rapid and quantitative method for the study of AHL 
production in bacteria. 
 
1.2 Introduction 
 
1.2.1 DPD Based Quorum Sensing. Quorum sensing is the cell density dependent regulation 
of gene expression, and these signaling systems are thought to be mechanisms by which 
bacteria can enact group beneficial behaviors only when enough members of the population are 
present to successfully carry out the desired task.3,29,75-76 Indeed, quorum sensing networks 
have been implicated in behaviors including luminescence, host colonization, biofilm formation, 
and virulence. Utilizing proper inter-species signaling systems, bacterial communities can 
behave as pseudo-multicellular organisms. Quorum sensing has also gained much interest due 
to the role it plays in infectious disease processes;75,77-82 however, our understanding of intra- 
and inter-species signaling in bacteria is still in its infancy. Controlling or attenuating biofilm 
production and/or colonization via quorum sensing could lead to fundamental new approaches 
for the treatment of bacterial infections.  
 
A single molecule, (S)-4,5-dihydroxy-2,3-pentanedione (DPD) (Scheme 1.1), may give rise to 
the universal bacterial signal,83-84 AI-2, as the gene encoding for the DPD signal synthase 
(luxS)59 has been found in the genomes of many sequenced bacteria, both gram-positive and 
gram-negative.85 Further, cell-free supernatants from many species for which the genome has 
not been sequenced have also been shown to produce AI-2 activity via the Vibrio harveyi 
reporter assay that is based on the bioluminescence of this organism.86 Despite the interest in 
AI-2 mediated signaling systems, the concentration of this molecule in complex, biologically 
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relevant samples has not, as of yet, been determined. Indeed, it may be that the concentration 
of AI-2 in the environment is much lower than that necessary to observe a phenotype under 
laboratory conditions. Recent model studies utilizing human saliva have shown that mutualistic 
biofilm formation by two oral bacteria, Streptococcus oralis 34 and Actinomyces naeslundii 
T14V, is mediated by AI-2 and that the concentration of the signal in the effluent from the biofilm 
ranged from 135-197 nM,87 concentrations much lower than the typical µM concentrations found 
for single species cultures grown in laboratory media.88-90 Further, evidence is mounting that 
some bacterial species, such as Escherichia coli and Salmonella enterica serovar typhimurium 
may import and degrade AI-2 as a mechanism to interfere with signaling in competitive 
species.19-22  
 
Complete characterization of the active form of AI-2 for each species producing DPD has been 
hindered since AI-2 is actually a mixture of inter-converting borated and unborated 
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Scheme 1.1. 4,5-Dihydroxy-2,3-pentanedione is the precursor to a set of molecules that are 
collectively termed AI-2. Two of these molecules have been shown to be used as signals in vivo. 
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molecules.83,91 (Scheme 1.1) The chemical properties of DPD and molecules derived thereof are 
also responsible for the difficulties encountered during attempts to quantitate AI-2. The major 
impediments are that no chromophore is contained in the molecule for fluorescent or similar 
detection, the low ionization potential of AI-2 renders mass spectrometric (MS) based detection 
impossible, and the instability of DPD at high molarities does not allow concentration of the 
molecule. The inability to determine the concentrations of DPD present in the environment of 
bacteria living in complex communities has left open questions concerning the relevance of this 
molecule as a signal in vivo. 
 
1.2.2 Previous DPD Detection. To date, three classes of methods for the detection of AI-2 
have been utilized, the Vibrio harveyi luminesence bioassay,86-87 biosensors derived from AI-2 
receptor proteins,88-89 and liquid chromatography (LC)-MS or gas chromatography (GC)-MS 
analysis of a DPD derivative.90 The V. harveyi luminescence bioassay has been the most 
utilized method for the detection of AI-2 via the induction of light in a reporter strain by cell-free 
supernatants from cultures of interest. While this assay is sensitive over several orders 
magnitude with a limit of detection (LOD) in the low nM range, the culture to culture variability 
for V. harveyi has been shown to affect the reproducibility.62,87 Further, other molecules present 
in the cell-free supernatants of the studied species can alter the sensitivity of V. harveyi to AI-
2.90,92 The small linear range of this assay (0.08 – 0.8 µM) also limits the quantitative ability.87 
Recent work has constructed real-time biosensors for AI-2 derived from the V. harveyi receptor 
protein, LuxP.88-89 These reporter proteins rely on a change in fluorescence from LuxP modified 
to contain chromophores that change emission characteristics upon AI-2 binding.  This class of 
sensors has LOD of ~100 nM, and the linear response ranges from ~1 – 30 µM. However, these 
sensors are limited in sensitivity by the binding affinity (Kd ~100 nM ) of the ligand, and they only 
report on the fraction of DPD that has converted to the borate recognized by V. harveyi,  making 
this detection method sensitive to the borate concentration in the sample as well. Concurrent 
with our efforts to quantitate DPD, a method for gas chromatography (GC)-mass spectrometric 
detection of this molecule was reported.90 This technique utilized o-diaminobenzene as a 
derivatizing agent, and was able to detect the resulting quinoxaline with a LOD of 5.3 nM and a 
limit of quantitation of 16 nM. However, a series of two derivatizations, a solid-phase extraction, 
and a 50 fold concentration step were required to enable detection. Unfortunately, these 
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methods for the detection of DPD are either not easily reproduced, not sufficiently quantitative, 
difficult to perform, only report on one of the forms of DPD, or a combination thereof.  
 
We sought to develop a tool that would allow the facile measurement of DPD concentration from 
biologically relevant environments. For this technique, a derivative of DPD is detected via a 
selected reaction monitoring event (SRM) on a tandem MS after separation via LC. These 
events detect molecules by simultaneously monitoring for a specific parent ion mass-to-charge 
ratio (m/z) in the first mass analyzer and for a characteristic and/or abundant fragment ion m/z 
in a subsequent mass analyzer.93 Utilizing such techniques, compounds with identical nominal 
masses such as citrate and isocitrate can be distinguished by their unique fragmentation 
patterns without the need for chromatography.61,94 The requirement that the MS measure both 
the parent and fragment ion pair of the analyte give SRM-based techniques good sensitivity, 
specificity, and a large linear dynamic range. Here, we report the direct chemical detection and 
quantitation of DPD in both cultures of E. coli and V. harveyi and from the effluent of oral 
bacteria in human saliva. These results are the first to quantitate DPD in complex, clinically 
relevant media and show that DPD concentrations in the human mouth are sufficient to mediate 
behaviors observed in model systems.  
 
1.2.3 Acylhomoserine lactone based quorum sensing. Bacterial cell-cell signaling has been 
implicated as a controlling mechanism for many bacterial phenotypes ranging from 
bioluminescence95-97 to the production of virulence factors,22,98-99 and it is likely that social 
interactions among various bacterial species are critical for the establishment of microbial 
consortia, such as biofilms.76,100-101 One type of cell-cell signaling strategy employed by 
microorganisms is termed quorum sensing, and it is believed that these circuits allow bacteria to 
regulate gene expression based on the number or density of bacteria in the environment,8,22,76 
thus allowing for group beneficial behaviors to only be enacted once a sufficient number, i.e. a 
quorum, of cells are present to enhance the probability of successfully carrying out the desired 
behavior. 
 
Many quorum sensing signaling molecules have been termed autoinducers as early work 
predicted that these signals could upregulate their own production.8,57 To date, intra-, 
interspecies, and possibly interkingdom signaling systems have been discovered, and the 
diversity of signal structures in bacteria is broad. For example, many Gram positive organisms 
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utilize small autoinducing peptides for intraspecies communication,22 while a number of Gram 
negative species accomplish this task with acylhomoserine lactone (AHL) derived 
autoinducers.102 Due to this, an enhanced ability to quantitate these molecules will allow a more 
in depth study of cell-cell signaling processes. 
 
Naturally occurring AHLs are produced by transfer of an acyl group to the nitrogen of S-
adenosylmethionine.8,56-58 This is followed by cyclization of the amino acid portion of the 
resulting molecule to form the homoserine lactone moiety and expel the unneeded portion of the 
starting material. As the acyl 
group is provided by an acyl 
CoA, the organism has available 
a variety of lipids that can be 
incorporated in the AHL (Figure 
1.1). Indeed, wide variation of 
acyl groups on the conserved 
homoserine lactone core are 
known, and bacteria containing AHLs with acyl portions between 2 and 18 carbons in length 
have been observed. Oxidation at the 3 position of the acyl chain is also prevalent; and chains 
with an odd number of carbons, double bonds, and branching have also been characterized, 
although they are not as prevalent as those containing saturated, even numbered acyl tails.10,102 
 
1.2.4 Isotope dilution tandem mass spectrometry. The most widely used methods for the 
detection of AHLs are either based on bacterial bioreporter srains64-65 or chromatography–mass 
spectrometry (MS),29,67-71 although techniques using isolated bacterial detection machinery have 
recently been reported.103 The colorimetric bioassays, which often employ Agrobacterium 
tumefaciens104  or Chromobacterium violaceum64 as reporter strains, have good sensitivity and 
can be used to visualize AHLs separated by thin-layer chromatography.65 However, these 
methods suffer from limitations in the substrate scope of the AHL receptors, and this hinders 
detection of AHLs with a broad range of acyl chains. The reported MS-based methods, a 
selection of which are discussed in more detail below,29,67-71 offer good sensitivity and low limits 
of detection, although such techniques could be improved by the use of isotope dilution 
techniques. Adding an isotope labeled internal standard to the sample prior to analysis, provides 
a robust method for exact quantitation as it allows the concentration of an analyte to be 
Figure 1.1. Acylhomoserine lactone structures 
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determined without the need to construct an external calibration curve. Also, no corrections for 
matrix effects, such as competitive ionization, are necessary for isotope dilution mass 
spectrometric techniques because the analyte and internal standard are isotopomers that are 
equally influenced by all factors in the analysis. Further, our preferred detection technique relies 
on selected reaction monitoring (SRM) mass spectrometry;67 a robust tandem technique in 
which two mass analyzers and a collision cell are used to first select a desired parent mass to 
charge (m/z), fragment the selected molecule(s) with collisionally-induced dissociation (CID), 
and then to detect a fragment m/z that is characteristic for the molecule of interest. This 
technique facilitates quantitation of molecules in complex mixtures, and the power of such 
analyses is enhanced if a separation technique, e.g. liquid chromatography, is used for sample 
introduction. To this end, we aimed to synthesize dideuterated AHL standards and to develop 
an efficient high performance liquid chromatographic─tandem mass spectrometric (LC-MS/MS) 
method for the analysis of these molecules to facilitate our quantitative understanding quorum 
sensing signal production and utilization. 
 
1.3 Results and Discussion 
 
1.3.1 Determination of the optimal DPD derivatizing reagent for LC-MS/MS analyses.  The 
facile reaction of DPD with o-diaminobenzene, 1, (Figure 1.2A) has been used to qualitatively 
detect AI-2 as the 
resulting quinoxaline 
derivative, DPD-
Q.105-106 In our hands, 
1, was not useful for 
the LC-MS/MS 
quantitation of DPD; 
therefore, a set of 
functionalized o-
diaminobenzene 
tagging reagents 
(Figure 1.2B) were 
produced as 
H2N
H2N
HO
CH3
OH
O
O
-2 H2O N
NH3C
HO
OH
DPD
O
O
OH
O
OH
O
n
n
H2N
H2N
H2N
H2N
ORO
2, R = H
3, R = CH2CH3
DPD-Q1
4, n = 1
5, n = 2
6, n = 3
O
O
H2N
H2N
7
OCH3
O
OCH3
O
A
B
Figure 1.2. Quinoxaline formation and DPD tagging reagents used 
(A) Stable quinoxlines, such as DPD-Q, can be formed via the 
reaction of o-diaminobenzenes with α-diketones. (B) Molecular 
structures of the DPD tagging reagents used in this study. 
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described in the Supporting Information. All of the tagging reagents showed some utility for the 
measurement of DPD concentration via LC-MS/MS. To determine which quinoxaline was 
optimal to quantitate AI-2 when introduced via an electrospray ioization (ESI) source, standard 
solutions of each were generated and analyzed on a triple quadrupole MS. Briefly, synthetic 
DPD (2.35 mM, pH = 1.8) was reacted with each of the o-diaminobenzene tags, 2 - 7, in a 1:3 
molar ratio. After the reaction was allowed to proceed for 2 h, the solutions were diluted in water 
and introduced into the MS via direct infusion. In all cases, a peak was detected corresponding 
to the mass of the protonated quinoxaline in positive ionization mode, and the most sensitive 
SRMs for each quinoxaline were determined via a MS2 experiment (Table S1.1). After suitable 
detection parameters were established, each quinoxaline solution was injected onto an 
aminopropyl column and eluted using a chromatographic method modified from standard 
metabolomic procedures.61 Although a peak was detected for all compounds, the quinoxalines 
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Figure 1.3. Mass Chromatograms for each DPD derived quinoxaline. A 10 µL injection of a 10 µM 
solution for each was detected by an appropriate SRM after gradient elution from an aminopropyl LC 
column. (A) Chromatogram of DPD-BAQ as detected via SRM 249-231. (B) Chromatogram of DPD-
EBAQ as detected via SRM 277-231. (C) Chromatogram of DPD-M1CQ as detected via SRM 381-
202. (D) Chromatogram of DPD-1CQ as detected via SRM 353-231. (E) Chromatogram of DPD-2CQ 
as detected via SRM 381-219. (F) Chromatogram of DPD-3CQ as detected via SRM 409-219. 
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generated from 4 - 6 (DPD-1CQ, DPD-2CQ, and DPD-3CQ, respectively) gave no more than 
10% of the signal measured for the other quinoxalines (Figure 1.3). The quinoxalines derived 
from 3, collectively DPD-EBAQ, gave the most intense signal, however, the peak shape for this 
molecule was not Gaussian. Asymmetry was also seen in the peak from the quinoxalines 
derived from 2, collectively DPD-BAQ, presumably due to partial separation of the two 
regioisomeric quinoxalines generated from the reaction with DPD (Figure 1.3A and B).  
Although the absolute peak intensity for the quinoxaline generated via reaction with 7 (DPD-
M1CQ) was only 40% that of DPD-EBAQ, the fact that DPD-M1CQ was a single molecule with 
well behaved chromatographic characteristics was promising (Figure 1.3C). Due to the ease of 
detection for DPD-BAQ, DPD-EBAQ, and DPD-M1CQ in the preliminary experiments, each of 
these molecules were subjected to further investigation.  
 
While the LC-MS/MS detection of a molecule with an appropriate m/z for each quinoxaline gave 
strong evidence that the desired tagging reactions had occurred, further confirmation for the 
formation of these molecules was desired. To obtain these data as well as to probe the efficacy 
and product distribution for each reaction, proton nuclear magnetic resonance (1H NMR) 
spectroscopy was employed. For these experiments, the reactions yielding DPD-BAQ, DPD-
EBAQ, and DPD-M1CQ were studied by the addition of 2-3 mol equivalents of the appropriate 
tag in 1 mol equivalent portions to a solution of synthetic DPD (4.7 mM) in D2O, and the 
formation of product was observed by 1H NMR. For DPD-BAQ, 1 equivalent of tag was added to 
the DPD solution at 0, 1, and 2 h (Figure S1.1). Upon the addition 1 equivalent of tag 2, the 
DPD concentration decreased and the concentration of DPD-BAQ increased over the course of 
1 h. However, the reaction did not proceed to completion. Further addition of 2 more equivalents 
of 2 was also not sufficient to drive the reaction to completion after 2.5 h. Beyond revealing that 
the reaction leading to DPD-BAQ was not facile, this experiment also confirmed from the 
formation of an ~1:1 mixture of regioisomeric quinoxalines. Monitoring the formation of DPD-
EBAQ was then carried out as described for DPD-BAQ, except 2 equivalents of tag 3 were 
sufficient to drive the reaction to completion over a 2 h period (Figure S1.2). Addition of 1 
equivalent of 3 to DPD led to the consumption of 50% of the tag over 1 h, and another 
equivalent of 3 was added to the reaction. This addition was sufficient to drive the reaction to 
completion after another hour. Although we were hopeful that the added steric bulk of the ethyl 
ester would favor formation of one of the regioisomers of DPD-EBAQ, this was not the case as 
both were observed in an ~1:1 ratio. Due to the sluggish reaction and undesirable mixtures of 
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products generated during the formation of DPD-BAQ and DPD-EBAQ, we refocused our 
attention on 7. When 1 equivalent of this tag was added to synthetic DPD, reaction proceeded 
quickly, and 7 was ~90% consumed after 30 min. Addition of a second equivalent of tag led to 
complete conversion of the remaining 10% DPD to DPD-M1CQ after further reaction for 30 min 
(Figure S1.3). The efficiency of reaction coupled with the generation of only a single product, led 
to the selection of 7 as the tagging reagent for further experimentation.  
 
1.3.2 Validation of the sensitivity and selectivity for DPD detection. To determine the LOD 
for DPD-M1CQ, a standard solution of the quinoxaline was used to generate a calibration plot of 
signal vs. concentration (Figure S1.4). Serial dilutions of a 2.35 mM solution of DPD-M1CQ into 
water yielded calibration standards ranging in concentration from 74 pM to 23.5 µM. The 
resulting standards were analyzed via LC-MS/MS by monitoring SRMs 381-363, 381-231, 381-
202, and 381-201 (reported as parent m/z – product m/z). From these experiments, DPD-M1CQ 
could be detected at all concentrations of 230 pM or greater, and the signal was linear over the 
entire detectable concentration range. The SRM, 381-363, corresponding to the loss of water 
had a poor signal-to-noise ratio (S/N) and was not used for LOD determination. Monitoring the 
SRM 381-202 was more sensitive than monitoring either the 381-231 or 381-201 SRMs. The 
S/N of only ~3:1 for SRM 381-202 at 230 pM DPD was not sufficient for quantitation, although 
tentative detection of DPD-M1CQ is still possible. The signal from SRM 381-202 at the next 
highest DPD concentration, 740 pM, had a S/N of ~5:1, which is sufficient for detection and 
quantitation of the molecule (Figure S1.5). Further determination of the exact LOD was not 
carried out as the quantitation of the DPD concentration in subsequent experiments was to be 
performed via comparison of the signal for DPD-M1CQ to that observed for an isotope-labeled 
internal standard as described below. 
 
A possible complication for the selectivity of this method is that the Lobry de Bruin-van 
Ekenstein rearrangement or the Maillard reaction of carbohydrates can be promoted via the 
addition of o-diaminobenzene at pHs higher than 7.5.90,107 These reactions can lead to the 
formation of quinoxalines identical or similar in structure to those derived from DPD. In this 
work, care was taken to insure that the pH remained at or below 7.2 during sample preparation, 
handling, and analysis. In order to validate the selectivity of this derivatization and detection 
approach in complex media, tag 7 was added to Luria-Bertani Broth (LB) and allowed to 
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incubate for 1 h. These samples were subjected to LC-MS/MS analysis and monitoring of the 3 
most sensitive SRMs was performed to determine whether undesired side-reactions of 7 with 
carbohydrates had occurred. For SRMs 381-201 and 381-231, peaks with very low intensity 
were observed. Fortunately, SRM 381-202 did not have a peak derived from impurities. The 
samples were re-analyzed after sitting at 4 °C for 11 h, and no changes in the data were 
observed (Figure S1.6). These data showed that SRM 381-202 is selective for detection of 
DPD-M1CQ. 
 
1.3.3 Implementation of an internal standard for DPD quantitation. The addition of stable 
isotope-labeled internal standards has become a powerful technique that allows absolute 
quantitation of analytes during MS detection without the need to construct an external 
calibration plot.108-110 Two options for the addition of an internal standard during these 
experiments were possible. The first option would rely on the addition of an isotopically labeled 
version of the quinoxaline to provide internal calibration, similar to that reported in a recent GC-
MS DPD detection protocol;90 and the second option would utilize the addition of isotope-labeled 
DPD as the internal standard (Figure 1.4).  We were concerned that the use of (13C)DPD-M1CQ 
would not give accurate quantitation due to differential loss of DPD and the quinoxaline during 
sample handling or due to incomplete reaction of the tag with DPD. Both options were explored 
to determine the most 
accurate method. For these 
experiments, the internal 
standard, either (13C)DPD-
M1CQ or (13C)DPD, was 
added at a final 
concentration of 10 µM to 
aliquots of a V. harveyi 
BB120 culture grown for 
~8.5 h in Luria-Marine Medium (LM). The samples were then centrifuged to remove cells, and 
130 equivalents of tag 7 were added. After reaction for 1 h, LC-MS/MS was used to detect both 
the DPD-M1CQ from V. harveyi via SRM 381-202 and the internal standard via SRM 382-203. 
The concentration of DPD in each sample was then determined by taking the ratio of the 
integrated peak intensity for DPD-M1CQ and (13C)DPD-M1CQ (corrected as described below) 
O
O
N
NH313C
(13C)DPD-M1CQ
13CH3
O
O
OH
HO
HO
OH
OCH3
O
OCH3
O(13C)DPD
Figure 1.4. Structures of isotope labeled standards used for 
internal calibration during measurement of DPD concentration. 
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and multiplying by the concentration of added internal standard. For samples utilizing (13C)DPD-
M1CQ as the internal standard, the DPD concentration from V. harveyi was measured to be 5.6 
µM. However, the use of (13C)DPD as an internal standard led to a concentration measurement 
for the biologically derived DPD of 12.3 µM (Table S1.2). This confirmed our suspicion that DPD 
is either lost in the biological matrix during handling or that the tagging reaction does not go to 
completion in complex media. However, the latter explanation seems less plausible due to the 
large excess of derivatizing reagent (> 130 molar equiv tag 7) used in these studies. Based on 
these results, (13C)DPD was chosen as the internal standard for further experimentation.  
 
1.3.4 Selection of appropriate SRMs and error correction for internal standard calibration. 
Selection of the appropriate SRMs for the detection of the (13C)DPD-M1CQ is critical for proper 
quantitation. The fragmentation of the molecule is not significantly affected by the inclusion of 
13C isotopes, but care must be taken to insure that the proper reactions are monitored for the 
internal standard as each reaction has differing efficiencies that could lead to quantitative errors 
if non-analogous reactions are compared. For DPD-M1CQ, the SRMs 381-201, 381-202, 381-
231, and 381-363 were the most sensitive. This leads to 7 SRM options for the detection of 
(13C)DPD-M1CQ. If the 13C-methyl group remains in the fragment, the appropriate SRMs are 
382-202, 382-203, 382-232, and 382-364. However, if the fragment loses the 13C-methyl, the 
corresponding SRMs will be 382-201, 382-202*, and 382-231. The 382-364 SRM will remain 
unchanged as it corresponds to loss of water and cannot lose the 13C -label. Each of the four 
SRMs for DPD-M1CQ and all seven possible SRMs for (13C)DPD-M1CQ were monitored in cell-
free supernatants to which (13C)DPD and tag 7 had been added, and the ratio of intensities for 
sets of DPD-M1CQ and (13C)DPD-M1CQ SRMs were then determined.  For DPD-M1CQ 
measured from cultures of WT E. coli, the ratio of intensities was consistently 22:43:47:100 for 
SRMs 381-201:381-202:381-231:381-363, respectively (Figure 1.5A). If the 13C -label is 
retained in all fragmentation events for (13C)DPD-M1CQ, then the ratio of the SRM intensities 
for 382-202:382-203:382-232:382-364 should be the same as those measured for the 
corresponding SRMs of DPD-M1CQ (Figure 1.5B). However, if one or more of the fragments 
lose the 13C -methyl group, then an altered ratio of SRM intensities would be observed (Figure 
1.5D-F). Confirmation of the presence of the 13C-label in the fragments was most critical for 
SRMs 382-203 and 382-202, which retain the 13C -methyl, and 382-202* and 382-201, which 
lose the 13C-methyl, as the observation of signal for event 382-202 could be attributed to either 
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of two fragmentation reactions. The measurement of the SRM intensity ratios for (13C)DPD-
M1CQ from luxS- E. coli supernatants was 22:43:41:100 for SRMs 382-202:382-203:382-
232:382-364, respectively (Figure 1.5C). This is nearly identical to the ratio measured for 
analogous SRMs of DPD-M1CQ. These data indicate that the methyl group is retained during 
the monitored fragmentation events. 
  
Of the two widely utilized chemical syntheses of DPD,91,111 only one allows for the efficient 
incorporation of an isotopic label into the molecule. This route relies on the methylation of a 
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Figure 1.5. Ratios of SRM intensities for DPD-M1CQ and (13C)DPD-M1CQ. The intensity of 
either SRM 381-363 or 382-364 was normalized to 100% for each sample, and the signal for 
the other SRMs are reported as a percent of the relative intensity of that peak.   (A) 
Measured ratio of the intensities for the most sensitive SRMs used for DPD-M1CQ 
concentration determination. (B) Expected ratio of intensities for the SRMs needed to detect 
(13C)DPD-M1CQ if the 13C-methyl remains in the fragment.  (C) Measured ratio of the SRM 
intensities found during (13C)DPD-M1CQ concentration determination. (D) Expected ratio of 
intensities for (13C)DPD-M1CQ SRMs if fragment 202 has lost the 13C-label. (E) Expected 
ratio of intensities for (13C)DPD-M1CQ SRMs if fragment 203 has lost the 13C-label. (F) 
Expected ratio of intensities for (13C)DPD-M1CQ SRMs if both fragment 202 and 203 have 
lost the 13C-label. 
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terminal alkyne with 13CH3I to incorporate the labeled-C1 methyl of DPD (Scheme 1.2).91 
Unfortunately, this synthesis does not facilitate the incorporation of further 13C or D at non-
exchangeable positions. 
The inclusion of only one 
isotopic label in the internal 
standard introduces 
undesirable, although easily 
managed, complications 
during analysis. Specifically, 
two quantitative artifacts are 
noted, the first resulting 
from overlap of the M+1 
isotope peak of DPD-M1CQ with the molecular ion peak of (13C)DPD-M1CQ and the second 
from unavoidable contamination of (13C)DPD with ~1% unlabeled material resulting from 12C 
isotopic impurities in the 13CH3I. The use of SRM techniques diminishes the observed signal 
from naturally occurring isotopes of DPD-M1CQ as the heavy atom must be contained in both 
the parent and the product ion for signal to be observed. By analyzing samples of DPD-M1CQ 
in water, the intensity of the [M+1+H]+ peak for this molecule was measured to be 14.4% that of 
the [M+H]+ peak in SRM 381-202 (Table S1.3A). Each of these artifacts becomes more or less 
significant at differing ratios of (13C)DPD-M1CQ to DPD-M1CQ (See Table S1.4 for further 
details). The error introduced into the measurement from naturally occurring isotopes of DPD-
M1CQ is most significant when the endogenous DPD concentration is a 30% or higher that of 
the (13C)DPD internal standard. For measurements in which this was the case, 14.4% of the 
signal seen for DPD-M1CQ was subtracted from the observed signal for (13C)DPD-M1CQ. The 
error from 12C impurity in the (13C)DPD is most significant when the concentration of the internal 
standard is greater than or equal to ten times that of the endogenous DPD. For analyses in 
which this occurred, 0.8% of the signal observed for (13C)DPD-M1CQ was subtracted from that 
measured for DPD-M1CQ, as this was the average percentage of unlabeled contaminate 
measured in the internal standard used for these experiments (Table S1.3B). For analyses 
containing observed peak ratios for DPD-M1CQ and (13C)DPD-M1CQ between 20:100 and 
30:100, corrections were not needed as the two sources of error nearly cancel in these cases. 
 
O
O
O
O
CH3
CH3
O
O
OH
HO
i ii, iii
Scheme 1.2. Chemical synthesis of DPD. Reagents 
and conditions (i) nBuLi, THF, -78 °C, 30 min, then 
CH3I, -78 °C to r.t., 4 h; (ii) NaIO4, RuO2, CCl4, MeCN, 
H2O, 15 min; (iii) H2SO4, H2O, 3 h. 
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1.3.5 Detection and quantitation of DPD from biological sources. To validate our AI-2 
detection method in vivo, the DPD concentration was measured in cell free supernatants for 
both WT and luxS- strains of two species, E. coli and V. harveyi. These species were chosen as 
the relative levels of DPD produced during growth has been studied for both via several 
methods.86,88-90,112-113 Two aliquots from each of an E. coli BW25113 (wild type, WT) and E. coli 
JW2662-1 (luxS- strain) culture grown to stationary phase were diluted 50 fold in fresh LB, and 
samples of the cultures were collected at regular intervals until the cells entered late 
exponential/early stationary phase. A final concentration of 10 µM (13C)DPD was added to each 
aliquot. After centrifugation to remove cells and other particulates had occurred, tag 7 was also 
added to the samples at a final concentration of 1.3 mM. Following 1 h incubation, the samples 
were subjected to LC-MS/MS analysis. This led to facile detection of DPD in the WT E. coli 
supernatants, but not in those from the luxS- strain (Figure 1.6A). The concentration of DPD 
peaked at 3.5 h, and the molecule was then quickly consumed over the course of an hour as 
Figure 1.6. Production of DPD in relation to cell growth during the exponential growth phase. (A) 
Autoinducer production by E. coli. (B) Autoinducer production by V. harveyi. Measurement of the 
[DPD] for each WT species was performed in duplicate and the average data are reported. Although 
experiments for the luxS- strains were performed in duplicate, DPD concentration measurement for 
every time point was only performed once. For select time points, measurement was conducted in 
duplicate to confirm that no DPD was detected in the luxS-- strains. The average OD600 for all four 
cultures, two WT and two luxS-, was used as no growth differences were observed between the 
strains. Error bars in the graphs indicate the range of the data. 
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expected. Further, the maximum DPD concetration was measured to be 20.6 ±0.1 µM. 
Measurement of the DPD concentration in supernatants harvested from V. harveyi proceeded 
analogously to those described for E. coli, except that Luria Marine medium (LM) was used. In 
V. harveyi BB120 (WT) the maximum DPD concentration of 22.4 ±0.6 µM was reached at 6.5 h, 
before slowly decreasing and then beginning to level. Again, no signal was observed in the 
supernatants of the luxS- strain, V. harveyi MM30 (Figure 1.6B). To determine the reproducibility 
of these results, the V. harveyi experiments were performed on a separate day, and the 
maximum DPD concentration in the WT strain was determined to be 22.1 ±1.6 µM. Further, the 
intra- and inter-day variability among the cultures was greater than the error seen during 
multiple analyses of a single sample (Table S1.5). 
  
After the successful detection and quantitation of the DPD concentrations from cultures of both 
E. coli and V. harveyi, we sought to apply this technology to the measurement of DPD in a 
Table 1.1. Quantitation of the DPD Concentration in Saliva Collected from Eight Volunteers.  
Volunteer 
Observed 
Signal for 
DPD-M1CQ 
(ion counts) 
Observed 
Signal for 
(13C)DPD-M1CQ 
(ion counts) 
Corrected 
Signal for 
(13C)DPD-M1CQ 
(ion counts) 
DPD 
Concentration 
(nM) 
Average 
DPD 
Concentration 
(nM) 
1 Injection 1 9.32 x10
4
 2.37 x105 2.23 x105 417 406 Injection 2 1.50 x105 4.02 x105 3.81 x105 395 
2 Injection 1 1.12 x10
5
 2.51 x105 2.35 x105 477 474 Injection 2 1.58 x105 3.59 x105 3.36 x105 471 
3 Injection 1 2.08 x10
4
 5.40 x104 5.10 x104 407 426 Injection 2 6.72 x104 1.61 x105 1.51 x105 444 
4 Injection 1 1.32 x10
5
 2.97 x105 2.78 x105 473 464 Injection 2 1.63 x105 3.83 x105 3.60 x105 454 
5 Injection 1 1.66 x10
4
 4.42 x104 4.18 x104 398 400 Injection 2 1.15 x105 3.01 x105 2.85 x105 403 
6 Injection 1 3.27 x10
5
 4.46 x105 3.99 x105 819 832 Injection 2 2.68 x105 3.55 x105 3.17 x105 845 
7 Injection 1 1.11 x10
5
 4.35 x105 
 
256 244 Injection 2 7.09 x104 3.06 x105 
 
232 
8 Injection 1 3.41 x10
5
 3.98 x105 3.49 x105 977 965 Injection 2 4.09 x105 4.89 x105 4.30 x105 952 
     
Average 526 
Except for volunteer 7, data for all samples were corrected using the following calculation: 
(13C)DPD-M1CQ Signal = Obs. (13C)DPD-M1CQ Signal – 0.144 x Obs. DPD-M1CQ Signal 
For a discussion of data correction see the Section 1.3.4, Figure 1.5, and Tables S1.3 and S1.4.  
21 
 
complex, clinically relevant medium. Human saliva was chosen as measurement of DPD in 
bacterial model systems mimicking the oral cavity has been performed via the V. harveyi 
bioluminescence assay.16 Saliva from eight volunteers was collected in a specimen cup and 
then immediately spiked with 1 µM (13C)DPD. After centrifugation to remove any particulates, an  
aliquot of the supernatant was taken, and tag 7 was added to a concentration of 1.3 mM. The 
LC-MS/MS analysis was then performed in duplicate for each sample after the reaction with 
DPD had been allowed to proceed for 1 h. In all cases, DPD was detected, and the average 
DPD concentration was measured to be 526 nM with values ranging from 244 - 965 nM (Table 
1.1). It was also noted that the concentration in two of the samples was considerably higher 
than for the others, although the exact cause of this is as of yet undetermined. Indeed, this 
concentration is within two fold of that observed for studies of S. oralis 34 and A. naeslundii 
T14V cultured in 25% saliva.87  
 
1.3.6 Deuterated acylhomoserine lactone design parameters. The design rationale for the 
internal standards reported herein stems from a desire to place the isotope label in a conserved 
position of the homoserine core of the AHLs, which would then allow the construction of a 
common intermediate from which all internal standards could be synthesized. The use of robust 
solid phase methods for the AHL syntheses were also envisioned as they can provide the 
desired products without the need for purification. Further, incorporation of at least two stable 
isotope labels would allow the internal standard to be distinguished from the naturally occurring 
M+1 13C isotopes of the naturally 
produced autoinducers during MS 
analysis. All AHLs can undergo two 
characteristic collisionally activated 
fragmentation reactions (Scheme 1.3).67 
In one reaction the protonated amide 
bond is broken to generate an oxonium 
ion derived from the acyl portion with 
neutral loss of homoserine lactone. For 
the other fragmentation reaction, the 
protonated homoserine lactone core is liberated from the AHL with the neutral loss of the acyl 
portion as a ketene. Both fragmentation reactions are sufficient for SRM detection of AHLs, and 
O
O
N
H2
O
O
O
NH2
O
R RCID
CID O
O
NH3
CO R
Scheme 1.3. Collisionally-induced 
fragmentation of AHLs. 
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we have found that the fragmentation reaction generating the protonated homoserine lactone is 
more sensitive for detection of these molecules. Because of this reliable fragmentation, 
conserved placement of the isotope label on the homoserine lactone moiety of the AHL 
standards is desirable as it facilitates the choice of a predictable fragment for SRM detection of 
any AHL regardless of acyl chain composition. Further, the incorporation of the label into the 
core facilitates the synthesis of a large number of labeled AHLs as it proceeds through a 
common intermediate. Previous work has relied primarily on mass differentiating the acyl chain 
by addition of an isotope67 or as by using the AHL with a seven-carbon chain length (C7) as it is 
not thought to be biologically relevant.68 Recently, a molecule containing a tetradeuterated AHL 
core has been reported114 by first synthesizing the labeled homoserine lactone core and then by 
coupling the acyl chain via solution phase amide bond formation. However, this method did not 
take advantage of solid-phase synthesis and therefore required column chromatography or 
recrystallization to purify the synthetic intermediates as well as the AHL products. A synthesis of 
a side-chain deuterated AHL employing solid supported coupling reagents has also been 
reported,67 but this route is not amenable to late stage structural diversification. While the 
solution phase synthesis of AHLs provides access to these molecules, our synthesis takes 
advantage of an elegant 
biomimetic synthesis of AHLs 
that has been reported by the 
Ko laboratory115 and optimized 
by Blackwell and coworkers.101 
This route relies on the 
concerted cleavage from a 
solid support and cyclization of 
an acylated methionine to the 
desired acylhomoserine lactone (Scheme 1.4). In light of this work, we rationalized that N-Fmoc-
(4,4-2H2)methionine, 14, could serve as a common synthetic intermediate which would then 
allow the incorporation of the isotope label into the homoserine lactone core that is shared by all 
AHLs.   
 
1.3.7 Synthesis of N-acyl-(4,4-2H2)homoserine lactones. Synthesis of the common 
intermediate 14 began from the known protected aspartic acid derivative, 9. This molecule is 
commercially available, although its synthesis can also be accomplished by the efficient route 
NH
HN
O
R
O
O
NH
S
R
CN
CH3
NH
N
H
O
R
+H2O
NH3
-H3CSCN -
Scheme 1.4. Biomimetic generation of AHLs via solid 
phase synthesis 
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developed by Merrified and coworkers.116 The protecting groups were chosen to be able to 
survive the basic conditions used in many of the subsequent reactions, and the steric bulk 
presented by the tBu ester was critical for maximizing the yield in the conversion of 9 to 10 in 
which reaction at the α-carbonyl is also possible. With 9 in hand, dideuterated homoserine 
derivative, 10, was prepared in 84% yield via conversion of the γ-carboxylic acid to an acyl ethyl 
carbonate with ethyl chloroformate and subsequent reduction with NaBD4 in D2O.117 Mesylation 
of the resulting primary alcohol followed by displacement with NaSCH3 gave N-Boc-(4,4-
2H2)methionine-OtBu, 12, in 87% yield and 81% purity, and this material was used directly in the 
subsequent reaction without further purification. Despite efforts to preserve the stereochemistry 
of the starting amino acid, the reduction and/or thiol substitution reaction consistently racemized 
the material. However, the use of enantiomeric or diastereomeric mixtures of the AHLs was not 
problematic during LC-MS/MS analyses since the stereoisomers did not separate. Global 
deprotection of 12 with trifluoroacetic acid (TFA) afforded (4,4-2H2)methionine, 13, as the TFA 
salt in quantitative conversion,  and this material could then be reprotected with a N-t-
Fluorenylmethyloxycarbonyl (Fmoc) group (Scheme 1.5) to generate 14 in 95% yield and 91% 
Scheme 1.5. Synthesis of (D2)AHLs. Detailed procedures for the isolation and purification of these 
compounds are outlined in the experimental section and may include common reagents not listed in 
the scheme. 
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purity after only an extraction. This material could be further purified via recrystallization (77% 
recovery); however, coupling semi-crude 14 directly to the aminopolystyrene resin did not 
compromise the efficiency of subsequent steps in the reaction sequence or the purity of the final 
products. Presumably, this is due to an inability of the impurities in 14 to couple or to be cleaved 
from the solid support.  
 
The generation of solid supported aminomethyl-(4,4-2H2)methionine, 15, was accomplished 
using standard peptide coupling conditions, followed directly by removal of the Fmoc protection 
with 25% piperidine in DMF. The resulting amines were then coupled with suitable acyl donors 
using DIC, HOBt, and 
DIPEA in DMF to generate 
the penultimate 
intermediate in the AHL 
syntheses. If a carbonyl 
was present at the 3 
position in the acyl chain, 
this functionality was 
protected as an ethylene 
glycol acetal, while acyl 
groups containing a 
hydroxyl in the 3 position 
needed no protection. 
Treatment of the solid 
supported acyl methionines 
with CNBr in CHCl3 and 
aqueous TFA for 24 h 
initiated cyclization of the 
homoserine lactone ring 
and simultaneously 
accomplished the cleavage of the desired product from the resin (Scheme 1.5). For syntheses 
employing acetal protection, the acidic cyclization and cleavage conditions were sufficient to 
hydrolyze the protecting group as well. For all reactions, the material was obtained analytically 
pure after removal from the solid support. Using this methodology, 8 novel dideuterated AHLs 
Table 1.2. Structures, abbreviations, and SRMs for AHLs  
Structure  Abbreviation  
SRM  
Parent–
Fragment 
(m/z–m/z)  
 
C4  
(D2)C4  
172–102 
174–104 
 
3OHC4  
(D2)3OHC4  
188–102 
190–104 
 
C6  
(D2)C6  
200–102 
202–104 
 
3OC6  
(D2)3OC6  
214–102 
216–104 
 
C7  
(D2)C7  
214–102 
216–104 
 
C8  
(D2)C8  
228–102 
230- 04 
 
C12  
(D2)C12  
284–102 
286–104 
 
C14  
(D2)C14  
312–102 
314–104 
(D) indicates a position occupied either by a proton or deuterium 
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(Table 1.2) were generated in >95% purity and variable yields of up to ~50% from ~100 mg 
(4,4-2H2)methionine resin 15. Yield increased with hydrophobicity of the acyl chain, suggesting 
that partitioning of material into the discarded aqueous phases during the final extraction caused 
material loss. While recovery of the AHLs could have been improved with larger initial reaction  
masses or  use of microwave assisted reactions in the final step,101 this work focused on 
replicating small scale reaction and cleavage conditions that could be replicated by researchers 
in laboratories that without advanced synthetic capabilities. Further, avoidance of preparative 
chromatography during the generation of high purity material was more important than quantity 
for this study, and it should be noted that ~1 mg of (D2)AHL is sufficient to generate ~20-25 L of 
a 200 nM solution.  
 
1.3.8 Separation, detection, and quantitation of isotope labeled AHLs via isotope dilution 
LC-MS/MS. With suitable stable-isotope labeled internal standards in hand, we turned our 
attention to developing a robust method for LC-MS/MS detection of these compounds. Typical 
methods for detecting AHLs by LC-MS or LC-MS/MS range from 33 to 50 min,67-70 although two 
shorter methods have been reported.29,71 However, these latter methods use high flow rates,29 
high column temperatures or employ an atypical additive, ethylenediaminetetraacetic acid 
(EDTA),71 in the mobile phase; and these conditions are not readily compatible with common 
LCs and/or MSs. EDTA is most likely used to facilitate detection of the longer chain AHLs, which 
are known to form dimers or aggregates118 that hinder detection. To obtain the throughput 
necessary to facilitate parallel biological studies, we sought to develop as short a method as 
possible that did not need atypical additives, high flow rates, or increased column temperatures 
to achieve separation of a broad spectrum of AHLs.  
 
To help minimize the chromatographic run time, a high-efficiency Kinetex core-shell C18 column 
(Phenomenex) was used in these studies. The (D2)AHLs used were chosen because they 
contain acyl chains that are representative of those most prevalent natural AHLs,102 and since 
they would allow separation parameters for molecules with differing chemical properties to be 
developed. The retention time for 8 stable-isotope labeled AHLs were determined, and a shift in 
chemical behavior occurred between the short and long chain AHLs once 6-7 carbons were 
incorporated into the side chain. Specifically, retention times for the AHLs increased 
dramatically (~1-2 min/methylene unit) with the number of carbons in the acyl chain if acidic 
water is replaced with acidic ACN at a rate of 3.6% over 25 min (Gradient 1, Figure 1.7A).  
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The long run time necessary due to the differential retention between the short and long chain 
AHLs was avoided by using a more complex, step gradient (Gradient 2) that rapidly switched 
solvent polarity once the shorter chain AHLs were nearly eluted from the column (Figure 1.7B). 
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Figure 1.7. (A) and (B) Solvent gradient profiles for (A) Gradient 1 and (B) Gradient 2 ( 0.1% AcOH 
in H2O  0.1% AcOH in ACN) (C)–(E) Separation and detection of AHLs. (C) Selected ion 
chromatograms for the dideuterated AHLs showing separation in both the time and mass domain 
injected at a concentration of 200 nM in H2O. Note: The intensity for (D2)3OHC4 is divided by 2 and 
the intensity intensities for (D2)C12 and (D2)C14 are multiplied by 5. (D) Selected ion chromatograms 
for the dideuterated AHLs showing separation in both the time and mass domain injected at a 
concentration of 6.2 µM in H2O. Note: The intensities for (D2)C12 and (D2)C14 are multiplied by 10.  
(E) Detection of AHLs from V. fischeri MJ1 grown in LM. Note: Brackets indicate that a mixture of 
deuterated and non-deuterated AHLs are present in solution 
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This gradient was developed after noting that rapid changes in the gradient hindered 
chromatographic resolution of AHLs with similar chemical properties and that the AHLs were 
split into two sets of compounds based on hydrophobicity. From the data collected using 
Gradient 1, it was observed that the more hydrophilic AHLs eluted within the first 4 min, while 
the more hydrophobic compounds did not begin to elute until 12 min (Figure 1.7C). The 
implementation Gradient 2 allowed the two groups of compounds to be separated during two 
time regimes where the ratio of solvents did not change rapidly while avoiding a waste of 
instrument time by quickly switching between them. The final 5 min of the gradient are critical to 
re-equilibrate the column, and longer chain AHLs may also elute during this period. This LC-
MS/MS method is 12.5 min and can sufficiently resolve AHLs with side chains ranging from 4 to 
14 carbons and with varying chemical functionality (Figure 1.7D and E, Figure S1.7). Most 
importantly, for compounds with the same mass but different side chain composition, i.e. 
(D2)3OC6 and (D2)C7, excellent chromatographic separation was observed  (Figure 1.7D). This 
is important as MS/MS would not be able to differentiate these compounds since the fragments 
would also have identical masses. Further, it is expected that these methods will be amenable 
to separating other 3O and 3OH AHLs, as earlier methods have shown that the retention times 
for a series of these molecules increases with the number of methylene units in the acyl tail in a 
manner similar to that for the unoxidized 
AHLs.68-69  
 
The use of 0.1% acetic acid (AcOH) in both 
mobile phases enhanced detection for all 
AHLs, and this effect was most evident for 
those containing longer acyl chains (Table 
1.3). Presumably, this occurs due to 
disruption of aggregation as was observed 
with EDTA in previous methods.71  While 
the peak area and height decreased by 
~20-25% if AcOH was not included in 
organic mobile phase, the LOD of ~2-6 nM 
and retention time for the shorter chain AHLs remained nearly constant (e.g. see (D2)C6 Figure 
1.8). However, all analytical metrics except retention time changed dramatically for the long 
chain AHLs, as can be seen by the increase in peak area (~5-fold) and peak height (~4-fold) 
Table 1.3.  pH effects on the limits of detection 
(D2)AHL  Neutral ACN  Acidic ACN  
(D2)C4  6.23 nM  6.23 nM 
(D2)3OHC4  6.23 nM 6.23 nM 
(D2)C6  6.23 nM 1.97 nM 
(D2)3OC6  6.23 nM 1.97 nM 
(D2)C7  6.23 nM 1.97 nM  
(D2)C8  6.23 nM 1.97 nM 
(D2)C12  19.6 nM 1.97 nM 
(D2)C14  196 nM 1.97 nM  
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and the enhanced LOD (~100-fold) for 
(D2)C14 analyzed under conditions 
that only varied by the addition of 
AcOH to the ACN mobile phase (See 
(D2)C14 Figure 1.8). 
 
Once suitable methods for the 
resolution of the AHLs were 
determined, we sought to measure the 
LOD for these compounds in water 
(Table 1.4). The LODs for all AHLs 
were in the low nM range, and the 
signal to noise ratio (S/N) for each 
was >3/1 at 2 nM except for the 
(D2)C4, (D2)3OHC4, and (D2)C7 which 
had a S/N >3/1 at 6 nM. Further, the 
S/N was sufficient at 6 nM (>5/1) to 
allow quantitation of all AHLs used in 
this study, even though signal intensity 
dropped dramatically once the side 
chain became longer than 8 carbons. It should be noted that the peak area for the (D2)AHLs 
varied by ~10-fold for injections at 196 nM, which indicates that the use of a single internal 
standard is not suitable for the exact quantitation of multiple AHLs with different acyl chains 
(Table 1.4). Although linearity in the response is not a necessity for quantitation employing 
internal standards, we also determined that the signal intensity was linear with respect to 
concentration from 2 nM to 6 µM (Figure S1.8). These data demonstrate that the separation and 
detection method reported here can be used for relative quantitation of AHLs even if isotope-
labeled internal standards are not employed. 
 
While the use of water as the solvent for the AHLs adequately approximates laboratory 
conditions that employ minimal media, we also sought to determine the detection metrics using 
media that more appropriately represent conditions found in the natural environment of AHL-
producing bacteria, such as Vibrio fischeri. To this end, we determined the LODs for the  
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Figure 1.8. Comparison of detection metrics in H+ 
and neutral conditions for (D2)C6 and (D2)C14. 
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 (D2)AHLs in a pair of high-salt, rich medias LM119 and SWTO120 that were formulated to mimic 
conditions found in the marine environment. For AHLs injected in LM, the LODs for most were 
10-fold higher than for the corresponding water injections, while the LODs of the most 
hydrophilic molecule (D2)3OHC4 and the most hydrophobic molecule (D2)C14 were 100- and 
30-fold higher, respectively. Further, the detection metrics for all molecules in the higher salt 
media, SWTO, were generally worse by ~3-fold than those in LM (Figures S1.9 and S1.10 and 
Tables S1.6 and S1.7). While LODs in the 20-200 nM range may be sufficient to detect AHLs 
from some species such as Vibrio fischeri MJ196 or Vibrio harveyi,121 they are not suitable for 
detection of AHLs from all strains of bacteria, e.g V. fischeri ES114 that only produces 0.2 nM 
3OC6.95 Because of this, extraction of the (D2)AHLs from both LM and SWTO with acidic EtOAc 
was studied. In most cases, extraction only led to a modest 3 to 10-fold improvement in the 
LODs in either media, and for AHLs of intermediate chain length, e.g. (D2)C7 and (D2)C8, the 
LODs slightly increased. However, the acidic EtOAc extracts led to higher signal for the majority 
of the AHLs when compared to injections of these molecules in unextracted media (Figures 
S1.9 and S1.10 and Tables S1.6 and S1.7). These data indicate that extraction followed by 
concentration would be a suitable technique for the detection and quantitation of low abundance 
AHLs, although this strategy was not employed in the experiments discussed below.     
 
Next the precision of the method was investigated by using the isotope-dilution technique to 
measure the concentration C8 produced from V. fischeri  MJ1 grown in LM for 8.75 h at 22 ºC 
(OD600 = 1.64). This experiment also provided an opportunity to determine the optimal point 
Table 1.4. Detection metrics for all (D2)AHLs in H2O  
 
(D2)C4 (D2)3OHC4 (D2)C6 (D2)3OC6 (D2)C7 (D2)C8 (D2)C12 (D2)C14 
LOD  6.23 
nM 6.23 nM 
1.97 
nM 1.97 nM 
1.97 
nM 
1.97 
nM 1.97 nM 1.97 nM 
LOQ  6.23 
nM 6.23 nM 
6.23 
nM 6.23 nM 
6.23 
nM 
1.97 
nM 6.23 nM 6.23 nM 
Peak 
Heighta  
4.7 
x104 6.4 x10
4
 
5.5 
x104 5.9 x10
4
 
7.3 
x104 
1.1 
x105 8.1 x10
3
 1.1 x104 
Peak 
Areaa  
3.4 
x105 5.1 x10
5
 
4.7 
x105 5.1 x10
5
 
5.1 
x105 
6.2 
x105 4.0 x10
4
 5.9 x104 
 
aPeak Height and Area were measured in arbitrary ion counts at a concentration of 196 nM.  
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during sampling to add the internal standard as partitioning of the molecules into the cells or the 
cell pellet during centrifugation may be of concern (see below), and direct addition of (D2)C8 to 
an aliquot of the culture containing cells (Method 1) was compared to addition of this molecule 
to the cell-free supernatants after removal of the bacterial cells (Method 2). For Method 1, three 
aliquots of a single culture were taken, and (D2)C8 was added to final concentration of 200 nM. 
After removal of cells, each of these replicates was analyzed in triplicate, and the endogenous 
C8 concentration was measured to 590 ±43, 
627 ±37, and 562 ±31 nM for replicate 
samples 1-3, respectively. If the concentration 
of 566 ±61 nM obtained by averaging all nine 
measurements, i.e. the group average, is used 
as the benchmark, then the % error in the 
average for the triplicate injections of any one 
sampling is less than 11%. Using Method 2, 
(D2)C8 was added to three aliquots of cell free 
supernatants to a final concentration of 200 
nM, and the C8 concentration was measured 
at 612 ±50, 566 ±22, and 572 ±44 nM for 
sampling replicates 1-3, respectively, with an 
overall average of 583 ±41 nM. The precision 
of these measurements was higher than for 
those that added the internal standards to the 
cell suspensions, and the % error with respect 
to the group average was ≤5% for each 
replicate (Figure 1.9 ). The MS variability 
contributed from measurement of the ratio of 
isotopologues was determined to be equal to 
that of other factors in the sampling. For example, the three injections of replicate 1 using 
Method 1 had 9.7, 6.0, and 3.7 % error when compared to the average of the three injections, 
and the variability in all replicates from experiments using both Methods 1 and Method 2 was 
comparable. 
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Figure 1.9. C8 concentration in MJ1 
measured by adding (D2)C8 to cells 
(Method 1, red circles) or supernatants 
(Method 2, blue triangles) from triplicate 
injections of three sampling replicates 
(Rep 1–Rep 3). The dotted line displays 
the average C8 concentration 
determined from all measurements using 
Method 1 and the solid line represents 
the average from all replicates using by 
Method 2. Note: Some symbols are 
overlapping. 
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The accuracy of the technique was then probed by adding synthetic C4, 3OC6, and C14 to a 
final concentration of 157 nM for each into a culture of Vibrio fischeri ES114 grown in LM to an 
OD600 of 1.84. This species was chosen since it only produces sub-nM concentrations of 
3OC695 and no C4 or C14. Loss of the endogenous AHLs 
and/or the stable-isotope labeled internal standards 
during removal of the bacterial cells is a source of 
concern. For example, material could diffuse into the 
cytoplasm or be trapped in cell membranes. Passive 
diffusion of material into the cytoplasm is not expected to 
be a major source of error as typical experimental cell 
numbers are in the range of 109 cell/mL, and if an 
average bacterial cell is modeled to be a sphere with a 2 
µm diameter, the total volume of 109 cells is only 4 µL. 
However, partitioning of the lipid-derived AHLs into the 
bacterial membranes is of concern. Because of this, the 
concentration of each added AHL was determined 
separately using both Methods 1 and 2 for the addition of 
the internal standard as described above. The 
concentration of each AHL was also calculated from 
linear calibration plots generated from the addition 157 
nM C4, 3OC6, and C14 to cell-free supernatants of the V. 
fischeri culture (Figure 1.10). The concentration of added 
C4 was measured to be 161 ±21 and 152 ±21 nM, if 
(D2)C4 was added via Method 1 or 2, respectively. The 
concentration calculated from the external calibration plot 
(Figure 1.11), 167 ±13 nM, was also in good agreement with the expected value, suggesting 
that all three methods are equally accurate for stable, hydrophilic molecules. For 3OC6, addition 
of (D2)3OC6 by either Method 1 or 2 provided acceptable quantitation, and the concentration 
was measured to be 135 ±23 and 146 ±6 nM from these experiments, respectively. For this 
molecule, external calibration was not suitable to determine the concentration, and a value of 
111 ±14 nM was calculated (29% error based on the expected average). It should be noted that 
3OC6 is the least stable of the AHLs used in the study, and the ~10% variation from the 
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Figure 1.10. Accuracy for 
measuring the concentration 
C4, 3OC6, and C14 added 
to ES114 at 157 nM. 
Concentrations of these 
AHLs were determined by 
Methods 1 and 2 (white and 
gray bars, respectively) or 
by external calibration 
(black bars). The horizontal 
black line denotes 157 nM. 
Error bars represent the 
range of data.  
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expected value when using internal standards could be from either measurement error or from 
slight degradation of the analytical standards. The most striking differences in concentrations 
measured via the three methods were observed while determining the concentration of C14. In 
this case, only addition of (D2)C14 by Method 1 provided accurate measurement of the 
concentration (158 ±21 nM). The observation that addition of the internal standard to the cell-
free supernatants (Method 2) led to a 
concentration measurement of only 90 
±3.1 nM indicates that ~50% of the added 
C14 is being lost during removal of the 
cells, either by partitioning into the 
membrane or by some other means. Use 
of an external calibration plot to quantitate 
the concentration of this molecule was 
less successful than either Method 1 or 2, 
and a value of 40 ±1.5 nM was obtained. 
Together, these data indicate that 
addition of the dideuterated AHL 
standards to the sample before removal 
of cells provides the most reliable and 
accurate method for the quantitation of 
AHLs in the supernatants.  
 
As a proof-of-concept for these methods, AHLs were detected directly from the supernatants of 
V. fischeri MJ1. This species was chosen as bioluminescence, which is controlled by 3OC6, has 
been shown to vary based on the environment, e.g. in the laboratory vs. in a symbiotic host,95 
and due to other factors, such as aeration of the culture for MJ1 and/or ES114.96 The latter 
variable can be manipulated by a number of factors including changing the shaking speed of the 
culture or by altering the accessible surface area by switching flask sizes and culture volumes, 
and experiments were designed to measure the concentrations of 3OC6 and C8 from cultures 
of three different volumes (25, 50, and 100 mL) shaken at three different speeds (40, 76, and 
102 rpm). The concentration of 3OC6 from V. fischeri MJ1 grown in SWTO has been previously 
reported to be 2,100 and 7,400 nm from cultures grown to an OD of 1.5 and 2.8, respectively, 
and the C8 concentration at these ODs was 180 and 1,700 nM.96 However, the exact growth 
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Figure 1.11. External Calibration curve 
generated by adding C4 (blue diamonds), 
3OC6 (red squared), and C14 (green triangles) 
to supernatants of Vibrio fischeri ES114. 
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conditions were not given in this report,96 and the method used to determine the concentrations 
relied on 14C incorporation into the AHL during biosynthesis.97 In our hands, V. fischeri MJ1 
cultured in 25 mL SWTO at 22 ºC and shaken at 40 rpm for 14 h after inoculation of an 
overnight culture into fresh medium produced AHLs in concentrations that most closely matched 
the published values, and this species produced 1220 ±100 nM 3OC6 and 217 ±12 nM C8 at an 
OD600 of 1.62 under these conditions as measured via LC-MS/MS using internal standards 
Method 1 and LC Gradient 2 (Table 1.5, entry 1). Further, shaker speed, culture volume, and 
media all had marked effects on both cell density and AHL concentrations (Table 1.5), although 
the variation in the concentrations of the latter was not entirely due to differences in cell 
numbers. For example, the SWTO cultures that were grown using the smallest volume and 
lowest shaker speed, 25 mL and 40 rpm, and those using the largest volume and highest 
shaker speed, 100 mL and 102 rpm, had nearly identical OD600s (1.62 vs. 1.48), while the 
concentrations of 3OC6 and C8 varied by 13 and 3-fold, respectively (Table 1.5, entries 1 and 
5). These data suggest that the variation in V. fischeri luminescence observed under differing 
growth conditions is due in part to varying concentrations of AHLs. Further, an isolated report 
indicates that C6 AHL122 may also be produced by this species, and this molecule was detected 
in these experiments. These data show that the method presented in this paper is suitable for 
the detection of AHLs from biological sources, and further work aimed at detecting and 
quantitating these quorum sensing signals from a variety of sources is underway.  
  
Table 1.5.  AHL concentrations from V. fischeri MJ1 grown in differing conditions.  
Entry  
Culture 
Volume 
(mL)  
Shaker 
Speed 
(rpm)  
Media  
Cell Density  AHL Concentration (nM)  
(OD600)  C6  3OC6  C8  
1  25  40  SWTO  1.62 ± 0.00  33 ± 16  1220 ± 100  217 ± 12  
2  25  76  SWTO  1.93 ± 0.08  42 ± 4.6  278 ± 1.5  813 ± 40  
3  25  102  SWTO  2.58 ± 0.02  65 ± 4.4  1007 ± 35  644 ± 117  
4  50  102  SWTO  1.60 ± 0.01  14 ± 14  110 ± 2.0  704 ± 58  
5  100  102  SWTO  1.48 ± 0.00  14 ± 14  95 ± 4.5  695 ± 62  
6  25  76  LM  4.52 ± 0.08  24 ± 1.6  223 ± 13  250 ± 10  
Entries 1-5 taken at a temp of 22 °C while entry 6 was at 26 °C. The AHL concentration reported is at 
14 hours. Everything was sampled in duplicate and error is the range of data. 
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Figure S1.1. Monitoring the conversion of DPD and 2 to DPD-BAQ in D2O by 1H NMR. 
Extraneous peaks in these spectra arise from cyclohexanone present as a byproduct of DPD 
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(D)
1H NMR spectrum of DPD + 1 eq. 2 added at t = 0 h in D2O (pD = 1.8,
total t = 1 h)
(E)
1H NMR spectrum of DPD + 1 eq. 2 added at t = 0 h and 1 eq. 2 added at t = 1 h in       
D2O (pD = 1.8, total t = 2 h)
(F)
1H NMR spectrum of DPD + 1 eq. 2 added at t = 0 h, 1 eq. 2 added at t = 1 h 
and 1 eq. 2 added at t = 2 h in D2O (pD = 1.8, total t = 2.5  h)
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deprotection. (A) The 1H NMR spectrum of 4.7 mM DPD-BAQ in D2O (pD = 1.8); (B) The 1H 
NMR spectrum of 4.7 mM DPD in D2O (pD = 1.8); (C) The 1H NMR spectrum of 4.7 mM DPD 
and 1 mol eq. 2 in D2O (pD = 1.8, total t = 0 h); (D) The 1H NMR spectrum of 4.7 mM DPD + 1 
mol eq. 2 in D2O (pD = 1.8, total t = 1 h); (E) The 1H NMR spectrum of 4.7 mM DPD + 1 mol eq. 
2 added at t = 0 h and 1 mol eq. 2 added at t = 1 h in D2O (pD = 1.8, total t = 2 h); (F) The 1H 
NMR spectrum of 4.7 mM DPD + 1 mol eq. 2 at t = 0 h, 1 mol eq. 2 at t = 1 h and 1 mol eq. 2 at 
t = 2 h in D2O (pD = 1.8, total t = 2.5 h). 
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Figure S1.2. Monitoring the conversion of DPD and 3 to DPD-EBAQ in D2O by 1H NMR. 
Extraneous peaks in these specta arise from cyclohexanone present as a byproduct of DPD 
deprotection. (A) The 1H NMR spectrum of 4.7 mM DPD-EBAQ in D2O (pD = 1.8); (B) The 1H 
NMR spectrum of 4.7 mM DPD in D2O (pD = 1.8); (C) The 1H NMR spectrum of 4.7 mM DPD + 
1 mol eq. 3 in D2O (pD = 1.8, total t = 0 h); (D) The 1H NMR spectrum of 4.7 mM DPD + 1 mol 
eq. 3 in D2O (pD = 1.8, total t = 1 h); (E) The 1H NMR spectrum of 4.7 mM DPD + 1 mol eq. 3 
added at t = 0 h and 1 mol eq. 2 added at t = 1 h in D2O (pD = 1.8, total t = 2 h). 
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(E) 
1H NMR spectrum of DPD + 1 eq. 3 added at t = 0 h and 1 eq. 3 added at t = 1
h in D2O (pD = 1.8, total t = 2 h)
(D) 
1H NMR spectrum of DPD + 1 eq. 3 added at t = 0 h in D2O (pD = 1.8, 
total t = 1  h)
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Figure S1.3. Monitoring the conversion of DPD and 7 to DPD-M1CQ in D2O by 1H NMR. 
Extraneous peaks in these spectra arise from cyclohexanone present as a byproduct of DPD 
deprotection. (A) The 1H NMR spectrum of 4.7 mM DPD-M1CQ in D2O (pD = 1.8); (B) The 1H 
NMR spectrum of 4.7 mM DPD in D2O (pD = 1.8); (C) The 1H NMR spectrum of 4.7 mM DPD + 
1 mol eq. 7 in D2O (pD = 1.8, total t = 0 h); (D) The 1H NMR spectrum of 4.7 mM DPD + 1 mol 
eq. 7 in D2O (pD = 1.8, total t = 0.5 h); (E) The 1H NMR spectrum of 4.7 mM DPD + 1 mol eq. 7 
added at t = 0 h and 1 mol eq. 7 added at t = 0.5 h in D2O (pD = 1.8, total t = 1 h). 
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(D) 
1H NMR spectrum of DPD + 1 eq. 7 added at t = 0 h in D2O (pD = 1.8, 
total t = 0.5 h)
(E) 
1H NMR spectrum of DPD + 1 eq. 7 added at t = 0 h and 1 eq. 7 added at t = 0.5
h in D2O (pD = 1.8, total t = 1 h)
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Figure S1.4. Calibration curves to determine linearity of DPD-M1CQ signal in water. Each plot 
is linear across the range of measured DPD-M1CQ Concentration ([DPD-M1CQ]), with the 
possible exception of the point corresponding to the measurement at the lowest concentration. 
(A) Plot constructed from signal monitored by SRM 381-201. (B) Plot constructed from signal 
monitored by SRM 381-202. (C) Plot constructed from signal monitored by SRM 381-231. R2 
values were calculated using the data analysis tool pack in Excel and include all data displayed 
on each graph.  
 
Data Used to Construct Calibration Curve for SRM 381-202 
[DPD-M1CQ] 
(µM) 
Intensity 
(Ion Counts) 
Log of 
[DPD-M1CQ] 
Log of 
Intensity 
7.43 x10-5 6.41 x103 -4.13 3.81 
2.35 x10-4 7.84 x103 -3.64 3.89 
7.43 x10-4 2.09 x104 -3.13 4.32 
2.35 x10-3 4.78 x104 -2.64 4.68 
7.43 x10-3 2.20 x105 -2.13 5.34 
2.35 x10-2 7.07 x105 -1.64 5.85 
7.43 x10-2 1.76 x106 -1.13 6.25 
2.35 x10-1 6.60 x106 -0.64 6.82 
7.43 x10-1 1.91 x107 -0.13 7.28 
2.35 4.77 x107 0.36 7.68 
7.43 9.07 x107 0.87 7.96 
2.35 x101 1.57 x108 1.36 8.20 
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Data Used to Construct Calibration Curve for SRM 381-201 
[DPD-M1CQ] 
(µM) 
Intensity 
(Ion Counts) 
Log of 
[DPD-M1CQ] 
Log of 
Intensity 
7.43 x10-5 1.00 x103 -4.13 3.00 
2.35 x10-4 1.54 x103 -3.64 3.19 
7.43 x10-4 4.31 x103 -3.13 3.63 
2.35 x10-3 1.55 x104 -2.64 4.19 
7.43 x10-3 9.36 x104 -2.13 4.97 
2.35 x10-2 3.42 x105 -1.64 5.53 
7.43 x10-2 8.73 x105 -1.13 5.94 
2.35 x10-1 3.27 x106 -0.64 6.51 
7.43 x10-1 9.43 x106 -0.13 6.97 
2.35 2.34 x107 0.36 7.37 
7.43 4.50 x107 0.87 7.65 
2.35 x101 7.82 x107 1.36 7.89 
    
 
Data Used to Construct Calibration Curve for SRM 381-231 
[DPD-M1CQ] 
(µM) 
Intensity 
(Ion Counts) 
Log of 
[DPD-M1CQ] 
Log of 
Intensity 
7.43 x10-5 9.29 x102 -4.13 2.97 
2.35 x10-4 1.82 x103 -3.64 3.26 
7.43 x10-4 9.62 x103 -3.13 3.98 
2.35 x10-3 3.41 x104 -2.64 4.53 
7.43 x10-3 1.90 x105 -2.13 5.28 
2.35 x10-2 6.41 x105 -1.64 5.81 
7.43 x10-2 1.63 x106 -1.13 6.21 
2.35 x10-1 6.14 x106 -0.64 6.79 
7.43 x10-1 1.75 x107 -0.13 7.24 
2.35 4.44 x107 0.36 7.65 
7.43 8.43 x107 0.87 7.93 
2.35 x101 1.47 x108 1.36 8.17 
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Figure S1.5. Chromatograms for DPD-M1CQ in water used to determine LOD. The 
approximate S/N for each is graphically displayed by stacking of double headed bars equal in 
height to the average noise next to a double-headed bar representing the maximum average 
signal. (A) Peak observed by monitoring SRM 381-202 with DPD-M1CQ concentration = 230 
pM. The approximate S/N for this plot is 3:1. (B) Peak observed by monitoring SRM 381-202 
with DPD-M1CQ concentration = 740 pM. The approximate S/N for this plot is 5:1. (C) Peak 
observed by monitoring SRM 381-202 with DPD-M1CQ concentration = 2.3 nM. The 
approximate S/N for this plot is 8:1. Note, the data used to generate these mass 
chromatograms were also used to determine the linear range as outlined in Figure S1.4B. The 
peak areas were determined by manually identifying the beginning of each peak and then 
integrating over 1.5 min. 
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Figure S1.6. Test for unwanted reactivity of tag 7 with media. Chromatograms of LB to which 
1.3 mM tag 7 had been added and allowed to react. (A) Signal of SRM 381-201 and 381-231 
from unwanted reactivity of tag 7 with carbohydrates present in LB after 1 h incubation at room 
temperature. (B) Three replicate samples showing that SRM 381-202 does not have signal 
attributable to unwanted reactivity with LB matrix components after 1 h incubation at room 
temperature. (C) Further incubation for 11 h at 4 °C also does not lead to unwanted reactivity. 
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Figure S1.7.  Total Ion Chromatograms (D2)AHLs generated by Quan Browser from (A) 
Gradient 1 and (B) Gradient 2. 
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Figure S1.8. Linear range and limit of detection for (D2)AHLs 
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Figure S1.9. Linear range and limit of detection for (D2)AHLs in LM (blue diamonds) and 
extracted from LM with H+EtOAc (red open squares). 
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Figure S1.10. Linear range and limit of detection for (D2)AHLs in SWTO (red triangles) and 
extracted from LM with H+EtOAc (blue open circles). 
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1.4.2 Supplemental Tables  
 
Most Sensitive SRMs for Each Quinoxaline 
Quinoxaline Parent Ion (m/z) 
Product Ion 
(m/z) 
Collision Energy  
(V) 
DPD-BAQ 249 
144 35 
173 27 
201 24 
231 17 
DPD-EBAQ 277 
144 36 
173 29 
201 25 
231 17 
DPD-M1CQ 381 
201 36 
202 43 
231 29 
363 17 
DPD-1CQ 353 
175 31 
202 42 
231 30 
335 18 
DPD-2CQ 381 
272 23 
291 31 
291 24 
363 14 
DPD-3CQ 409 
190 49 
219 28 
237 25 
305 20 
 
Table S1.1. Fragment masses and collision energies for the SRMs of each quinoxaline were 
automatically determined on a Thermo Discovery Max triple quadrupole MS using the 
automated compound detection and SRM determination parameters of the Thermo Quantum 
Tune software. Each compound was introduced into the MS at concentrations ranging from 23 
µM - 2.3 mM using direct infusion via a syringe pump at 20 µl/min. The selectivity of the 
technique relies on the proper choice of parent mass ─ fragment mass pairs, and the frequency 
of reactions leading to these transitions are maximized by proper choice of collision energy.  
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(A)  
Measurement of [DPD] using 
10 µM (13C)DPD-M1CQ as Internal Standard 
 
 
Intensity for  
DPD-M1CQ  
(ion counts) 
Intensity for  
(13C)DPD-M1CQ 
(ion counts) 
[DPD] 
(µM) 
Replicate 1 5.08 x105 1.00 x106 5.48 
Replicate 2 2.97 x105 5.71 x105 5.63 
 
(B)  
Measurement of [DPD] using 
10 µM (13C)DPD as Internal Standard 
 
 
Intensity for  
DPD-M1CQ  
(ion counts) 
Intensity for  
(13C)DPD-M1CQ 
(ion counts) 
[DPD] 
(µM) 
Replicate 1 1.30 x106 1.22 x106 12.46 
Replicate 2 9.04 x105 8.74 x105 12.12 
 
 
Table S1.2. Assessment of the utility of (13C)DPD-M1CQ and (13C)DPD as internal standards for 
the quantitation of DPD concentrations in cell-free supernatants. A culture of E. coli was grown 
for 9h in LB, and aliquots (300 µL) were then collected and mixed with either (13C)DPD-M1CQ 
or (13C)DPD (341 µM in 10 µL H2O). After centrifugation to remove cells and other particulates, 
a portion of the supernatants (200 µL) were mixed with a solution of tag 7 (14 µM in 20 µL H2O) 
and incubated 1 h at ambient temperature. (A) Data collected for the measurement of DPD 
concentration ([DPD]) utilizing pre-formed (13C)DPD-M1CQ as the internal calibrant. The 
average measured [DPD] from these experiments was 5.56 ±0.08 µM. (B) Data collected for the 
measurement of [DPD] utilizing pre-formed (13C)DPD as the internal calibrant. The average 
[DPD] measured during these experiments was 12.29 ±0.17 µM. The observation that the [DPD] 
concentration is lower when calculated via comparison with (13C)DPD-M1CQ via comparison 
with (13C)DPD indicates that either the molecule of interest and the internal standard partition 
into the pelleted biomass at different efficiencies or that the reaction to form DPD-M1CQ fails to 
reach completion in media.  
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(A) 
Measurement of the percentage of naturally occurring isotopes for DPD-M1CQ 
Concentration 
DPD-M1CQ (µM) 
Signal for [M+H]+  
SRM 381-201  
(ion counts)  
Signal for [M+1+H]+ 
via SRM 382-202  
(ion counts)  
Percent naturally 
occurring M+1 
isotopes of DPD-
M1CQ  
0.074 1.78 x106 2.59 x105 14.57 
0.235 6.64 x106 9.62 x105 14.48 
0.740 1.93 x107 2.75 x106 14.24 
2.35 4.79 x107 6.76 x106 14.10 
7.40 9.23 x107 1.32 x107 14.35 
23.5 1.61 x108 2.33 x107 14.49 
  
Average 14.37 
(B)    
Measurement of the percentage of 12C contaminate in [13C]DPD-M1CQ 
Data Collected 
from 
Signal from DPD-M1CQ  
SRM 381-201 
(ion counts) 
Signal for [13C]DPD-
M1CQ  
SRM 382-202 
(ion counts) 
% isotopic error 
luxS- E. coli  9. 64 x103 1.16 x106 0.83 
luxS- E. coli 7. 27 x103 1.02 x106 0.72 
luxS- E. coli 7.12 x103 1.02 x106 0.70 
luxS- E. coli 6.26 x103 1.02 x106 0.61 
luxS- E. coli 3.61 x103 4.70 x105 0.77 
luxS- E. coli 1.48 x104 1.58 x106 0.94 
  
Average 0.76 
 
Table S1.3. Measurement of isotopic contaminants. (A) During detection of DPD-M1CQ, some 
signal is seen at the same parent and fragment m/z expected for (13C)DPD-M1CQ. This signal 
is mainly derived from the unavoidable presence of (15N)DPD-M1CQ and (13C)DPD-M1CQ 
resulting from naturally occurring isotopes in both tag 7 and DPD. The intensity for the peak 
observed by SRM 382-203 is routinely measured to be 14.4% that of the intensity seen for the 
molecular ion of DPD-M1CQ as monitored via SRM 381-202. The data used in this table were 
collected from the samples of DPD-M1CQ in water used to determine the LOD for this molecule. 
(B) When (13C)DPD is used as the internal standard, a small DPD concentration is introduced 
into the sample. This is unavoidable since the 13CH3I used to synthesize the isotope labeled 
internal standard contains ~1% 12C contaminant. As the percent contaminant is different for 
each batch of 13CH3I, measurement of the percent unlabeled DPD is measured frequently. 
Usually, this occurs by careful examination of SRM 381-202 and 382-203 during analysis of 
bacterial strains that do not produce DPD as these data are routinely collected. For experiments 
where this is not possible, such as for the measurement of the DPD concentration in saliva, care 
is taken to insure the use of a batch of (13C)DPD for which the percent 12C contaminant has 
been measured. 
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Table S1.4. Isotopes of DPD-M1CQ and (13C)DPD-M1CQ are detected as signal in the SRMs 
used for detection of the other molecule. (A) Naturally occurring isotopes of DPD-M1CQ lead to 
the observation of extra signal in SRM 382-203 used to detect (13C)DPD-M1CQ. The error from 
this is most significant when the DPD concentration is 20% or higher than  that of the internal 
standard. The percent by which this overestimates the signal arising from (13C)DPD is shown in 
(A) Prediction of Error in Measuring (13C)DPD-
M1CQ Arising from Naturally Occurring 
Isotopes of DPD-M1CQ  
(B) Prediction of Error in Measuring DPD-M1CQ 
Arising from 12C contaminants in (13C)DPD-
M1CQ 
Ratio of Observed 
SRM 381-202:382-
203 Intensity 
Actual 
SRM 382-
203 
Intensity 
% Over 
Estimation 
SRM 382-203 
Intensity 
Ratio of Observed 
SRM 381-202 :382-
203Intensity 
Actual 
SRM 381-
202 
Intensity 
% Over 
Estimation 
SRM 381-202 
Intensity 
0.9:100 99.87 0.13 0.9:100 0.10 800.00 
1:100 99.86 0.14 1:100 0.20 400.00 
2:100 99.71 0.29 2:100 1.20 66.67 
3:100 99.57 0.43 3:100 2.20 36.36 
4:100 99.42 0.58 4:100 3.20 25.00 
5:100 99.28 0.73 5:100 4.20 19.05 
6:100 99.14 0.87 6:100 5.20 15.38 
7:100 98.99 1.02 7:100 6.20 12.90 
8:100 98.85 1.17 8:100 7.20 11.11 
9:100 98.70 1.31 9:100 8.20 9.76 
10:100 98.56 1.46 10:100 9.20 8.70 
20:100 97.12 2.97 20:100 19.20 4.17 
30:100 95.68 4.52 30:100 29.20 2.74 
40:100 94.24 6.11 40:100 39.20 2.04 
50:100 92.80 7.76 50:100 49.20 1.63 
60:100 91.36 9.46 60:100 59.20 1.35 
70:100 89.92 11.21 70:100 69.20 1.16 
80:100 88.48 13.02 80:100 79.20 1.01 
90:100 87.04 14.89 90:100 89.20 0.90 
100:100 85.60 16.82 100:100 99.20 0.81 
110:100 84.16 18.82 110:100 109.20 0.73 
120:100 82.72 20.89 120:100 119.20 0.67 
130:100 81.28 23.03 130:100 129.20 0.62 
140:100 79.84 25.25 140:100 139.20 0.57 
150:100 78.40 27.55 150:100 149.20 0.54 
160:100 76.96 29.94 160:100 159.20 0.50 
170:100 75.52 32.42 170:100 169.20 0.47 
180:100 74.08 34.99 180:100 179.20 0.45 
190:100 72.64 37.67 190:100 189.20 0.42 
200:100 71.20 40.45 200:100 199.20 0.40 
210:100 69.76 43.35 210:100 209.20 0.38 
220:100 68.32 46.37 220:100 219.20 0.36 
230:100 66.88 49.52 230:100 229.20 0.35 
240:100 65.44 52.81 240:100 239.20 0.33 
250:100 64.00 56.25 250:100 249.20 0.32 
260:100 62.56 59.85 260:100 259.20 0.31 
270:100 61.12 63.61 270:100 269.20 0.30 
280:100 59.68 67.56 280:100 279.20 0.29 
290:100 58.24 71.70 290:100 289.20 0.28 
300:100 56.80 76.06 300:100 299.20 0.27 
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the table. The bold text indicates relative concentrations of DPD to (13C)DPD for which the data 
were corrected by subtraction of 14.4% of the signal of SRM 381-202 from SRM 382-203. (B) 
The unavoidable presence of ~1% 12C isotope in the (13C)DPD internal standards leads to extra 
intensity in SRM 381-202 used to detect DPD-M1CQ. The error from this is most significant 
when the DPD concentration is lower than that of the internal standard. The percent by which 
this over estimates the actual DPD concentration is shown in the above table, and the bold text 
indicates relative concentrations relative concentrations of DPD to (13C)DPD for which the data 
were corrected by subtraction of 0.8% of the signal of SRM 382-203 from SRM 381-202. 
 
 
 
 
 
Determination of Measurement Variability  
via Triplicate Injections of Two Samples 
 
Sample Source:  
WT V. harveyi  
grown for 8 h in LM 
DPD-M1CQ Intensity, 
SRM 381-202  
(ion counts) 
(13C)DPD-M1CQ Intensity, 
SRM 382-203  
(ion counts) 
[DPD] 
(µM) 
Replicate 1 1.89 x106 1.28 x106 18.71 
Replicate 2 1.06 x106 7.08 x105 19.19 
Replicate 3 5.31 x105 3.65 x105 18.41 
  Average =  18.77 µM Range = 0.78 µM 
  
 
 
    
Sample Source:  
WT V. harveyi  
grown for 12 h in LM 
DPD-M1CQ Intensity, 
SRM 381-202  
(ion counts) 
(13C)DPD-M1CQ Intensity, 
SRM 382-203  
(ion counts) 
[DPD] 
(µM) 
Replicate 1 5.83 x105 8.91 x105 7.23 
Replicate 2 1.91 x105 2.87 x105 7.38 
Replicate 3 1.67 x105 2.59 x105 7.12 
  Average = 18.77 µM Range = 0.78 µM 
 
Table S1.5. Measurement of the error for multiple LC-MS/MS analyses of a single sample. The 
DPD concentration ([DPD]) from two of the time points of an experiment utilizing V. harveyi 
BB120 was determined via three separate injections of the same sample into the LC-MS. The 
average [DPD] for the three injections as well as the range is shown above for both samples. 
From these data, it was determined that the measurement variability in the LC-MS/MS analysis 
was ~4% for measurements in the µM range. 
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(D2)C4 (D2)3OHC4 (D2)C6 (D2)3OC6 (D2)C7 (D2)C8 (D2)C12 (D2)C14 
LM 62.3 
nM 623 nM 
19.7 
nM 19.7 nM 
19.7 
nM 
19.7 
nM 19.7 nM 62.3 nM 
H+ 
EtOAc 
19.7 
nM 197 nM 
1.97 
nM 19.7 nM 
62.3 
nM 
62.3 
nM 19.7 nM 62.3 nM 
Extraction with H+EtOAc from LM  
 
Table S1.6. Detection metrics for all (D2)AHLs in LM 
 
 
 
 
 
(D2)C4 (D2)3OHC4 (D2)C6 (D2)3OC6 (D2)C7 (D2)C8 (D2)C12 (D2)C14 
SWTO 197 
nM 197 nM 
62.3 
nM 62.3 nM 
19.7 
nM 
19.7 
nM 62.3 nM 623 nM 
H+ 
EtOAc 
19.7 
nM 620 nM 
6.23 
nM 19.7 nM 
62.3 
nM 
62.3 
nM 19.7 nM 62.3 nM 
Extraction with H+EtOAc from SWTO 
 
Table S1.7. Detection metrics for all (D2)AHLs in SWTO   
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1.4.3 Methods 
 
1.4.3a Synthesis of DPD Tags 
 
2,3-Diaminobenzoic acid, 2. The known compound 2 was synthesized following a previous 
procedure123 with only a slight modification to the solvent used. A solution of 2-
amino-3-nitro-benzoic acid (0.9609 g, 5.28 mmol) in ethanol (56 mL) was 
hydrogenated in a PARR apparatus using 5% Pd/C (0.7011 g, 6.59 mmol) 
catalyst at 35 bar H2 for 1.5 h. The reaction was then filtered and concentrated 
in vacuo to give 2 as an impure solid which was then redissolved in water (30 
mL) and acidified to pH 2 using concentrated HCl. The resulting mixture was 
filtered through celite, and the filtrate was concentrated in vacuo to give pure 2 as a red solid.  
1H NMR (300 MHz, D2O) δ 7.75 (d, J = 8.1 Hz, 1H), 7.25 (d, J = 7.8 Hz, 1H), 6.68 (t, J = 7.9 Hz, 
1H). 
 
  
0.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.510.0
f1 (ppm)
1H NMR spectrum of 2 in D2O
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Ethyl 2,3-diaminobenzoate, 3. Synthesis of known compound 3 124-125 was performed by the 
modified procedure below. A solution of 2 (0.482 g, 3.17 mmol) and 95% 
ethanol (40 mL) in a pressure vessel was cooled to 0 °C. Thionyl chloride 
(2.4 mL, 32.9 mmol) was then added dropwise. The reaction vessel was 
then sealed, and the reaction was heated with stirring to 100 °C for 24 h. 
At this time, the reaction was cooled to room temperature and extracted 
with dichloromethane (3 x 20 mL). The resulting organic layers were 
combined and dried with MgSO4. Following the removal of the MgSO4, the dried organic layer 
was concentrated in vacuo to give a dark brown/black oil. This oil was then redissolved in 
dichloromethane (10 mL) and added to a pad of silica on a filtration apparatus. After elution of 
impurities with a 7:3 v/v hexanes:ethyl acetate (50 mL), the product is recovered via elution with 
100% ethyl acetate. A yellow band of product is noted during this process. Concentration in 
vacuo yields clean 3 as a yellowish oil. (0.249 g, 1.382 mmol, 43.6%). 1H NMR (300 MHz, D2O) 
δ 7.37 (d, J = 8.1 Hz, 1H), 6.89 (d, J = 7.5 Hz, 1H), 6.57 (t, J = 7.9 Hz, 1H), 4.18 (q, J = 7.1 Hz, 
2H), 1.20 (t, J = 7.1 Hz, 3H). 
 
 
  
0.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.510.0
f1 (ppm)
1H NMR spectrum of 3 in D2O
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Diethyl 2,2'-(1,2-phenylenebis(oxy))diacetate, 8a. Known compound 8a was synthesized via 
slight modification of a previously reported procedure.126 Under inert 
atmosphere, potassium carbonate (25.048 g, 182 mmol) was added 
to a solution of catechol (5.030 g, 45.4 mmol) in dry acetone (100 
mL). Ethyl bromoacetate (9.97 mL, 90 mmol) was then added to the 
suspension, and the mixture was refluxed for 48 h. The excess 
carbonate was removed by filtration, and the filtrate was 
concentrated in vacuo to give a brown oil. This oil was then dissolved in diethyl ether (40 mL). 
The resulting solution was then washed with 5% sodium hydroxide in water (80 mL) and brine (2 
x 80 mL), and the organic layer was dried with MgSO4 and concentrated in vacuo to give 6.222 
g (48.5%) crude 8a as a light brown oil which was used in subsequent reactions without further 
purification. 1H NMR (300 MHz, CDCl3) δ 6.91 (m, 4H), 4.25 (q, J = 7.1 Hz, 4H), 1.28 (t, J = 7.1 
Hz, 6H). 
 
 
  
0.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.510.0
f1 (ppm)
1H NMR spectrum of 8a in CDCl3
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Dimethyl 3,3'-(1,2-phenylenebis(oxy))dipropanoate, 8b. Catechol (10.00 g, 91.00 mmol) was 
placed in a pressure vessel and completely dissolved in methyl 
acrylate (32.70 mL, 363.00 mmol). Sodium methoxide (0.49 g, 9.08 
mmol) was then added to the solution, and shaking was continued 
until all solid was dissolved. The reaction was then sealed, stirred, and 
heated to 100° C for 24 h. Methyl acrylate was removed via distillation 
in vacuo yielding a brown residue which was then dissolved in diethyl 
ether (40 mL). The resulting solution was washed with 5% sodium 
hydroxide in water (40 mL) and brine (2 x 40 mL). The organic layer was then dried with MgSO4 
and concentrated in vacuo to give 8b as and pale white, oily solid (1.21 g, 4.29 mmol, 4.72%). 
mp: 43 °C; 1H NMR (300 MHz, CDCl3) δ 6.93 (s, 4H), 4.27 (t, J = 6.6 Hz, 4H), 3.72 (s, 6H), 2.82 
(t, J = 6.6 Hz, 4H); 13C NMR (75 MHz, CDCl3) δ 171.76, 148.96, 122.27, 115.63, 65.29, 52.06, 
34.73; HRMS-DART (m/z): [M+H]+ calculated for C14H19O6 283.11816; found, 283.11879. 
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Diethyl 4,4'-(1,2-phenylenebis(oxy))dibutanoate, 8c. Known compound 8c was synthesized 
according to a previously reported literature procedure.127 
Briefly, potassium carbonate (25.224 g,  182 mmol) was added 
to a solution of catechol (5.056 g, 45.4 mmol) in dry acetone 
(100 mL) under inert atmosphere. Ethyl 4-bromobutyrate (12.87 
mL, 90 mmol) was then added to the suspension and the 
reaction was refluxed for 48 h. The excess carbonate was 
removed by filtration, and the filtrate was concentrated in vacuo to give a brown oil. This oil was 
then dissolved in diethyl ether (40 mL). After washing with 5% sodium hydroxide in water (80 
mL) and brine (2 x 80 mL), the organic layer was dried with MgSO4 and concentrated in vacuo 
to give 12.169 g (79%) crude 8c as a light brown oil which was used in subsequent reactions 
without further purification. 1H NMR (300 MHz, CDCl3) δ 6.90 (s, 4H), 4.14 (q, J = 7.1 Hz, 4H), 
4.04 (t, J = 6.2 Hz, 4H), 2.54 (t, J = 7.3 Hz, 4H), 2.13 (m, 4H), 1.26 (dd, J = 9.3 Hz, 4.9 Hz, 6H). 
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2,2'-(4,5-dinitro-1,2-phenylene)bis(oxy)diacetic acid, 9a. Concentrated HNO3 (4 mL) was 
added dropwise to a solution of 8a (0.685 g, 2.427 mmol) in sulfuric 
acid (4 mL) at 0 °C. The reaction flask was then sealed, and the 
reaction was stirred at room temperature. After 24 h a precipitate had 
formed, and water (4 mL) was added dropwise to the reaction. The 
reaction was frozen and thawed to facilitate precipitation of a white 
solid which was then collected via filtration and washed with cold 
water (3 x 25 mL) to yield 9a as a white solid (0.488 g, 1.543 mmol, 63.6%). mp: 182 °C; 1H 
NMR (300 MHz, DMSO-d6) δ 7.79 (s, 2H), 4.99 (s, 4H); 13C NMR (75 MHz, DMSO-d6) δ 169.93, 
150.52, 136.39, 110.19, 66.29; HRMS-DART (m/z): [M-H]- calculated for C10H7N2O10 315.01007; 
found, 315.01348. 
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3,3'-(4,5-dinitro-1,2-phenylene)bis(oxy)dipropanoic acid, 9b. Water (198 µL) was added to 
concentrated HNO3 (6.5 mL) and the resulting solution was added 
dropwise to a solution of 8b (0.517 g, 1.831 mmol) in acetic acid (6.5 
mL) at 0 °C. The reaction flask was then sealed and stirred at 50° C 
for 11 h. At this time, water (6.7 mL) was added, and the reaction was 
allowed to stir for 1.5 h. The reaction was then frozen and thawed to 
facilitate precipitation of a yellow solid. This precipitate was collected 
via filtration and washed with cold water (3 x 30 mL) to yield 9b as a 
yellow solid (0.375 g, 1.089 mmol, 59.5%). mp: 155 °C; 1H NMR (300 MHz, DMSO-d6) δ 7.82 (s, 
2H), 4.37 (t, J = 5.9 Hz, 4H), 2.75 (t, J = 5.9 Hz, 4H); 13C NMR (75 MHz, DMSO-d6) δ 172.24, 
151.12, 136.64, 109.86, 66.61, 34.39; HRMS-DART (m/z): [M-H]- calculated for C12H11N2O10 
343.04137; found, 343.03795. 
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4,4'-(4,5-dinitro-1,2-phenylene)bis(oxy)dibutanoic acid, 9c. Water (121 µL) was added to 
concentrated HNO3 (4.0 mL) and the resulting solution was 
added dropwise to a solution of 8c (0.318 g, 0.940 mmol) in 
acetic acid (4.0 mL) at 0 °C. The reaction flask was then sealed 
and stirred at 50° C for 11 h. Water (4.0 mL) was then added, 
and the reaction was stirred for 1.5 h. At this time, the reaction 
was frozen and thawed to facilitate precipitation of a yellow solid. 
This precipitate was collected via filtration and was washed with cold water (3 x 25 mL) to yield 
9c as a yellow solid (0.335 g, 0.900 mmol, 96.0%). mp: 162.3 °C; 1H NMR (300 MHz, DMSO-d6) 
δ 12.50 (s, 2H), 7.83 (s, 2H), 4.36 (t, J = 6.1 Hz, 4H), 2.75 (t, J = 6.1 Hz, 4H); 13C NMR (101 
MHz, DMSO-d6) δ 174.37, 151.65, 136.37, 109.30, 69.41, 30.19, 24.25; HRMS-DART (m/z): [M-
H]- calculated for C14H15N2O10 371.07267; found, 371.07083. 
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2,2'-(4,5-diamino-1,2-phenylene)bis(oxy)diacetic acid ● xHCl, 4. To a solution of tin (II) 
chloride (1.905 g, 8.44 mmol) in concentrated HCl (20 mL) was added 
9a (0.402 g, 1.271 mmol) in one portion. The reaction was then 
heated to 50 °C and stirred in air for 2.5 h. Concentration of the 
reaction in vacuo gave a brown oil that was then coevaporated with 
methanol (3 x 30 mL) to give a brown solid. The resulting solid was 
dissolved in water (50 mL), and hydrogen sulfide was bubbled through 
the solution to precipitate the tin as an insoluble brown sulfide. The mixture was then filtered 
through celite with water (2 x 15 mL), and the filtrate was collected. Further treatment of the 
filtrate with hydrogen sulfide followed by another filtration through celite was performed to insure 
complete removal of tin from the product. Concentration of the solution in vacuo yielded the 
hydrochloride salt, 4, as a purple solid (0.421 g, 1.280 mmol, quantitative yield). mp: 195 °C 
dec; 1H NMR (300 MHz, D2O) δ 6.64 (s, 2H), 4.58 (s, 4H); 13C NMR (101 MHz, D2O) δ 173.03, 
144.56, 122.61, 108.75, 66.43; HRMS-DART (m/z): [M+H]+ calculated for C10H13N2O6 
257.07736; found, 257.07842. 
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3,3'-(4,5-diamino-1,2-phenylene)bis(oxy)dipropanoic acid● xHCl, 5. To a solution of tin (II) 
chloride (83 mg, 0.370 mmol) in concentrated HCl (1 mL) was added 
9b (19.5 mg, 0.057 mmol) in one portion. The reaction mixture was 
then heated to 50 °C and stirred in air for 2.5 h. Concentration of the 
solution in vacuo gave a brown oil that was then coevaporated with 
methanol (3 x 5 mL) to give a brown solid. The resulting solid was 
dissolved in water (30 mL), and hydrogen sulfide was bubbled 
through the solution to precipitate the tin as an insoluble brown 
sulfide. The mixture was then filtered through celite with water (2 x 15 mL), and the filtrate was 
collected. Further treatment of the filtrate with hydrogen sulfide followed by another filtration 
through celite was performed to insure complete removal of the tin from the product. 
Concentration of the solution in vacuo yielded the hydrochloride salt, 5, as a purple solid (10.2 
mg, 0.029 mmol, 50.4%). mp: > 230 °C; 1H NMR (300 MHz, D2O) δ 6.83 (s, 2H), 4.05 (t, J = 5.9 
Hz, 4H), 3.64 (s, partial exchange with solvent), 2.54 (t, J = 7.0 Hz, 4H), 2.05 (s, 4H); 13C NMR 
(101 MHz, CD3OD) δ 171.60, 147.96, 119.80, 110.08, 65.73, 33.66; MS-DART (m/z): [2M + 
Sn]2+ was observed. The molecular ion for 5 was elusive. However, the mass of the 
corresponding Sn compound was found to be 339 m/z. 
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4,4'-(4,5-diamino-1,2-phenylene)bis(oxy)dibutanoic acid ● xHCl, 6. To a solution of tin (II) 
chloride (0.108 g, 0.478 mmol) in concentrated HCl (3 mL) was 
added 9c (0.028 g, 0.072 mmol) in one portion. The reaction was 
then heated to 50 °C and stirred in air for 2.5 h. Concentration of 
the reaction in vacuo gave a brown oil that was then 
coevaporated with methanol (3 x 10 mL) to yield a brown solid. 
The resulting solid was dissolved in water (20 mL), and 
hydrogen sulfide was bubbled through the solution to precipitate the tin as an insoluble brown 
sulfide. The mixture was then filtered through celite with water (2 x 15 mL), and the filtrate was 
collected. Further treatment of the filtrate with hydrogen sulfide followed by another filtration 
through celite was performed to insure complete removal of the tin from the product. 
Concentration of the solution in vacuo yielded the hydrochloride salt, 6, as a purple solid (0.011 
g, 0.030 mmol, 40.8%). mp: > 230 °C; 1H NMR (300 MHz, D2O) δ 6.81 (s, 2H), 4.24 (m, 4H), 
3.68 (s, partial exchange with solvent), 2.76 (m, 4H); 13C NMR (101 MHz, CD3OD) δ 173.92, 
148.37, 119.05, 109.31, 68.84, 29.89, 24.14; HRMS-DART (m/z): [M+H]+ calculated for 
C14H20N2O6 313.13996; found, 313.13888. 
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Dimethyl 2,2'-(4,5-diamino-1,2-phenylene)bis(oxy)diacetate ● xHCl, 7. Under inert 
atmosphere, 4 (75.6 mg, 0.230 mmol) was dissolved in 20 mL dry 
methanol. The resulting solution was cooled to 0 °C, and thionyl 
chloride (0.034 mL, 0.459 mmol) was added dropwise. The 
reaction was allowed to reflux for 1 h and was then concentrated 
in vacuo to yield 7 as a purple solid (76.2 mg, 0.213 mmol, 93%). 
mp: 105 °C; 1H NMR (300 MHz, D2O) δ 6.77 (s, 2H), 4.77 (s, 
partially under solvent), 3.77 (s, 6H), 3.30 (s, 4H); 13C NMR (101 MHz, D2O) δ 171.59, 144.30, 
123.17, 108.88, 66.66, 52.81; HRMS-ESI (m/z): [M+H]+ calculated for C12H17N2O6 285.10866; 
found, 285.10983. 
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1.4.3b Synthesis of (D2)AHLs 
 
N-Boc-(4,4-2H2)homoserine-α-OtBu ester, 10. To a stirring solution of N-Boc-Asp-α-OtBu, 9, 
(5.64 g, 19.49 mmol) in 50 mL dry THF at -5 °C was added triethylamine (1.973 g, 2.74 mL, 
19.49 mmol). Ethyl chloroformate (2.116 g, 1.872 mL, 19.49 mmol) in 10 mL anhydrous THF 
was then added to the solution via canula, and the reaction was allowed to continue at this 
temperature. A precipitate formed during the course of the reaction. After 45 min, this material 
was removed via filtration, washed with 10 mL of anhydrous THF, and the resulting filtrate was 
added dropwise over 30 min to a stirred solution of sodium borodeuteride (1.632 g, 39.00 mmol) 
in 15 mL D2O at 10-12 °C. The cooling bath was then removed, and the reaction was allowed to 
warm to room temperature and stir for an additional 4 h. At this time, the solution was acidified 
to pH 2 with 1M HCl and extracted with diethyl ether (3 X 80 mL). The combined organic layers 
were then dried with MgSO4 and collected via filtration. The resulting solution was concentrated 
in vacuo to give a yellow oil which was purified via silica chromatography eluted with 7:3 
hexanes:EtOAc. The product 10 (4.27 g, 15.40 mmol) was isolated as a clear oil in 84% yield.  
 
Rf = 0.49 (1:1 hexanes:EtOAc); IR (neat) 3380, 2978, 2098, 1713, 1510, 1366, 1247, 1161 cm-1; 
1H NMR (300 MHz, CDCl3) δ 5.35 (d, J = 7.5 Hz, 1H), 4.42 – 4.23 (m, 1H), 3.46 (s, 1H), 2.11 
(dd, J = 13.8, 3.1 Hz, 1H), 1.56 – 1.48 (partially buried under protons at 1.46 ppm, m, 1H), 1.46 
(s, 9H), 1.43 (s, 9H); 13C NMR (126 MHz, CDCl3) δ 172.00, 156.60, 82.28, 80.30, 59.16 – 55.74 
(m), 50.86, 36.36, 28.25, 27.97; HRMS-DART (m/z): [M+H]+ calculated for C13H242H2NO5 
278.19365; found, 278.19338. 
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68 
 
N-Boc-(4,4-2H2)homoserine-γ-OMs-α-OtBu ester, 11. To a stirred solution of 10 (0.9015 g, 
3.25 mmol) in 30 mL dry CH2Cl2 at 0 °C was added triethylamine (0.658 g, 0.914 mL, 6.50 
mmol), which was immediately followed by addition of mesyl chloride (0.745 g, 0.507 mL, 6.50 
mmol). The solution was allowed to warm up to ambient temperature over 2 h and then allowed 
to stir at this temperature for another 5 h. At this time, the solution was concentrated in vacuo to 
give a yellow oil that was then redissolved in 20 mL CH2Cl2. The resulting solution was washed 
with water (3 X 20 mL), and the combined water layers were then extracted with CH2Cl2 (3 X 20 
mL). All organic layers were then combined, dried with MgSO4, and filtered. The filtrate was then 
concentrated in vacuo to give 11 (1.18 g, 3.32 mmol, quant., 80% purity) as a yellow oil which 
was used without further purification in subsequent reactions.  An analytical sample was purified 
twice by silica column chromatography. The first purification eluted the material with 9:1 
hexanes:EtOAc, and the second used 100% pentane for ~3 column volumes followed by a 
switch to 1:1 Pentane:EtOAc to elute the product as an analytically pure white solid. 
 
Rf = 0.32 (7:3 hexanes:EtOAc); IR (neat) 3381, 2979, 1715, 1513, 1358, 1249, 1166 cm-1; 1H 
NMR (500 MHz, CDCl3) δ 5.16 (s, 1H), 4.28 (d, J = 4.2 Hz, 1H), 3.02 (s, 3H), 2.28 (dd, J = 14.0, 
2.6 Hz, 1H), 2.03 (dd, J = 14.5, 7.5 Hz, 1H), 1.47 (s, 9H), 1.43 (s, 9H); 13C NMR (126 MHz, 
CDCl3) δ 170.77, 155.35, 82.75, 80.09, 66.51 – 64.29 (m), 50.89, 37.30, 32.02, 28.28, 27.95; 
MS-DART (m/z): [M-Boc+H]+ found, 256.18048. 
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N-Boc-(4,4-2H2)methionine-OtBu ester, 12. Sodium thiomethoxide (2.86 mL of a 15% solution 
in H2O, 6.58 mmol) was added to a stirred solution of 11 (1.176 g, 3.29 mmol) in 50 mL of 95% 
EtOH. The reaction was allowed to proceed at room temperature for 18 h. At this time, saturated 
NH4Cl (~50 mL) was added to the solution until a white precipitate formed. The mixture was 
then extracted with EtOAc (3 X 75 mL), and the combined organic layers were dried with 
MgSO4, filtered, and concentrated in vacuo to give 12 as a yellow oil (0.721 g, 2.87 mmmol) in 
87% yield and 81% purity. Although the product can be purified by silica chromatography eluted 
with 9:1 hexanes:EtOAc, the material is initially obtained in sufficient purity to be used directly in 
the next reaction.  
 
Rf = 0.68 (7:3 hexanes:EtOAc); IR (neat) 3354, 2976, 2928,1795, 1508, 1451, 1364, 1248, 
1192, 1048 cm-1; 1H NMR (300 MHz, CDCl3) δ 5.12 (d, J = 7.9 Hz, 1H), 4.21 (dd, J = 12.5, 7.5 
Hz, 1H), 2.10 – 1.95 (overlapping protons, m, 4H), 1.83 (dd, J = 13.9, 7.5 Hz, 1H), 1.42 (s, 9H), 
1.39 (s, 10H); 13C NMR (101 MHz, CDCl3) δ 171.35, 155.32, 82.08, 79.73, 53.41, 32.42, 28.66 – 
30.19 (m), 28.31, 28.00, 15.37; HRMS-DART (m/z): [M+H]+ calculated for C14H262H2NO4S 
308.18646; found, 308.18597. 
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 (4,4-2H2)methionine, 13. A 1:1 solution of CH2Cl2 and trifluoroacetic acid (TFA) (14 mL) was 
added to a flask containing 12 (0.355 g, 1.155 mmol), and the resulting solution was allowed to 
stir for 5 h at room temperature. At this time, the reaction was concentrated in vacuo to give a 
brown oil. Diethyl ether (10 mL) was then added to the oil and the resulting mixture was and 
extracted with H2O (2 X 10 mL). The aqueous layer was then washed with diethyl ether (2 X 20 
mL), and the water layer was concentrated in vacuo to give 13 as the TFA salt (0.305 g, 1.15 
mmol) in quantitative yield. Trituration of the TFA salt of 13 with 95% EtOH selectively 
solubilized the TFA and, if any, removed impurities, affording the free base of 13 after filtration 
for analytical analysis. 
 
mp = 218 °C (decomp); IR (KBr) 3440, 2952, 2762, 2659, 2106, 1583, 1518, 1414, 1338, 1259, 
1156 cm-1; 1H NMR (300 MHz, D2O) δ 3.79 (dd, J = 7.1, 5.4 Hz, 1H), 2.17 – 1.99 (overlapping 
protons, m, 5H); 13C NMR (126 MHz, D2O) δ 174.13, 53.82, 29.41, 27-75 – 28.73 (m), 13.76; 
HRMS-DART (m/z): [M+H]+ calculated for C5H102H2NO2S 152.07143; found, 152.07072. 
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N-Fmoc-(4,4-2H2)methionine, 14. To a stirred solution of 1.203 g (14.33 mmol) sodium 
bicarbonate in 60 mL 1:1 acetone:H2O was added the TFA salt of 13 (1.900 g, 7.16 mmol). After 
the mixture became homogeneous, Fmoc-OSu was added (2.416 g, 7.16 mmol) in one portion. 
Reaction was allowed to proceed at room temperature for 18 h. At this time, the solution was 
acidified to pH 3 with 1M HCl. The acetone was then removed by evaporation under reduced 
pressure, and the resulting mixture was extracted with EtOAc (3 X 50 mL). The combined 
organic layers were dried with MgSO4 and filtered. The filtrate was concentrated in vacuo to give 
14 (2.54 g, 6.80 mmol) as an off white solid in 95% yield and 93% purity. The product could 
either be further purified via recrystallization from CH2Cl2: hexanes (77% recovery), or coupled 
to the solid phase directly without further purification.  
 
Rf = 0.166 (7:3 hexanes:EtOAc); mp = 144 - 146 °C; IR (neat) 3321, 3050, 1713, 1524, 1447, 
1334, 1263, 1056, 746 cm-1; 1H NMR (500 MHz, CDCl3) δ 7.77 (d, J = 7.5 Hz, 2H), 7.60 (s, 2H), 
7.41 (t, J = 7.5 Hz, 2H), 7.32 (t, J = 7.5 Hz, 2H), 5.45 (d, J = 7.6 Hz, 1H), 4.64 – 4.49 (m, 1H), 
4.45 (d, J = 6.7 Hz, 2H), 4.24 (t, J = 6.8 Hz, 1H), 2.22 (dd, J = 13.8, 4.0 Hz, 1H), 2.11 (s, 3H), 
2.01 (dd, J = 14.0, 7.9 Hz, 1H)
.
13C NMR (101 MHz, CDCl3) δ 176.02, 156.12, 143.69, 141.36, 
127.78, 127.11, 125.02, 120.03, 67.19, 52.94, 47.17, 31.27, 15.32; HRMS-DART (m/z): [M+H]+ 
calculated for C20H202H2NO4S 374.13951; found, 374.13825. 
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Representative N-Fmoc-(4,4-2H2)methionine resin loading protocol. Aminomethyl 
polystyrene resin (0.100 g, 0.110 mmol) was placed in a 5 mL peptide vessel and washed 
extensively with DMF, H2O, EtOH, Acetone, and CH2Cl2, in that order. Approximately 10 mL of 
each solvent was used for each washing, and the vessel was agitated for ~5 seconds with each 
solvent to ensure removal of the prior solvent. After washing the resin, 1 mL of CH2Cl2 was 
added to swell the resin. In a separate vial, an activated solution of N-Fmoc-(4,4-
2H2)methionine, 14, (0.163 g, 0.440 mmol), 1-hydroxybenzotriazole (HOBT, 0.017 g, 0.110 
mmol), N,N-diisopropylcarbodiimide (DIC, 0.069 mL, 0.440 mmol) and Diisopropylethylamine 
(DIPEA, 0.095 mL, 0.550 mmol) was prepared in 2 mL DMF. This activated solution was 
allowed to sit at room temperature for 15 min, and was then added to the peptide vessel 
containing the resin. The reaction was then shaken for 2 h at room temperature. The resin was 
then filtered, and washed as described above. Although this material was prepared as needed 
for this study, it is well suited for long term storage at low temperature and can be differentiated 
to various (D2)AHLs as needed. 
 
Synthesis of a representative (D2)AHLs 8, N-octanoyl-(4,4-2H2)homoserine lactone, (D2)C8. 
To the resin supported N-Fmoc-(4,4-2H2)methionine 15 generated above in a standard peptide 
synthesis vessel was added 4 mL of a 25% piperidine solution in DMF. The reaction mixture 
was allowed to shake for 1 h at room temperature. At this time, the resin was filtered and 
washed as described previously. An activated solution of octanoic acid (0.087 mL, 0.550 mmol), 
HOBT (0.017 g, 0.110 mmol), DIC (0.069 mL, 0.440 ionmmol) and DIPEA (0.095 mL, 0.550 
mmol) were prepared in 3 mL DMF in a separate flask, and allowed to sit at room temperature 
for 15 min. At this time, the activated coupling solution was added to the peptide vessel 
containing 16, and the resulting mixture was shaken for 18 h at ambient temperature. The resin 
was then filtered and again washed as previously described starting with DMF and finishing with 
CH2Cl2. The washed material was left on the filtration apparatus for 2 h to dry. At this time, the 
resin was then transferred to a 20 mL vial; and 1.67 mL of 1M CNBr in CHCl3, 0.330 mL H2O, 
and 0.330 mL TFA were added. The reaction was allowed to stir at room temperature for 24 h, 
after which the resin was filtered and washed with CHCl3 (3 X 5 mL). The filtrate was then 
collected and concentrated to give crude (D2)C8 a yellow oil, which was redissolved in CH2Cl2 
(15 mL) and washed with water (3 X 15 mL). The organic layer was then dried with MgSO4 and 
concentrated in vacuo to give (D2)C8 AHL (0.0109 g, 0.0475 mmol) as a white solid in 43% yield 
and >95% purity. Note that the synthesis of other AHLs can be accomplished via this procedure, 
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and only changes in reagent amounts and coupling time are needed. Completion of the coupling 
reaction can be determined by the  Kaiser (ninhydrin) test.128 
 
(D2)C4. 1H NMR (500 MHz, CDCl3) δ 5.99 (s, 1H), 4.56 (ddd, J = 11.6, 8.6, 5.7 Hz, 1H), 2.88 
(dd, J = 12.5, 8.6 Hz, 1H), 2.25 (td, J = 7.4, 2.1 Hz, 2H), 2.13 (t, J = 12.1 Hz, 1H), 1.80 – 1.64 
(m, 2H), 0.98 (t, J = 7.4 Hz, 3H). 13C NMR (126 MHz, CDCl3) δ 175.48, 173.53, 66.86 – 64.22 
(m), 49.27, 38.05, 30.50, 18.87, 13.68. HRMS-DART (m/z): [M+H]+ calculated for C8H142H2NO3 
174.10992; found, 174.10910 
 
(D2)3OHC4. 1H NMR (300 MHz, D2O) δ 4.66 (dd, J = 20.4, 10.9 Hz, 1H), 4.27 – 4.11 (m, 1H), 
2.66 – 2.54 (m, 1H), 2.45 (d, J = 6.6 Hz, 2H), 2.32 (td, J = 12.2, 5.1 Hz, 1H), 1.21 (d, J = 6.3 Hz, 
3H). 13C NMR (126 MHz, D2O) δ 178.47, 173.92, 64.78, 49.08, 44.38, 27.47, 21.76. Deuterated 
carbon not seen. HRMS-DART (m/z): [M+H]+ calculated for C8H122H2NO4 190.10484; found, 
190.10444 
 
(D2)C6. 1H NMR (500 MHz, CDCl3) δ 6.02 (s, 1H), 4.55 (ddd, J = 11.6, 8.6, 5.8 Hz, 1H), 2.86 
(dd, J = 12.5, 8.6 Hz, 1H), 2.26 (td, J = 7.4, 1.5 Hz, 2H), 2.12 (t, J = 12.0 Hz, 1H), 1.66 (dt, J = 
15.1, 7.6 Hz, 2H), 1.33 (dd, J = 7.2, 3.8 Hz, 4H), 0.91 (t, J = 7.1 Hz, 3H). 13C NMR (75 MHz, 
CDCl3) δ 175.48, 173.70, 49.27, 36.15, 31.34, 30.49, 25.09, 22.34, 13.88. Deuterated carbon 
not seen. HRMS-DART (m/z): [M+H]+ calculated for C10H162H2NO3 202.14122; found, 
202.14083 
 
(D2)3OC6. 1H NMR (300 MHz, CDCl3) δ 7.67 (s, 1H), 4.59 (ddd, J = 11.5, 8.8, 6.6 Hz, 1H), 3.46 
(s, 2H), 2.74 (dd, J = 12.5, 8.8 Hz, 1H), 2.51 (t, J = 7.3 Hz, 2H), 2.22 (t, J = 12.0 Hz, 1H), 1.70 – 
1.54 (m, 2H), 0.98 – 0.89 (m, 3H). 13C NMR (126 MHz, CDCl3) δ 206.42, 174.72, 166.26, 67.15 
– 62.44 (m), 49.04, 48.04, 45.77, 29.65, 16.83, 13.50. Deuterated carbon not seen. HRMS-
DART (m/z): [M+H]+ calculated for C10H142H2NO4 216.12049; found, 216.12074 
 
(D2)C7. 1H NMR (300 MHz, CDCl3) δ 5.98 (s, 1H), 4.54 (ddd, J = 11.6, 8.6, 5.7 Hz, 1H), 2.85 
(dd, J = 12.5, 8.6 Hz, 1H), 2.28 – 2.21 (m, 2H), 2.11 (t, J = 12.1 Hz, 1H), 1.64 (dt, J = 15.2, 7.7 
Hz, 2H), 1.39 – 1.20 (m, 6H), 0.88 (dd, J = 9.0, 4.6 Hz, 3H). 13C NMR (75 MHz, CDCl3) δ 
175.53, 173.73, 66.80 – 64.01 (m), 49.26, 36.19, 31.47, 30.48, 28.86, 25.38, 22.47, 14.02. 
HRMS-DART (m/z): [M+H]+ calculated for C11H182H2NO3 216.15687; found, 216.15664 
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(D2)C8. 1H NMR (300 MHz, CDCl3) δ 6.09 (d, J = 4.9 Hz, 1H), 4.55 (ddd, J = 11.6, 8.6, 5.9 Hz, 
1H), 2.83 (dd, J = 12.5, 8.6 Hz, 1H), 2.29 – 2.19 (m, 2H), 2.11 (t, J = 12.1 Hz, 1H), 1.71 – 1.56 
(m, 2H), 1.28 (dt, J = 9.2, 4.6 Hz, 8H), 0.87 (t, J = 6.7 Hz, 3H). 13C NMR (101 MHz, CDCl3) δ 
175.57, 173.77, 67.34 – 63.46 (m), 49.24, 36.20, 31.64, 30.42, 29.16, 28.96, 25.43, 22.58, 
14.04. HRMS-DART (m/z): [M+H]+ calculated for C12H202H2NO3 230.17252; found, 230.17303 
 
(D2)C12. 1H NMR (500 MHz, CDCl3) δ 6.01 (d, J = 4.3 Hz, 1H), 4.55 (ddd, J = 11.6, 8.6, 5.7 Hz, 
1H), 2.86 (dd, J = 12.5, 8.6 Hz, 1H), 2.25 (td, J = 7.4, 1.5 Hz, 2H), 2.12 (t, J = 12.1 Hz, 1H), 1.65 
(dt, J = 15.0, 7.6 Hz, 2H), 1.37 – 1.20 (m, 16H), 0.89 (t, J = 7.0 Hz, 3H). 13C NMR (126 MHz, 
CDCl3) δ 175.51, 173.73, 68.01 – 62.44 (m), 49.26, 36.20, 31.89, 30.48, 29.59, 29.44, 29.32, 
29.30, 29.20, 25.43, 22.67, 14.10. HRMS-DART (m/z): [M+H]+ calculated for C16H282H2NO3 
286.23512; found, 286.23441 
 
(D2)C14. 1H NMR (500 MHz, CDCl3) δ 6.03 (d, J = 4.8 Hz, 1H), 4.55 (ddd, J = 11.6, 8.6, 5.8 Hz, 
1H), 2.86 (dd, J = 12.5, 8.6 Hz, 1H), 2.25 (td, J = 7.3, 1.4 Hz, 2H), 2.12 (t, J = 12.1 Hz, 1H), 1.65 
(dt, J = 15.0, 7.6 Hz, 2H), 1.39 – 1.19 (m, 20H), 0.89 (t, J = 7.0 Hz, 3H). 13C NMR (126 MHz, 
CDCl3) δ 175.53, 173.74, 68.60 – 63.18 (m), 49.25, 36.20, 31.91, 30.45, 29.66 29.63, 29.59, 
29.45, 29.34, 29.31, 29.21, 25.43, 22.68, 14.11. HRMS-DART (m/z): [M+H]+ calculated for 
C18H322H2N1O3 314.26642; found, 314.26532 
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1H and 13C NMR spectra of (D2)3OC6 in CDCl3
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1H and 13C NMR spectra of (D2)C7 in CDCl3
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1H and 13C NMR spectra of (D2)C8 in CDCl3
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1H and 13C NMR spectra of (D2)C12 in CDCl3
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1.4.4  Detailed Methods 
 
General Chromatographic Details for DPD Analysis. High performance liquid 
chromatography (HPLC) was performed utilizing a quaternary pump to generate a gradient for 
the elution of compounds from the stationary phase. For all samples, 10 µL was injected onto 
the column via an autosampler cooled to 4 °C. A flow rate of 150 µL/min was used, and the 
eluent was introduced directly into the MS for ion detection. The mobile phases were HPLC 
grade water (solvent A) and HPLC grade acetonitrile (solvent B), and these were used to 
construct the following 18 min gradient elution profile: (t = 0 min, 15% solvent A, 85% solvent B; 
t = 2 min, 15% solvent A, 85% solvent B;  t = 4 min, 95% solvent A, 5% solvent B; t = 14, 95% 
solvent A, 5% solvent B; t = 16, 15% solvent A, 85% solvent B; t = 18, 15% solvent A, 85% 
solvent B). The stationary phase used for these studies consisted of aminopropyl functionalized 
particles (5 µm pore size, 100 Å particle size) packed into a 250 x 2 mm column (Phenomenex 
Luna NH2). All separations were performed with a column temperature of 10 °C. 
 
General Mass Spectrometric Detection Parameters for DPD analysis. All MS analyses were 
performed on a TSQ Quantum Discovery Max triple quadrupole MS (Thermo Electron 
Corporation). Samples were introduced into the electrospray ionization (ESI) chamber through a 
0.1 mm internal diameter fused silica capillary after delivery by HPLC as described above, or by 
direct infusion via a syringe pump at a flow rate of 20 µL/min. The spray voltage for ESI was set 
to 4500 V, and detection occurred in positive ion mode. Nitrogen was used as the sheath gas 
(10 psi), and the inlet capillary temperature was 300 °C. The argon used as the collision gas 
was set at 1.5 mTorr. The scan time for each SRM was 0.05 s with a scan width of 1 m/z. All 
peaks from the Mass Chromatograms were integrated manually using the Xcalibur MS software 
package (Thermo Electron Corporation). 
 
Preparation of Synthetic DPD (or (13C)DPD) for Biological Studies. This molecule was 
synthesized as described previously,91 and only general handling protocols are described here. 
Fresh DPD was prepared daily from a stock solution of (S)-4,5-cyclohexylidenedioxy-2,3-
pentadione (Pro-DPD) in water (1 mg/mL, 4.7mM). This solution was routinely stored at -80 ºC 
for a period of up to 3 weeks, and no change in the data were observed.  When needed, 100 µL 
aliquots of the Pro-DPD solution were prepared by addition of 1 µL 10% H2SO4 . Deprotection 
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was allowed to proceed for 3 h at ambient temperature, and the resulting DPD solution (4.7 mM) 
was used without modification for further experimentation.  
 
Bacterial Strains and Growth Conditions. The E. coli wild type strain BW25113 and luxS- 
strain JW2662-1 were established as part of the Keio Collection129 and were purchased from the 
Coli Genetic Stock Center at Yale University. For all experiments, E. coli cultures were grown in 
Luria-Bertani medium (LB) at 37 ºC with aeration. The V. harveyi wild type strain BB12086 and 
luxS- strain MM30130 were a gift from B.L. Bassler (Princeton University and the Howard Hughes 
Medical Institute). Overnight cultures of V. harveyi BB120 were grown in LM112 at 37 ºC with 
aeration. Overnight cultures of V. harveyi MM30 were cultured in LM supplemented with 100 
mg/L kanamycin. For experiments in which the DPD concentration was to be determined, both 
V. harveyi strains were cultured in LM at 30 ºC with aeration.  
 
Collection of Saliva Samples. Volunteers were each asked to deposit ~1 mL of mucus free 
saliva into a specimen cup. The sample was then agitated to remove bubbles, and the saliva 
was then used for further experimentation as described below. 
 
General Procedure for the Determination of the DPD Concentration. For the detection of 
DPD in samples of E. coli or V. harveyi, 300 µL aliquots were taken at regular intervals from 
duplicate cell cultures of both the wild type and luxS- strain grown as described above. Single 
300 µL aliquots for each sample of saliva was generated as previously described. These 
aliquots were then added to a 1.5 mL microcentrifuge tube containing a solution of the internal 
standard, (13C)DPD (341 µM in 10 µL H2O for bacterial samples, 34.1 µM in 10 µL H2O for 
saliva samples). The resulting solution was thoroughly mixed and then centrifuged (13,200 rpm, 
16,100 rcf, 1 min for bacterial samples, 5 min in for saliva samples) to remove cells and other 
particulates. A portion of the resulting supernatant (200 µL) was then transferred to a 300 µL 
screwcap autosampler vial containing a solution of tag 7 (14 mM in 20 µL H2O), and the two 
liquids were thoroughly mixed. After 1 h incubation at ambient temperature, the samples were 
quickly frozen and then stored at -80 ºC until no more than 1.5 h prior to MS analysis. Duplicate 
injections of each saliva sample were performed. Two SRMs, 381-202 and 382-203, were used 
to determine the relative signal arising from detection of DPD-M1CQ to that of (13C)DPD-M1CQ. 
After manual peak integration, the data were corrected for isotopic impurities as described in the 
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Supporting Information Discussion and Supporting Information Table S4, and the following 
equation was used to calculate the DPD Concentration: DPD = DPD-M1CQ signal / (13C)DPD-
M1CQ signal) x (13C)DPD concentration 
 
(R)-3-(1,2-dihydroxyethyl)-2-methylquinoxaline-5-carboxylic acid and (R)-2-(1,2-
dihydroxyethyl)-3-methylquinoxaline-5-carboxylic acid (DPD-BAQ), reaction with DPD 
followed by 1H NMR. The known compound, DPD, was synthesized according to a previously 
reported procedure.91 Briefly, (S)-4,5-cyclohexylidenedioxy-2,3-pentadione, Pro-DPD, (1.1 mg, 
4.7 mmol) was fully dissolved in D2O (1.1 mL), and D2SO4 (1.1 µL) was then added to the 
solution. Deprotection was then allowed to proceed for 3 h. Tag 2 (1 molar equiv, 1.2 mg, 4.7 
mmol) was then added to the DPD solution, and the reaction was monitored by 1H NMR for 1 h. 
At this time, a second molar equiv of 2 (1.2 mg, 4.7 mmol) was added to the reaction mixture, 
and monitoring by 1H NMR was continued for another hour. After 2 h, a third molar equiv of 2 
(1.2 mg, 4.7 mmol) was added to the reaction mixture, and monitoring by 1H NMR was 
continued for another 0.5 h. After a total time of 2.5 h, conversion of DPD to DPD-BAQ was not 
complete, and the experiment was abandoned due to the sluggishness of the reaction. 1H NMR 
(300 MHz, D2O) characterized as a mixture of regioisomeric products. See Supporting 
Information Figure S1a for chemical shift assignments. 
 
(R)-ethyl 3-(1,2-dihydroxyethyl)-2-methylquinoxaline-5-carboxylate and (R)-ethyl 2-(1,2-
dihydroxyethyl)-3-methylquinoxaline-5-carboxylate (DPD-EBAQ), reaction with DPD 
followed by 1H NMR. Known compound, DPD, was synthesized according to a previously 
reported procedure.91 Briefly, Pro-DPD (1 mg, 4.7 mmol) was fully dissolved in D2O (1 mL), and 
D2SO4 (1 µL) was then added to the solution. Deprotection was then allowed to proceed for 3 h. 
Tag 3 (1 molar equiv, 1.2 mg, 4.7 mmol) was then added to the DPD solution, and the reaction 
was monitored by 1H NMR for 1 h. At this time, a second molar equiv of 3 (1.2 mg, 4.7 mmol) 
was added to the reaction mixture, and monitoring by 1H NMR was continued for another 1 h. 
After a total time of 2 h, DPD had completely converted to DPD-EBAQ as judged by 1H NMR. 
1H NMR (300 MHz, D2O) characterized as a mixture of regioisomeric products. See Supporting 
Information Figure S2a for chemical shift assignments. 
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(R)-dimethyl 2,2'-(2-(1,2-dihydroxyethyl)-3-methylquinoxaline-6,7-diyl)bis(oxy)diacetate 
(DPD-M1CQ), Reaction with DPD Followed by 1H NMR.  The known compound, DPD, was 
synthesize according to a previously reported procedure.91 Briefly, Pro-DPD (1.1 mg, 4.7 mmol) 
was dissolved fully in D2O (1.1 mL), and D2SO4 (1.1 µL) was then added to the solution. 
Deprotection was then allowed to proceed for 3 h. Tag 7 (1 molar equiv, 1.9 mg, 4.7 mmol) was 
then added to the DPD solution, and the reaction was monitored by 1H NMR for 0.5 h. At this 
time, a second molar equiv of 7 (1.9 mg, 4.7 mmol) was added to the reaction mixture, and 
monitoring by 1H NMR was continued for another 0.5 h. After a total time of 1 h, DPD had 
completely converted to DPD-M1CQ as judged by 1H NMR. 1H NMR (300 MHz, D2O) δ 7.58 (s, 
1H), 7.36 (s, 1H), 5.28 (t, J = 5.5 Hz, 1H), 5.05 (d, J = 6.0 Hz, 4H), 3.95 – 3.71 (m, 2H, peak 
partially overlapping with the methyl ester protons from both 7 and DPD-MICQ), 3.79 (s, 3H, 
peak overlapping with protons on DPD-M1CQ), 2.85 (s, 3H). 
 
Comparison of the Ionization Efficiencies for the Quinoxalines Derived from Reaction of 
Diamine Tags 2-7 with Synthetic DPD To generate each quinoxaline for study, an ~25 µL 
solution of the tagging reagent (14 mM in H2O) was mixed in a 1:1 v/v ratio with a solution of 
DPD (4.7 mM in H2O, pH = 1.8) to give a solution containing a 3:1 mixture of the diamine tag to 
DPD. After the reactions were allowed to proceed for 2 h at ambient temperature, each of the 6 
resulting solutions were diluted in water to a final concentration of 10 µM. Determination of the 
relative ionization efficiency for each was then accomplished via LC-MS/MS analysis utilizing 
the appropriate SRM detection parameters. See Figure 2 in the manuscript for results.   
 
Determination of the Approximate Linear Range and Limit of Detection for DPD-M1CQ To 
determine the ability to detect DPD-M1CQ via LC-MS/MS, an ~200 µL solution of the tagging 
reagent (14 mM in H2O) was mixed in a 1:1 ratio with a solution of DPD (4.7 mM in H2O, pH = 
1.8) to give a solution containing a 3:1 mixture of the diamine tag to DPD. After reaction was 
allowed to proceed for 30 min at ambient temperature, a 1:100 dilution of the sample was 
performed to give a 23.5 µM solution of DPD-M1CQ in H2O.   Further half log-dilutions of the 
molecule in water gave samples with a series of concentration ranging from 74 pM to 7.4 mM. 
For this experiment, samples were stored at -80 ºC until no more than 5 h before LC-MS/MS 
analysis. The total ion counts measured via each of the appropriate SRMs was determined by 
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integrating the peak for DPD-M1CQ in each mass chromatogram. The results of these data are 
summarized in Supporting Information Figure S4 and S5 and discussed in the manuscript. 
 
Validation of Selectivity for Tag 7 in Complex Media Three aliquots of sterile LB (200 µL) 
were mixed with a solution of tag 7 (14 mM in 20 µL H2O). After thorough mixing, the solutions 
were allowed to incubate for 1 h at ambient temperature to mimic the conditions used for the 
reaction of DPD with 7. To determine whether reaction of 7 with components in the media had 
occurred, the samples were analyzed via LC-MS/MS, and control samples containing only LB 
were also analyzed. During these experiments, the SRMs 381-201, 381-202, and 381-231 that 
were projected to be optimal for the detection of DPD were monitored. The results of these 
experiments are discussed in the text of the manuscript and shown in Supporting Information 
Figure S6. No signal was observed above background in any samples containing only LB in the 
SRMs used to detect either DPD-M1CQ or (13C)DPD-M1CQ. 
 
Comparison of Internal Standards (13C)DPD-M1CQ and (13C)DPD To determine the relative 
efficacy of these internal standards, the DPD concentration from a culture of V. harveyi BB120 
grown for 9 h was measured in duplicate relative to either (13C)DPD-M1CQ or (13C)DPD. The 
samples were prepared as described in the General Procedure for the Determination of the 
DPD concentration entry in the methods section, except that a solution of (13C)DPD-M1CQ (341 
µM in H2O) was substituted as the internal standard for two of the samples. The initial (13C)DPD-
M1CQ solution (2.35 mM in H2O) was produced by mixing a solution of 7 (14 mM in H2O) with 
(13C)DPD (4.7 mM in H2O) in a 1:1 v/v ratio and allowing the reaction to proceed for 1 h at 
ambient temperature.  
 
Determination of the DPD concentration in E. coli Wild Type Strain BW25113 and luxS- 
Strain JW2662-1. A culture of both strains was grown overnight, and then used to make two 2% 
(v/v) inocula of each in fresh LB (25 mL) in 125 mL glass Erlenmeyer flasks as described in the 
Bacterial Strains and Growth Conditions entry in the methods section of this document. At the 
time intervals indicated in the table below, the cell density was determined by measuring the 
OD600 for 1 mL aliquots of each culture, and separate 300 µL aliquots were used for 
measurement of the DPD concentration. Samples were prepared and analyzed as described in 
the general procedure for the Determination of the DPD concentration entry in the methods 
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section of this article. Only one of the cultures for the luxS- strain was fully analyzed as no DPD 
was detected, although several of the samples from random times in the second culture were 
used to confirm the lack of signal.  
 
Determination of the DPD concentration in V. harveyi Wild Type Strain BB120 and luxS- 
Strain MM30. A culture of both strains was grown overnight, and then used to make two 2% 
(v/v) inocula of each in fresh LM (25 mL) in 125 mL glass Erlenmeyer flasks as described in the 
Bacterial Strains and Growth Conditions entry in the methods section of this document. At the 
time intervals indicated in the table below, the cell density was determined by measuring the 
OD600 for 1 mL aliquots of each culture, and separate 300 µL aliquots were used for 
measurement of the DPD concentration. Samples were prepared and analyzed as described in 
the General Procedure for the Determination of the DPD concentration entry in the methods 
section of this article. Only one of the cultures for the luxS- strain was fully analyzed as no DPD 
was detected, although several of the samples from random times in the second culture were 
used to confirm the lack of signal  
 
Chromatographic Details for AHL detection. For all samples, 10 µL was injected onto a 
Phenomenex Kinetex reverse phase C18 core-shell column (5 µm pore size, 100 Å particle size, 
100 × 2 mm) via a Thermo Electron Surveyor Autosampler Plus. All separations were performed 
with the column at 25 °C. High performance liquid chromatography (HPLC) was performed 
utilizing a quaternary Thermo Electron Surveyor MS Pump Plus. A flow rate of 200 µL/min was 
used for both gradients, and the eluent was introduced directly into a Thermo Electron TSQ 
Quantum Discovery Max triple quadrupole MS for ion detection. For initial chromatographic 
method development, solutions of (D2)C4, (D2)3OHC4, (D2)C6, (D2)3OC6, (D2)C7, (D2)C8, 
(D2)C12, and (D2)C14 at 200 nM for Gradient 1 and 6.20 µM for Gradient 2 were injected into 
the MS for analysis. The mobile phases were 0.1% acetic acid in water (solvent A) and 0.1% 
acetic acid in HPLC grade acetonitrile (ACN) (solvent B), and these were used to construct the 
following gradient elution profiles: Gradient 1: t = 0 min, 95% solvent A : 5% solvent B; t = 5 min, 
95% solvent A : 5% solvent B; t = 30 min, 5% solvent A : 95% solvent B; t = 45 min, 5% solvent 
A : 95% solvent B; 5 minute column re-equilibration. Gradient 2: t = 0 min, 99% solvent A : 1% 
solvent B; t = 3 min, 90% solvent A : 10% solvent B; t = 4.2 min, 5% solvent A : 95% solvent B; t 
93 
 
= 7 min, 5% solvent A : 95% solvent B; t = 12 min, 99% solvent A : 1% solvent B; t = 12.5 min, 
99% solvent A : 1% solvent B. 
 
General Mass Spectrometric Detection Parameters for AHL analysis. Samples were 
introduced into the electrospray ionization (ESI) chamber of the triple quadrupole MS through a 
0.1 mm internal diameter fused silica capillary after delivery by HPLC as described above. The 
spray voltage for the ESI source was set to 4500 V, and detection occurred in positive ion 
mode. Nitrogen was used as the sheath gas (40 psi), and the inlet capillary temperature was 
290 °C. The argon used as the collision gas was set at 1.5 mTorr. Samples were analyzed 
using selected reaction monitoring (SRM), and the scan time for each SRM was 0.05 s with a 
scan width of 0.1 m/z. Optimized collision energies of 11 eV were used for each compound. 
Peaks from the extracted ion chromatogram were manually integrated, and the raw ion counts 
were converted to concentrations of bacterially produced autoinducers using the following 
equation: (Signal AHL/Signal (D2)AHL) x (concentration (D2)AHL) = concentration AHL. 
 
Determination of limit of detection (LOD) and sensitivity of AHL detection in various 
media and extracts. A solution of (D2)C4, (D2)3OHC4, (D2)C6, (D2)3OC6, (D2)C7, (D2)C8, 
(D2)C12, and (D2)C14 was generated in water at 6.2 µM of each. Half-log dilution serial dilution 
was used to generate a set of solutions with a minimum concentration of 1.92 nM in water and 
bacterial growth media, LM119 and SWTO120 A portion (300 µL) of these solutions was 
transferred to a 300 µL screwcap autosampler vial for LC-MS/MS analysis. A 300 µL aliquot of 
each solution in LM and SWTO was also extracted with acidic EtOAc (1% AcOH) (2 X 150 µL), 
and the combined organic layers were transferred to an autosampler vial for immediate MS 
analysis. 
 
Analysis of method precision. Measurement of C8 concentration using isotope dilution LC-
MS/MS by two different methods was tested to determine the precision of each. For all 
experiments, a solution of C8 was generated by culturing a fresh inoculum (1/50 dilution of a 
culture grown overnight) V. fischeri MJ1 in LM with shaking (76 rpm) at ambient temperature (22 
ºC) to an optical density (OD600) of 1.64. For Method 1, three 300 µL aliquots were added to 1.5 
mL microcentrifuge tubes containing a solution of (D2)C6, (D2)C7, (D2)C8, and (D2)3OC6 (6.2 
µM in 10 µL H2O) to generate samples containing cells, C8 from V. fisheri, and internal 
standards (200 nM final concentration of each). This suspension was then vortexed to 
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homogenize the sample and centrifuged (13,200 rpm, 16,100 rcf, 1 min) to remove the cells. 
260 µL aliquots of the resulting supernatants were then transferred to 300 µL screwcap 
autosampler vials for immediate analysis by LC-MS/MS. For Method 2, three 400 µL aliquots of 
the culture were added to 1.5 mL microcentrifuge tubes and centrifuged (13,200 rpm, 16,100 
rcf, 1 min) to remove the cells. Then, 300 µL aliquots of the resulting cell-free supernatants were 
added to 300 µL screwcap autosampler vials containing a solution of (D2)C6, (D2)C7, (D2)C8, 
and (D2)3OC6 (6.2 µM in 10 µL H2O). The resulting solution was vortexed to ensure thorough 
mixing, and then immediately analyzed via LC-MS/MS. Each of the three samples generated by 
both Methods 1 and 2 were injected in triplicate to generate 18 independent measurements of 
the C8 concentration. 
 
Analysis of method accuracy. The accuracies of internal standard addition Methods 1 and 2 
(described in the above section on method precision) were tested and compared to external 
calibration. For these experiments, V. fischeri ES114 was used since it does not produce 
detectable amounts of 3OC6, and a fresh inoculum (1/50 dilution of a culture grown overnight) 
of this species was grown in LM with shaking (76 rpm) at ambient temperature (22 ºC) to an 
OD600 of 1.84. Eleven 1 mL aliquots of the culture were taken and centrifuged (13,200 rpm, 
16,100 rcf, 1 min) to remove cells, and two 300 µL portions of each were placed in separate 300 
µL screwcap autosampler vials. Solutions of C4, 3OC6, and C14 were added to these cell-free 
supernatants to generate a set of analytical standards containing quarter-log (1.78-fold) serial 
dilutions of each AHL whose final concentrations ranged from 3.0 to 1,075 nM. The data 
obtained from LC-MS/MS analysis of these standards were used to construct linear calibration 
plots for the analytes. Simultaneously, two 1 mL aliquots of the culture were placed in 1.5 mL 
microcentrifuge tubes containing 50 µL of a 33 µM solution each of C4, 3OC6, and C14 to give 
a mixture with a final concentration of 157 nM of each analyte. Two samples were then 
prepared from via internal standard addition Method 1 from one of the culture aliquots, and two 
samples were also prepared by Method 2 from the other 1 mL culture aliquot. These samples 
were then analyzed via LC-MS/MS. The ion counts measured from the samples generated by 
Method 1 were compared to the linear calibration plots to determine the effectiveness of 
external calibration. 
 
Measurement of AHLs concentrations for V. fischeri MJ1 grown under varying 
conditions. Fresh inocula (1/50 dilution of an overnight culture) of V. fischeri MJ1 were 
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establish in SWTO at varying volumes. Six 25 mL cultures in 125 mL Erlenmeyer flasks, two 50 
mL cultures in 125 mL Erlenmeyer flasks, and two 100 mL cultures in 250 mL Erlenmeyer flasks 
were generated. All cultures were incubated at ambient temperature (22 ºC). Two 25 mL and all 
50 and 100 mL cultures were shaken at 102 rpm. Two each of the remaining 25 mL cultures 
were also shaken at both 40 and 76 rpm. All cultures were allowed to grow for 14 h at which 
time the cell density was measured and a 300 µL aliquot was removed from each sample for 
analysis. (D2)C6, (D2)3OC6, (D2)C7, and (D2)C8 internal standards were added to each sample 
via Method 1 as described above, and  the resulting solutions were analyzed via LC-MS/MS. 
 
General Methods For AHL Detection. All chemicals and solvents were purchased from Fisher 
Scientific, VWR, or ChemImpex and were used without further purification. Deuterated solvents 
used for NMR analysis were purchased from Cambridge Isotope Laboratories, Inc.; silica gel 
(230 X 400 mesh) and TLC plates were purchased from Sorbent Technologies. All NMR spectra 
were recored on either a Varian Mercury 300 MHz, Bruker Avance 400 MHz, or Varian INOVA 
500 MHz spectrometer. All high accuracy mass spectra were taken on a JEOL AccuTOF mass 
spectrometer with a DART ion source. IR spectra were recorded on a Thermo Electon Nicolet 
IR 100 FT-IR. The liquid chromatography-tandem mass spectrometer (LCMS/MS) used for 
detection of AHLs consisted of a Thermo Electron Surveyor Autosampler Plus, a Surveyor MS 
Pump Plus, and a TSQ Quantum Discovery Max triple quadrupole MS. All MS spectra were 
collected and analyzed using the Xcalibur MS v 2.0.7 software package from Thermo Electron 
Corporation. ). All HPLC separations were performed on a Kinetex reverse phase C18 core-shell 
column (5 µm pore size, 100 Å particle size, 100 × 2 mm) supplied by Phenomenex. 
 
Generation of 3-Dimensional Plots Displayed in Figure 1.7C-E.  An XYY wave plot was 
generated in Origin 8.1 with time as the independent variable and the SRM Intensity as the 
dependent variables. Figure 1.7C graphs were generated using the LC-MS/MS Gradient 2 and 
the SRMs graphed were 174–104, 190–104, 202–104, 216–104, 230–104, 286–104, and 314–
104 (parent m/z–product ion m/z), from the time of 1.0 minutes to 10 minutes. Figure 1.7D 
graphs were generated using the LC-MS/MS Gradient 2 and the SRMs used were 200–102, 
202–104, 214–102, 216–104, 228–102 and 230–104 (parent m/z–product ion m/z) graphed 
from the time of 1.0 – 10 minutes. Figure 1.7E graphs were generated using the LC-MS/MS 
Gradient 1 and the SRMs graphed were 174–104, 190–104, 202–104, 216–104, 230–104, 286–
104, and 314–104 (parent m/z–product ion m/z), from the time of 1.0 minutes to 30 minutes. 
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CHAPTER II 
THE DEFINITION OF QUORUM SENSING AND DETERMINING THE 
USE OF MULTIPLE AUTOINDUCERS WITHIN A SYSTEM 
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A version of this chapter was originally published by Jessica R. Gooding, Amanda L. May, 
Kathryn R. Hilliard, and Shawn R. Campagna: 
Reproduced with permission from Jessica R. Gooding, Amanda L. May, Kathryn R. Hilliard, and 
Shawn R. Campagna*. Establishing a Quantitative Definition of Quorum Sensing Provides 
Insight into the Information Content of the Autoinducer Signals in Vibrio harveyi and Escherichia 
coli. Biochemistry 2010, 49(27), 5621-5623; doi 10.1021/bi1001163. Copyright 2010 American 
Chemical Society.  
 
This chapter was kept mostly as is from the submitted version of the article listed above with 
minor adaptations. JRG performed DPD detection experiments and flux experiments. KRH 
provided help in DPD measurements. Raw Data Tables can be found in the publication and are 
not reported here. 
 
2.1 Abstract 
 
Extracellular autoinducer concentrations in cultures of Vibrio harveyi and Escherichia coli were 
monitored by liquid chromatography—tandem mass spectrometry to test whether a quantitative 
definition of quorum sensing could help decipher the information content of these signals. 
Although V. harveyi was able to keep the autoinducer-2 to cell number ratio constant, the ratio 
of signal to cell number for V. harveyi autoinducer-1 and E. coli autoinducer-2 varied as the 
cultures grew. These data indicate that V. harveyi uses autoinducer-2 for quorum sensing, while 
the other molecules may be used to transmit different information or are influenced by metabolic 
noise.  
 
After examining the autoinducer production in V. harveyi and E. coli, we set forth to study the 
autoinducer production in the marine organism Vibrio fischeri. Using the previously described 
method (Chapter I and Ref 131) for detecting acylhomoserine lactones we were able to discover 
a new autoinducer in V. fischeri, and show a temporal effect in the synthesis of the autoinducers 
produced. 
 
2.2 Introduction 
 
2.2.1 DPD and AHL based Quorum Sensing. Quorum sensing provides bacteria and other 
microorganisms the ability to regulate behaviors based on the number of cells present in the 
environment.4 The ability to socialize allows bacteria to behave as pseudo-multicellular 
organisms, and these circuits may be crucial mediators during the establishment of bacterial 
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colonies, formation of biofilms, and the onset of infectious diseases.4,24 Examples of 
intraspecies, intragenus, and interspecies signals have been identified.4 This work focuses on 
the proposed interspecies signal, autoinducer-2 (AI-2), and the interaction of this molecule with 
the V. harveyi intraspecies signal, autoinducer-1 (HAI-1).5 Herein, we propose that a quantitative 
definition of quorum sensing may be sufficient to determine the information content of these 
signals.  
 
Although the topic of much research, AI-2 has not been proven to function as a signal in all 
species that contain LuxS, the enzyme responsible for (S)-4,5-Dihydroxy-2,3-pentanedione 
(DPD) production, and the widespread inclusion of luxS in bacterial genomes could be due to 
quorum sensing or to the fact that LuxS is necessary for the recycling of methionine from the 
activated methyl cycle (Figure S2.1). The linkage of AI-2 production to metabolism, coupled with 
the observation that very few, if any, genes other than those necessary for DPD metabolism are 
regulated by this molecule in some species has left its role in question.132   
 
Species that produce acylhomoserine lactone signals, such as HAI-1, have a further link 
between signaling and metabolism because these molecules are also derived from the activated 
methyl cycle (Figure S2.1).4 For V. harveyi, HAI-1 and AI-2 are known to be signals, and several 
behaviors, e.g. bioluminescence, are under quorum sensing control.133 These two signals use 
shared regulatory components that act as coincidence detectors to mediate identical behaviors. 
Previous work has been unable to determine how V. harveyi distinguishes between the two, 
although it has been proposed that timing of autoinducer production could differentiate the two 
signals.134  
 
2.2.2 Quorum Sensing in V. harveyi and E. coli. We sought to determine whether 
autoinducers could be used to transmit information concerning cell density in two species, V. 
harveyi and E. coli, by quantitating the DPD concentration present in the supernatants for both 
as well as the HAI-1 concentration for V. harveyi. These bacteria were chosen because the 
pathways involved in signal production and utilization are characterized for both.6,135 DPD gives 
rise to AI-2 activity.136 because of this, the DPD concentration ([DPD]) is directly correlated with 
signaling ability. Methods to quantitate the [DPD] (as a stable quinoxaline derivative) and [HAI-
1] from a variety of media using LC—MS/MS and stable-isotope internal standards were critical 
to this work.67,137 Prior to this technology, the most widely used technique to quantitate DPD was 
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the V. harveyi luminescence assay.5 However, this bioassay suffers from a small linear range138 
and is prone to interference from other molecules, such as glucose.63  
 
At a phenotypic level, a quorum sensing signal is one that allows cells to differentiate between 
low and high cell density.4 This could be achieved in several ways. For instance, the bacteria 
could produce little quorum sensing activity at low cell density and then turn on high density 
behaviors like a switch after a burst of quorum sensing activity, or they could gradually turn on 
the response in a graded manner.134 
 
2.3 Results and Discussion 
 
2.3.1 Defining Quorum Sensing using V. harveyi and E. coli. We sought to provide a 
quantitative definition of a quorum sensing signal and hypothesized that if the primary 
information content is cell density, then the amount of extracellular signal must be held constant 
to the number of cells in the medium. Maintaining this relationship would allow information 
concerning cell density to be transmitted without the need to deconvolute conflicting metabolic 
or other cues from the signal. This leads to the equation:  
 
signal concentration/cell density = constant 
 
To test this hypothesis, [DPD] in supernatants of E. coli BW25113139 and [DPD] and [HAI-1] 
present in the supernatants of V. harveyi BB1205 were measured as the cultures progressed 
through the exponential to stationary growth phase.  Each species was grown in appropriate 
media with one of four added [glucose], 0.0, 0.08, 0.14, or 0.20 w/v %. With increased nutritional 
input and metabolic activity, the maximum [DPD] in the E. coli supernatants increased as more 
glucose was added to the media, and the maximum [DPD] ranged from 19 ± 2.4 µM with no 
added glucose to 130 ± 5.6 µM when 0.2 w/v % glucose was added (Figure 2.1A). For V. 
harveyi, the maximum [DPD] and [HAI-1] were 24 ± 0.9 µM and 27.9 ± 1.0 µM, respectively, at  
lower [glucose] (0 and 0.08 w/v %); and the [DPD] and [HAI-1] were 14 ± 0.5 µM and 7.1 ± 1.1  
µM, respectively, at higher [glucose] (0.14 and 0.20 w/v %) (Figure 2.1B and C). Neither E. coli 
nor V. harveyi showed significantly increased cell density with increased availability of nutrients, 
and the growth kinetics for both species were nearly unchanged during the exponential growth 
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phase at all [glucose]. However, growth of V. harveyi during stationary phase was slower in the 
cultures containing 0.14 and 0.20 w/v % added glucose, although the cells were still viable upon 
plating (Figure S2.2A-C).  The [glucose] in each culture was monitored via a colorimetric 
glucose oxidase assay140 to determine how quickly the bacteria were using this nutrient and to 
insure that the lack of increased growth was not due to  inability to metabolize the sugar. All E. 
coli cultures depleted the glucose in the media at ~3.5 h, corresponding to entry into stationary 
phase; and the V. harveyi cultures were able to take up all of the glucose by the onset of 
stationary phase at ~4.25 h, except cultures grown with 0.20 w/v % added glucose in which the 
sugar persisted into stationary phase (Figure S2.2D-E).      
 
With these data in hand, our quantitative definition of quorum sensing was tested in these two 
species. After calculating [DPD]/cell density for the E. coli cultures, it was apparent that AI-2 
was not simply a quorum sensing signal in this bacterium. It is known that E. coli imports AI-2 at 
early to mid-stationary phase and that this behavior can be suppressed by the addition of 
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Figure 2.1. Production of DPD and HAI-1, calculated autoinducer synthesis rates, and landscapes 
showing the  [signal]/cell density with varying [glucose]. Data for each culture grown with 0.00 (▲), 
0.08 (■), 0.14 (●), and 0.20 (♦) w/v % added glucose.  (A) and (B) Measured [DPD] (µM) in the 
supernatants of E. coli and V. harveyi, respectively. (C) Measured [HAI-1] (µM) in the supernatants of 
V. harveyi. (D) Graph of the rate of autoinducer appearance (µM/OD600/h) over 45 min intervals. (E) E. 
coli is unable to regulate the amount of [DPD]/cell density in either the nutrient or the temporal 
dimension. (F) Conversely, V. harveyi maintains this ratio in both dimensions for DPD, (F) while the 
ratio of [HAI-1]/cell density increases as the culture grows. All measurements were performed in 
duplicate, and the error bars express the range of the data. The 1 h time points were not used in E-F 
as the measured OD600 was out of the linear range. 
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glucose. However, previous work did not eliminate the possibility that AI-2 is a quorum sensing 
signal during exponential phase for this species. The observation of large variations (4.8 ± 0.5 to 
39 ± 4.8 µM/OD600) in the [DPD]/cell density indicate that AI-2 cannot transmit cell density 
information in E. coli without the need to filter metabolic noise (Figure 2.1E).  
 
For AI-2 in V. harveyi, the opposite was observed, and [DPD]/cell density was nearly constant 
under all nutrient conditions (Figure 2.1F). The average ratio was 5.5 ± 2.9 µM/OD600 if all points 
displayed in Figure 2.1F are used in the calculation. If only time point for 0.14 w/v % added 
glucose at 2 h is removed from this analysis, the error is considerably smaller giving a value of 
5.5 ± 1.8 µM/OD600. These data quantitatively show that V. harveyi can maintain the cell density 
information content of the AI-2 signal from exponential to mid-stationary phase even if nutrient 
availability fluctuates. However, the ratio of [HAI-1]/cell density was not constant and increased 
from 0.7 ± 0.2 to 6.6 ± 0.4 µM/OD600 as the cultures grew (Figure 2.1G); however, the [HAI-1] 
did not differ greatly between cultures with varying [glucose] during exponential phase. We 
believe this indicates that the information content of HAI-1 is not cell density, but rather 
metabolic in nature. These hypotheses are strengthened by the observation that V. harveyi 
lowers the per cell DPD synthesis rate from a maximum of 6.8 ± 0.1 to .03 ± 0.6 µM/OD600/h as 
the culture grows, as would be needed to maintain [DPD]/cell density in the absence of 
degradation, while the per cell HAI-1 synthesis rate was nearly constant at 2.2 ± 0.4 µM/OD600/h 
for healthy cultures (Figure 2.1D).  
 
In regards to the aspects of signal production and integration, neither of these signals seems to 
be produced in a switch-like manner, and these data support previous work134,141 indicating that 
signal reception and gene regulation in V. harveyi is able to give a graded response. Further, 
these data show that the appearance of HAI-1 lags behind that of AI-2 by ~45 min, although 
both are present at cell densities below which high density behaviors are usually observed142; 
and the ratio of these two signals may allow V. harveyi to determine both cell density and 
growth phase. 
 
2.3.2 Mechanism of Signal Production. After observing that E. coli and V. harveyi exhibited 
differences in AI-2 production, we used stable isotope flux profiling to probe the mechanism of 
signal production in both. Such experiments provide information on the rate and pathways used 
for biosynthesis and allow newly synthesized metabolites to be differentiated from old 
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molecules143. For these experiments, fully 13C-labeled glucose ((U-13C)glucose) was added to E. 
coli or V. harveyi cultures in rich media after unlabeled glucose was exhausted (2.5 and 3.0 h, 
respectively), and the incorporation of 13C into DPD was monitored for 3 h via LC-MS/MS. DPD 
isotopomers with 2, 3, or 5 ((13C5)DPD) 13C-labels are most likely144, and (13C5)DPD was 
observed to account for the majority of the labeled material in all experiments (Figures S2.3 and 
S2.4).  
 
2.3.3 Selection of appropriate selected reaction monitoring events (SRMs) for flux 
experiments. The biosynthetic source of the carbons in DPD can be traced to the ribose moiety 
of ATP. Therefore, if DPD is to be labeled by introduction of (U-13C)glucose, the most direct 
routes are through the pentose phosphate pathway giving the common precursor, ribulose-5-
phosphate. This can occur through several pathways although four are most efficient. All 5 13C 
may be introduced at once through the conversion of glucose to gluconate-6-phosphate. 
Alternatively, ribulose-5-phosphate can be built from 2 and 3 carbon units through fructose-6-
phosphate and glyceraldehyde-3-phsophate interconversions, respectively to give the DPD 
isotopomers shown (Figure S2.3a-b). These isotopomers were chosen to be most relevant to 
the flux studies. However, more routes to labeled DPD are possible, although less likely, as 
other possible sugar interconversions available in bacteria could also be used.  In initial 
experiments, measurement of SRMs for each of the five possible isotopomers was attempted, 
and no significant amounts of appropriately labeled 13C1-DPD or 13C4-DPD were observed. 
Further, no isotopomer that would interfere with the quantitation of the (13C1)DPD internal 
standard was measured in pilot experiments, thus allowing the addition of internal standard and 
exact quantitation in the final work. 
 
Selection of the correct SRMs for the detection of the labeled isotopomers of DPD is critical for 
proper quantitation. The fragmentation of the molecule is not significantly affected by the 
inclusion of 13C isotopes, but care must be taken to insure that the proper reactions are 
monitored for the isotopomers as each reaction has differing efficiencies that could lead to 
quantitative errors if non-analogous reactions are compared. For DPD-M1CQ, the SRMs 381-
201, 381-202, 381-231, and 381-363 are the most sensitive. This leads to 19 SRM options for 
the detection of (13C5)DPD-M1CQ (Figure S2.3c). If all 13C remain in the fragment, the 
appropriate SRMs are 386-206, 386-207, 386-236, and 386-368. However, if the fragment loses 
a 13C, the corresponding SRMs will be 386-205, 386-206*, and 386-235, etc. The 386-368 SRM 
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will remain unchanged as it corresponds to loss of water and cannot lose a 13C. Each of the 19 
possible SRMs for (13C5)DPD-M1CQ were monitored in cell-free supernatants to which 
(13C1)DPD and M1CQ had been added, and the ratio of intensities for (13C5)DPD-M1CQ SRMs 
were then determined.  For DPD-M1CQ the ratio of intensities was previously reported2 as 
22:43:47:100 for SRMs 381-201:381-202:381-231:381-363. The ratio of the analogous 
reactions of (13C5)DPD-M1CQ should be similar to those for DPD-M1CQ. The measurement of 
the SRM intensity ratios for (13C5)DPD-M1CQ from V. harveyi supernatants was 25:56:51:100 
for SRMs 386-205:386-206:386-236:386-368, respectively (Figure S2.3d-e). The similarity of 
these two sets of ratios allowed us to choose an SRM for quantitation of (13C5)DPD-M1CQ, 
namely 386-206. This SRM corresponds to the SRM 381-202 that was used for quantitation of 
DPD-M1CQ in previous experiments. During fragmentation, (13C5)DPD-M1CQ loses a carbon 
from (13C5)DPD. From expected chemical reactivity, that carbon is almost certain to be C5.  Also 
note that metabolic evidenc144 indicates that (13C2)DPD is labeled at C4 and C5 and whereas 
(13C3)DPD is labeled at carbons 1-3. We also observed that (13C2)DPD loses a carbon during 
fragmentation but (13C3)DPD does not, again indicating that it is C5 that is lost during the 
fragmentation reaction.  
 
2.3.4 Isotope Labeling Profiles for DPD production in V. harveyi and E. coli. For E. coli, the 
lsrB-
 
mutant strain (JW1509-1) was used to probe the synthesis of DPD in the absence of 
degradation. To determine whether the higher [DPD] observed with increased [glucose] was 
wholly due to repression of DPD degradation for this species, DPD flux profiles for cultures 
spiked with 0.04 and 0.14 w/v % (U-13C)glucose were obtained (Figure 2.1A). The maximum 
[(13C5)DPD] was 6.6 ± 0.4and 48.1 ± 0.3 µM in the cultures with 0.04 and 0.14 w/v % (U-
13C)glucose, respectively. Further, the production of unlabeled material continued at nearly 
identical rates in both cultures. These data indicate that the higher [DPD] observed in Figure 
2.1A are partially from upregulated biosynthesis.  
 
For V. harveyi, we sought to determine whether the extracellular [DPD] was controlled by 
biosynthesis or by degrading excess signal in the medium. During flux profiling, labeled 13C-
DPD was detected within 15 min of (U-13C)glucose addition, and 13C-DPD was made 
preferentially to unlabeled DPD as long as (U-13C)glucose was available (30 and 60 min for 0.04 
and 0.14 w/v % (U-13C)glucose, respectively) (Figure 2.2B and Figure S2.5). Further, the sums 
of the [DPD] for all isotopomers from cultures with (U-13C)glucose were nearly identical to the 
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[DPD] observed in previous experiments over the corresponding [glucose] and times (Figure 
S2.5B), indicating that V. harveyi regulates DPD synthesis. Also, the persistence of the initial 
unlabeled DPD shows that the rate of degradation is negligible.  
 
We also sought to determine whether 
the addition of exogenous DPD would 
lead to a misregulation of AI-2 
signaling. This could occur by either 
changing the DPD synthesis rate or 
by triggering DPD importation as 
mechanisms to correct the external 
[DPD]/cell density after recognition of 
the exogenous signal, and the ability 
to differentiate new versus old DPD 
via labeling allowed us to probe 
whether V. harveyi does either. By 
adding 0.14 w/v % (U-13C)glucose 
either with or without 27.7 ± 1.0 µM 
synthetic DPD145 at 3 h and then 
monitoring the (13C5)DPD production for 180 min, it is clear the that V. harveyi does not alter 
DPD synthesis rates in response to exogenous signal (Figure 2.2C). Again, the persistence 
unlabeled DPD rules out significant degradation. In conclusion, we show that a quantitative 
investigation of quorum sensing signal production and biosynthesis can provide insight into the 
true utilization and information content of these molecules. In E. coli, the production of DPD is 
altered by nutritional availability making signaling prone to metabolic noise. In contrast, V. 
harveyi can regulate the DPD production to maintain the fidelity of the cell density related 
information content of this molecule. However, HAI-1 is produced at a constant rate and may be 
used to signal metabolic fitness instead of cell density. 
 
2.3.5 Temporal Effect of autoinducer production in V. fischeri. After the initial study of E. 
coli and V. harveyi, we then went on to study the quorum sensing circuits in two V. fischeri 
wildtype strains, ES114 and the extra bright strain MJ1.9,120,146 These bacteria are known to 
make two AHLs, C8 and 3OC6,120,147 and the interspecies signal, DPD.147 The phenotypes for 
0
2
4
6
8
10
12
0 60 120 180
[D
PD
] ( µµ µµ
M
)
Time (min)
0
2
4
6
8
10
0 60 120 180
[D
PD
] ( µµ µµ
M
)
Time (min)
20
30
4
M
)
0
5
10
15
20
25
30
0 60 120 180
[D
PD
] ( µµ µµ
M
)
Time (min)
40
5 B CA
Figure 2.2. Flux profiling of DPD biosynthesis. 
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both AHLs are known and are thought to act in a temporal cascade. The C8 AHL aids in 
colonization of the squid of which these are found in the ocean, while the 3OC6 turns on 
luminescence.147 It was previously unknown how DPD played into the cascade, however our 
results show that it is the autoinducer synthesized first in the cascade event. We have not 
completed the experiments necessary to determine whether V. fischeri fits our definition as a 
cell density signal.  
 
The growth curves for the bacteria are similar (Figure 2.3a and e) while the acylhomoserine 
lactone concentration varies a fair amount between the two wildtype strains. The DPD 
concentrations for each reach a maximum around 4 hours into the growth curve and 
approximately 1.5 µM of DPD is produced (Figure 2.3c and g). ES114 makes around 2.5 µM 
while MJ1 makes about 10-fold less at 250 nM at 14 h into their growth curve. While the 3OC6 
AHL is out of our detectable range for ES114 (it is reported to make 0.2 nM), MJ1 synthesizes 
around 280 nM of this AHL (Figure 2.3b and f). Our screening of AHLs also allowed us to 
discover two other AHLs, the C6 and C7. There is a single report of the C6 being made by V. 
Figure 2.3. Growth kinetics, production of AI-1s, DPD, and timing cascades of autoinducer 
production for V. fischeri ES114 and MJ1.  (a) and (e) Growth kinetics measured by the OD600 for 
ES114 and MJ1, respectively. (b) and (f) Signal output determined by measuring AI-1 concentration 
(µM), (▲, 3OC6), (●, C8), (♦, C6), and (■, C7) via LC-MS/MS in the supernatants of ES114 and MJ1, 
respectively. (c) and (g) Signal output determined by measuring DPD concentration (µM), via LC-
MS/MS in the supernatants of ES114 and MJ1, respectively. (d) Timing cascade showing autoinducer 
production (DPD, 3OC6, C8, C6, C7) in ES114. Note: There is no 3OC6 AHL detected, and the C6 
and C7 AHL concentrations are multiplied by 10 for clarity. (h) Timing cascade showing autoinducer 
production (DPD, 3OC6, C8, C6, C7) in MJ1. Note: The 3OC6 and C8 AHL concentrations are 
multiplied by 5 and the C6 and C7 AHL concentrations are multiplied by 10 for clarity. 
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fischeri, while this is the first time it has been shown that they make the C7. When graphed all 
together, the temporal pattern of autoinducer can be seen for both ES114 and MJ1 (Figure 2.3d 
and h) potentially signaling different phases of growth for these bacteria. Further studies are 
being done to determine if the previously undescribed AHLs are biologically relevant. 
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2.4 Appendix 
 
2.4.1 Supplemental Figures 
 
 
Figure S2.1. Quorum sensing links extracellular signaling to the activated methyl cycle 
metabolism. AI-2 is made during a critical methionine salvage step, and species that produce 
AHL-type AI-1 signals have a further link between metabolism and cell – cell signaling.  
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Figure S2.2. Glucose uptake, growth kinetics, and viability tests. Data for each culture grown in 
media with 0.00 (▲), 0.08 (■), 0.14 (●), and 0.20 (♦) w/v % added glucose. (A) and (B) Growth 
kinetics measured by the OD600 for E. coli and all V. harveyi respectively. (C) Viability tests for 
V. harveyi  grown in media with 0.00 and 0.14 w/v % added glucose sampled at 6.5 h.  (D) and 
(E) Glucose uptake observed by a glucose oxidase colorimetric assay in the supernatants for all 
E. coli, and all V. harveyi during DPD analysis, respectively. Measurements for (A), (C), and (D) 
were performed in duplicate. Measurements for (B) and (E) were performed in quadruplicate. 
Error bars express the range of the data for all experiments. The 0 time point for each has not 
been shown as the OD600 was below the detection limit. The glucose values are reported as the 
percent sugar remaining, and all plots are normalized to the 0.20 w/v % sample.  
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Figure S2.3.  Selection of appropriate SRMs for flux experiments. (A) Biosynthetic routes to 
isotopically labeled ribulose-5P a common precursor to DPD. (B) Relevant isotopomers of DPD 
and their corresponding quinoxaline derivatives and SRMs listed as parent m/z – fragment m/z. 
(C) Relative intensities of all possible SRMs of (13C5)DPD-M1CQ.  Reported numbers are the 
average of four experiments using cell-free supernatants of V. harveyi 120 min after addition 
0.14 w/v % (U-13C)glucose plus 28 µM DPD or 0.14 w/v % (U-13C)glucose with no added DPD. 
Error bars express the range of the data. (D) and (E) graphs depicting analogous SRMs for 
(13C5)DPD-M1CQ and DPD-M1CQ, respectively.  
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Figure S2.4.  Production of DPD Probed by Flux Analysis. E. coli and V. harveyi cultures 
were spiked with either 0.04 or 0.14 w/v % (U-13C)glucose once the initial glucose pool was 
depleted (2.5 and 3 h, respectively) and the incorporation of the isotope into DPD was 
monitored for 180 min. The concentration of unlabeled DPD (▲), (13C3)DPD (●), (13C2)DPD (■), 
and (13C5)DPD (♦) are given. (A) and (B), DPD isotopomer concentrations ([DPD], µM) in the 
supernatants of E. coli with 0.04 or 0.14 w/v % (U-13C)glucose, respectively. (C) and (D), DPD 
isotopomer concentrations ([DPD], µM) in the supernatants of V. harveyi with 0.04 or 0.14 w/v % 
(U-13C)glucose, respectively. Panels (E) and (F), V. harveyi with 0.14 w/v % (U-13C)glucose plus 
28 µM DPD and V. harveyi with 0.14 w/v % (U-13C)glucose and no added DPD, respectively. 
Data were collected in duplicate, and the error bars express the range of the data.  
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Figure S2.5. Glucose uptake, sum of all DPD isotopomer concentrations and growth kinetics 
from flux experiments. Data for cultures spiked with either 0.04 (■) or 0.14 (●) w/v % (U-
13C)glucose, and 0.14 w/v (U-13C)glucose plus 28 µM DPD (▲). (A), (B), and (C) Glucose 
uptake observed by a glucose oxidase colorimetric assay in the supernatants of E. coli, V. 
harveyi,  and V. harveyi  with 28 µM added DPD, respectively. (D), (E), and (F) Total DPD 
concentration of all isopomers measured for E. coli, V. harveyi,  and V. harveyi  with 28 µM 
added DPD, respectively. (G), (H), and (I) Growth kinetics measured by OD600 for E. coli, V. 
harveyi, and V. harveyi  with 28 µM added DPD, respectively. All measurements were 
performed in duplicate, and the error bars express the range of the data. The glucose values 
are reported as the percent sugar remaining, and all plots are normalized to the 0.14 w/v % 
sample.  
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2.4.2 Methods 
 
General Methods. Optical densities were measured on a BioPhotometer (Eppendorf), and all 
absorbance measurements for the glucose oxidase assay were performed on a µQUANT 
Universal Microplate Spectrophotometer (Bio-Tek Instruments, Inc.). The liquid 
chromatography-tandem mass spectrometer (LC-MS/MS) used for these studies consisted of 
either a Surveyor Autosampler Plus (Thermo Electron Corporation), a Surveyor MS Pump Plus 
(Thermo Electron Corporation), or an Agilent 1100 Series HPLC and a TSQ Quantum Discovery 
Max triple quadrupole MS (Thermo Electron Corporation). All MS spectra were collected and 
analyzed using the Xcalibur MS software package (Thermo Electron Corporation). The 
stationary phase of the column was aminopropyl functionalized particles (5 µm pore size, 100 Å 
particle size) packed into a 250 × 2 mm column (Phenomenex Luna NH2) for the DPD analysis 
and a Gemini-NX C18 (5µm pore size, 110 Å particle size) packed into a 150 × 2 mm column 
(Phenomenex) for the HAI-1 Analysis. (S)-4,5-Dihydroxy-2,3-pentanedione (DPD)145, (13C1)-(S)-
4,5-Dihydroxy-2,3-pentanedione ((13C)DPD)145 and the derivatizing agent, dimethyl 2,2'-(4,5-
diamino-1,2-phenylene)bis(oxy)diacetate ● xHCl (M1CQ)137 were prepared according to 
reported methods. The following chemicals were commercially available as an ACS grade 
compound and used without further purification unless otherwise noted: water (HPLC, VWR 
International), sodium dihydrogen phosphate dihydrate (99+%, Fluka Chemical), glycerol (J.T. 
Baker), and sulfuric acid (Mallinckrodt). All other reagents listed below were ordered from Fisher 
Scientific: Acetonitrile (HPLC), ethyl acetate, sodium chloride, cyclohexanone, 
Tris(hydroxymethyl)aminomethane (Tris) (99+ %), kanamycin monosulfate (biotech reagent), 
tryptone, yeast extract, glucose, o-dianisidine, peroxidase, and glucose oxidase type X. 
 
Bacterial Strains and Growth Conditions. Escherichia coli BW25113 (wild type)148 was 
established as part of the Keio Collection and purchased from the Coli Genetic Stock Center 
(Yale University). Cultures of E. coli were grown aerobically in Luria broth (LB)149 at 37oC with 
shaking (~100 rpm). Vibrio harveyi  BB120 (wild type)5 was a gift from Bonnie L. Bassler 
(Princeton University and the Howard Hughes Medical Institute). Cultures of V. harveyi were 
grown aerobically in Luria marine medium (LM)119 at 30oC with shaking (~100 rpm). 
 
Chromatographic Details for DPD detection. High performance liquid chromatography 
(HPLC) was performed utilizing a quaternary pump to generate a gradient for the elution of 
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compounds from the stationary phase. For all samples, 10 µL was injected onto the column via 
an autosampler cooled to 4 °C. A flow rate of 150 µL / min was used, and the eluent was 
introduced directly into the MS for ion detection. The mobile phases were HPLC grade water 
(solvent A) and HPLC grade acetonitrile (solvent B), and these were used to construct the 
following 18 min gradient elution profile: (t ) 0 min, 15% solvent A, 85% solvent B; t ) 2 min, 15% 
solvent A, 85% solvent B; t ) 4 min, 95% solvent A, 5% solvent B; t ) 14, 95% solvent A, 5% 
solvent B; t ) 16, 15% solvent A, 85% solvent B; t ) 18, 15% solvent A, 85% solvent B). All 
separations were performed with the column at ambient temperature. 
 
Chromatographic Details for HAI-1 detection. High performance liquid chromatography 
(HPLC) was performed utilizing a quaternary pump to generate a gradient for the elution of 
compounds from the stationary phase. For all samples, 10 µL was injected onto the column via 
an autosampler. A flow rate of 150 µL / min was used, and the eluent was introduced directly 
into the MS for ion detection. The mobile phases were 0.1% Acetic Acid (solvent A) and HPLC 
grade acetonitrile (solvent B), and these were used to construct the following 13 min gradient 
elution profile: (t) 0 min, 95% solvent A, 5% solvent B; t) 1 min, 95% solvent A, 15% solvent B; t) 
3 min, 50% solvent A, 50% solvent B; t) 8 min, 50% solvent A, 50% solvent B; t) 10 min, 5% 
solvent A, 95% solvent B; t) 12 min, 5% solvent A, 95% solvent; B t) 0 min, 95% solvent A, 5% 
solvent B). All separations were performed with the column at 25 oC. 
 
General Mass Spectrometric Detection Parameters. Samples were introduced into the 
electrospray ionization (ESI) chamber of the triple quadrupole MS  through a 0.1 mm internal 
diameter fused silica capillary after delivery by HPLC as described above. The spray voltage for 
the ESI source was set to 4500 V, and detection occurred in positive ion mode. Nitrogen was 
used as the sheath gas (40 psi), and the inlet capillary temperature was 290 °C. The argon used 
as the collision gas was set at 1.5 mTorr. Samples were analyzed using selected reaction 
monitoring (SRM), and the scan time for each SRM was 0.05 s with a scan width of 1 m/z.  
  
Measurement of DPD Concentration ([DPD]) by Derivatization with a Substituted 1,2-
Diaminobenzene. Samples were prepared as previously reported137 with only the minor 
addition of an extraction step.  At each timepoint, a 300 µL aliquot of the culture was sampled 
and then added to a 1.5 mL microcentrifuge tube containing a solution of the (13C1)-(S)-4,5-
Dihydroxy-2,3-pentanedione internal standard ((13C)DPD)  (341 µM in 10 µL H2O) to give a 310 
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µL volume solution (solution A) containing 11 µM internal standard. The contents were 
thoroughly mixed by vortexing and then centrifuged (13,200 rpm, 16,100 rcf, 1 min) to remove 
cells and other particulates. A portion of the resulting supernatant (260 µL) was then transferred 
to a separate 1.5 mL microcentrifuge tube containing a solution of derivatizing agent, dimethyl 
2,2'-(4,5-diamino-1,2-phenylene)bis(oxy)diacetate ● xHCl  (M1CQ) (14 mM in 26 µL H2O)  to 
give a 286 µL volume solution (solution B) containing 1.3 mM M1CQ. The two liquids were 
thoroughly mixed by vortexing, and reaction was allowed to proceed for 45 min at ambient 
temperature. At this point, the reaction mixture (solution B) was extracted twice with 130 µL 
ethyl acetate, and the organic layers were combined in a 300 µL screwcap autosampler vial. 
Samples were stored at 4 °C until MS analysis. Note: Extraction with ethyl acetate removes 
excess salts and derivatizing reagent from the reaction samples without hindering quantitation 
due to the use of an internal standard. This purification step minimizes the amount of 
contaminates that are introduced into the MS. 
 
Measurement of HAI-1 Concentration ([HAI-1]). At each timepoint, a 300 µL aliquot of the 
culture was sampled and then added to a 1.5 mL microcentrifuge tube containing a solution of 
the N-(3-hydroxybutanoyl)-L-homoserine lactone internal standard ((D2)HAI-1)  (526 µM in 11.4 
µL H2O) to give a 310 µL volume solution containing 19.25 µM internal standard. The contents 
were thoroughly mixed by vortexing and then centrifuged (13,200 rpm, 16,100 rcf, 1 min) to 
remove cells and other particulates. A portion of the resulting supernatant (260 µL) was then 
transferred to a separate 1.5 mL microcentrifuge. The supernatants were then extracted twice 
with 130 µL ethyl acetate, and the organic layers were combined in a 300 µL screwcap 
autosampler vial. Samples were then used immediately for MS analysis. Note: Extraction with 
ethyl acetate removes excess salts from the reaction samples without hindering quantitation due 
to the use of an internal standard. This purification step minimizes the amount of contaminates 
that are introduced into the MS. Acyl homoserine lactones have been readily detected via 
LC/MS methods29,68-69,150-153, and our method had a limit-of-detection (LOD) for (D2)HAI-1 of 5.3 
nM and a linear range from 5.3 nM to 66 µM. 
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Data Handling for [DPD]. Data from SRMs 381-202 and 382-203 (parent-product ion) with a 
collision energy of 43 eV were selective for the quinoxalines DPD-M1CQ and (13C1)DPD-M1CQ 
respectively and were used to calculate [DPD]. Chromatographic peaks were manually 
integrated over the same time interval within a sample. Integrations were then corrected by one 
of two methods depending on the ratio of (12C)DPD-M1CQ signal to (13C)DPD-M1CQ signal. 
Correction Type 1 is a correction for (12C)DPD impurities in the (13C)DPD internal standard and 
was applied when the ratio of (12C)DPD-M1CQ to (13C1)DPD-M1CQ was less than 0.2 
 
		
	12CDPD-M1CQ	
= 			
	DPD-M1CQ		– 	0.008
× 		
	13C1DPD-M1CQ	 
 
Correction Type 2 is a correction for naturally occurring (13C1)DPD or other [M+1] DPD 
molecules and was applied when the ratio of DPD-M1CQ to (13C1)DPD-M1CQ was greater than 
0.3 
 
		
	13C1DPD-M1CQ	
= 			
	13C1DPD-M1CQ		– 	0.144
× Observed	Signal	12CDPD-M1CQ 
 
After correction, the following formula was applied to calculate the [DPD] of the culture. 
 
Signal	DPD-M1CQ		
Signal	13C1DPD-M1CQ	
× 	 213C1DPD	in	solution	A7 ×
volume	solution	A
volume	culture	sampled
=	 2DPD7 
 
For experiments measuring isotopomers, the additional SRMs 383-203, 384-205, 386-206 were 
monitored for quantitation of (13C2)DPD-M1CQ, (13C3)DPD-M1CQ, and (13C5)DPD-M1CQ 
respectively. Corrected ion counts for (13C1)DPD-M1CQ were still used due to the presence of 
DPD in solution. Isotopomer concentrations were then calculated using the following formula. 
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Signal	Isotopomer	
Signal	13C1DPD-M1CQ	
× 	 213C1DPD	in	solution	A7 ×
volume	solution	A
volume	culture	sampled
=	 2DPD7 
 
Data Handling for [HAI-1]. Data from SRMs 188-102 and 190-104 (parent-product ion) with a 
collision energy of 11 eV were selective for the HAI-1 and (D2)HAI-1 respectively and were used 
to calculate [HAI-1]. Chromatographic peaks were manually integrated over the same time 
interval within a sample. 
 
The following formula was applied to calculate the [HAI-1] of the culture. 
 
Signal	HAI-1		
Signal	D2HAI-1	
× 	 2D2HAI-1	7 = 	 2HAI-17 
 
Establishment of an External Calibration Curve for Colorimetric Glucose Oxidase Assay. 
A set of wells containing 110 µL solutions of known glucose concentrations ([glucose]) were 
established on each assay plate so that an external calibration curve could be constructed to 
allow quantitation.  This set of calibration solutions contained 0.3960, 0.1980, 0.0990, 0.0495, 
0.0248, 0.0124, 0.0062, and 0 w/v % glucose and were generated by diluting 2.2 µL of a 40 w/v 
% glucose stock solution into 220 µL LB followed by two-fold serial dilutions. Aliquots (12 µL) of 
the calibration curve were transferred to different wells and diluted with 90 µL LB such that each 
sample plate had two calibration curves at two different sets of concentrations (undiluted and 
12:102 dilution). This dilution step was necessary to fit the higher glucose concentrations into 
the linear range of the assay. The calibration standards for each plate were used to generate a 
calibration equation by least-squares regression of the linear portion of the data (0 to 0.0248 % 
for the undiluted curve and 0 to 0.0990 % for the diluted curve) of the form: 
 
A500 = > × 2?7 	+ 	 
 
This equation was then used to determine the glucose concentrations from the absorbance 
measured for each sample. The undiluted calibration curve and samples were used to calculate 
[glucose] for all experiments performed without the addition of glucose. When either 0.08, 0.14, 
or 0.20 w/v % glucose was added to the culture, the diluted calibration curve was used as the 
samples also required dilution to bring the values into linear range. The assay was not found to 
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be quantitative, however it was qualitatively useful. [Glucose] was therefore normalized to the 
highest concentration (0.2 % added) and reported as % added glucose remaining.  
 
Measurement of Glucose Concentrations by Colorimetric Glucose Oxidase Assay. For 
each time point, a 150 µL aliquot of the culture was added to a 1.5 mL microcentrifuge tube and 
centrifuged (13,200 rpm, 16,100 rcf, 1 min) to remove cells and other particulates. At this time, 
130 µL of the supernatant was transferred to a new 1.5 mL microcentrifuge tube, and the 
samples were immediately frozen and stored at -80 °C until the assay was performed (no longer 
than 48 h after collection). After all samples were collected, a 112 µL aliquot of each was 
transferred to a clear, flat-bottomed, 96-well plate.  Aliquots (12 µL) of the cell supernatants 
were then transferred to different well and diluted with 90 µL LB such that each sample was 
measured at two different concentrations (undiluted and 12:102 dilution).  A 200 µL aliquot of an 
assay reagent154 containing 0.30 M Tris, 0.36 M NaH2PO4 ●2H2O, 5.4 M glycerol, 1.0 mM o-
dianisidine, 3 kU/ L peroxidase and 1 kU/L glucose oxidase type X in water was added to each 
well and the plate was incubated for 15 h at 37 °C. At this time, the absorbance at 500 nm was 
measured, and the [glucose] was calculated according to the method described above.  
 
Measurement of Cell Density by Optical Density. For early time points (t = 0 – 2.75 h  E. coli 
or t = 0 – 3.5 h V. harveyi),  cell density was determined by measuring the OD600 of 700 µL 
aliquots of each culture, a 300 µL portion of this aliquot was then used to measure [DPD], and a 
150 µL portion of this aliquot was used to determine [glucose]. For later time points, the optical 
density was above the linear range of the spectrometer, therefore a 300 µL aliquot of each 
culture was mixed with 900 µL of fresh media, mixed and cell density was determined by 
measuring the OD600 of the diluted samples. For points that required dilution, separate aliquots 
of 300 µL and 150 µL were taken directly from the culture for the determination of [DPD] and 
[glucose] respectively and used immediately. All [DPD] and [glucose] measurements were 
performed as described above. 
 
Measurement of Culture Viability. A 5 mL culture of V. harveyi  was grown overnight in LM. 
The overnight culture was then used to make 2 v/v % inocula in each of two 125 mL glass 
Erlenmeyer flasks by diluting 500 µL of the culture into 25 mL LM supplemented with either 0.00 
or 0.14 w/v % glucose. After 6.5 h of growth, aliquots (10 µL) were diluted 1:100 into LM and 8 
ten-fold serial dilutions were made (10 µL into 100 µL LM). Aliquots (10 µL) of each dilution 
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were then spread on LM plates in duplicate and incubated at 30oC overnight. The number of 
colonies was then counted and converted to colony forming units (CFU) per mL using the 
following equation. 
 
A?>	B	
	C	
?
	B	 ÷ 	10	μF	C	1000	μF	/	>F 
 
Monitoring Extracellular AI-2 Under Varying Nutrient Conditions. For each experiment, a 5 
mL culture of the strain of interest was grown overnight in appropriate media as described 
above. The overnight cultures were then used to make 2 v/v % inocula in each of four 125 mL 
glass Erlenmeyer flasks by diluting 500 µL of the culture into 25 mL LB (E. coli) or LM (V. 
harveyi) supplemented with either 0.00, 0.08, 0.14, or 0.20 w/v % glucose. Cultures were 
sampled for [DPD] and [glucose] at the time intervals indicated and analyzed as described 
above. 
 
Monitoring Extracellular V. harveyi Autoinducer-1 Under Varying Nutrient Conditions. For 
each experiment, a 5 mL culture of the strain of interest was grown overnight in appropriate 
media as described above. The overnight cultures were then used to make 2 v/v % inocula in 
each of four 125 mL glass Erlenmeyer flasks by diluting 500 µL of the culture into 25 mL LB (E. 
coli) or LM (V. harveyi) supplemented with either 0.00, 0.08, 0.14, or 0.20 w/v % glucose. 
Cultures were sampled for [HA1-1] and [glucose] at the time intervals indicated and analyzed as 
described above. 
 
Flux Profiling of Nutrient Effects on DPD Biosynthesis. Two overnight cultures of the strain 
to be tested were grown overnight in either LB or LM for E. coli or V. harveyi strains, 
respectively. A 500 µL aliquot of the overnight cultures were then used to make 2 v/v % inocula 
in each of four 125 mL glass Erlenmeyer flasks containing 25 mL LB (E. coli) or LM (V. harveyi). 
After 2.5 h (E. coli) or 3 h (V. harveyi) of growth, 0.04 or 0.14 w/v % (U-13C)glucose (25 and 88 
µL of 40 w/v% in H2O) was added to each culture. Cultures were sampled at the time intervals 
indicated and analyzed as described above.  
 
Flux Profiling of Exogenous DPD Effects on DPD Biosynthesis. Two overnight cultures of 
V. harveyi to be tested were grown overnight in LM. Aliquots (500 µL) of the overnight cultures 
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were then used to make 2 v/v % inocula in each of four 125 mL glass Erlenmeyer flasks 
containing LM. After 3 h of growth, 0.14% glucose (40 w/v% in 88 µL H2O) was added to each 
culture, as well as either synthetic (12C)DPD to make 28 µM solutions of exogenous DPD (133 
µL of 4.7 mM DPD in H2O) or a control solution of acidic cyclohexanone (133 µL of 4.7 mM 
cyclohexanone pH=1 in H2O) to account for other constituents of the synthetic DPD solution. 
Cultures were sampled at the time intervals indicated and analyzed as described above.  
 
Generation of 3-Dimensional Plots Displayed in Figure 2.1. A Microsoft Excel 2007 
spreadsheet was created containing columns for time (h), intitial [glucose] added (w/v %), 
[AI]/OD600 (µM/OD) replicate 1, [AI]/OD600 (µM/OD) replicate 2, and the calculated average of 
[AI]/OD600 (µM/OD). These data were then imported into a MATLAB 7.9 workspace as vectors. 
The plot3 function was used to plot the average [AI]/OD600 data. The meshgrid, griddata, and 
mesh functions were then used to create the mesh surface with time on the x axis, initial 
[glucose] added on the y axis, and average [AI]/OD600 on the z axis. The higher of the two 
values measured for the [AI]/OD600 from the replicate experiments was graphed to indicate the 
upper range of the error. These points are displayed as error bars generated with the plot3 
function. Because of the opaqueness of the surface, the lower error bars were not graphed. 
However, since the [AI]/OD600 data is averaged from two points and the error indicates the 
range, the magnitude of the upper and lower error bars is equal. 
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CHAPTER III 
METABOLIC EFFECTS OF QUORUM SENSING MOLECULES IN 
MARINE BACTERIA 
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Portions of this chapter was originally published by Benjamin A. S. Van Mooy, Laura R. Hmelo, 
Laura E. Sofen, Shawn R. Campagna, Amanda L. May, Sonya T. Dyhrman, Abigail Heithoff, 
Eric A. Webb, Lily Momper and Tracy J. Mincer: 
Benjamin A. S. Van Mooy*, Laura R. Hmelo, Laura E. Sofen, Shawn R. Campagna, Amanda 
L. May, Sonya T. Dyhrman, Abigail Heithoff, Eric A. Webb, Lily Momper and Tracy J. Mincer. 
“Quorum sensing control of phosphorus acquisition in Trichodesmium consortia.” The ISME 
Journal (2012) 6, 422–429; doi:10.1038/ismej.2011.115 
 
The Trichodesmium parts of this chapter were taken as is from the submitted form of the 
manuscript listed above. Trichodesmium data collection was performed by BASVM, LRM, LES, 
STD, AH, EAW, LM, and TJM on board a cruises to the north Atlantic and Pacific Oceans. DPD 
measurements and data analysis were performed by ALM and SRC. 
 
3.1 Abstract 
 
Colonies of the cyanobacterium Trichodesmium are abundant in the oligotrophic ocean, and 
through their ability to fix both CO2 and N2 play pivotal roles in the cycling of carbon and nitrogen 
in these highly nutrient-depleted environments.155-156  Trichodesmium colonies invariably include 
complex consortia of epibiotic heterotrophic bacteria,157-161 and yet the role of these epibionts in 
nutrient acquisition is unknown.  Here we show that bacterial quorum-sensing (QS) acts as a 
control on the alkaline phosphatase (APase) enzymes used by epibionts in the acquisition of 
phosphate from dissolved organic phosphorus (DOP) molecules.157,162   We found that a class of 
QS molecules, acylated homoserine lactones (AHLs), were produced by cultivated epibionts, 
and that adding these AHLs to Trichodesmium colonies collected at sea led to a consistent 
doubling of APase activity.  By contrast, (S)-4,5-dihydroxy-2,3-pentanedione (DPD) - the 
precursor to autoinducer-2 (AI-2) family of universal interspecies signalling molecules136,163-164 - 
caused repression of APase activity.  Colonies collected at sea were found by high performance 
liquid chromatography/mass spectrometry to contain both AHLs and AI-2, and both types of 
molecules were found to turn over rapidly, an observation that we ascribe to quorum-quenching. 
Furthermore, AI-2 synthesis was rapidly induced by exogenous AHLs, suggesting a counter-
response to quorum-quenching.  Overall our data reveal a complex chemical interplay among 
epibionts using AHLs and AI-2 to control access to phosphate in DOP. While APase activity in 
Trichodesmium colonies may generally reflect availability of phosphate in the environment,162 
our data indicate that microscale microbial interactions158,165 may be equally important in 
effecting the success of Trichodesmium in obtaining phosphate in the oligotrophic ocean. 
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After learning about the effects of DPD and AHLs on epibionts APase activity, we set forth to 
study the metabolic effects that these two quorum sensing molecules have marine bacteria. We 
first chose a marine species, Sulfitobacter NAS14-1, isolated from the North Atlantic Ocean166 
and found that the metabolic differences between the additions of AHLs and DPD also have 
opposing effects on certain groups of metabolites. We also measured the AHL and DPD 
concentrations throughout the experiment. This species was found to synthesize 3OC6, C8, 
3OHC8, 3OC8, C10, 3OHC10, and 3OC10 AHLs and has two known LuxI homologues. We 
also studied the metabolism of mixed cultures from the Sargasso Sea. These were also 
incubated with DPD or AHLs and the same trends were observed. These studies show how 
metabolism is altered by exogenous quorum sensing molecules, and how these molecules can 
also change the dissolved organic matter (DOM) content in the ocean. 
 
3.2 Introduction 
 
Quorum sensing molecules have long been shown to alter phenotypic behavior in single culture 
lab bacterial studies.13-14,19,23,31-55,167 However, it has yet to be shown whether these molecules 
have an effect on the intracellular concentration of metabolites in these cultures. Not only would 
understanding how bacteria react to changing concentrations of inter- and/or intra-cellular 
signaling molecules help us to understand the mechanism of which they are used, but when 
applied to broader environmentally relevant studies, we can start to ask questions such as can 
nutrient cycling in the ocean be further understood by knowing how these molecules change the 
concentration of metabolites released from cells. 
 
3.2.1 Mass Spectrometry Based Metabolomics. Metabolomics is the study of the whole small 
molecule content (metabolome) of a cell at a specific time.60 Understanding the complete 
biological system post translationally complements data from genomics, transcriptomics, and 
proteomics. This allows us to obtain a real time picture of what is taking place in the cell while 
other “omics” fields tell us what the system is capable of doing (Figure 3.1). The current state of 
the system allows us to understand potential mutations in the system, real time relative 
concentrations of the small molecule content, and how things can change over a short time 
period. 
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Unlike the other “omics” fields where similar chemical functionality, e.g. proteins or nucleic 
acids, is typically measured, the chemical diversity in properties of small molecules creates a 
challenging analytical problem as compound classes like amino acids, lipids, sugars, and 
carbohydrates all have very different 
properties. Along with the many 
structurally different metabolites leading 
to analytical challenges, concentrations 
of these metabolites also vary over a 
large magnitude, up to five fold.109 
These challenges have led us to adopt 
a liquid-chromatography/tandem-mass 
spectrometry (LC-MS/MS) method from 
the Rabinowitz lab at Princeton168-169 that 
allows us to look for ~400 known water 
soluble metabolites using multiple 
reaction monitoring (MRM) technology 
on a triple quadrupole mass 
spectrometer. 168-169 
 
The LC-MS/MS system provides a 
three-dimensional separation of 
metabolite mixtures. A crude separation 
on a reverse phase column introduces 
metabolites into the mass spectrometer via an electrospray ionization (ESI) source, a soft 
ionization technique that does not fragment molecules. Each compound is then detected using a 
selected reaction monitoring (SRM) event where a unique parent-fragment mass-to-charge ratio 
(m/z) is chosen and observed (Figure 3.2). The first mass analyzer (quadrupole) is used to 
detect the parent mass of the compound while the third mass analyzer detects a specific 
fragment mass.170 This allows for distiguishing between molecules of the same parent ion m/z to 
be observed separately, for example, leucine and isoleucine can be detected by their unique 
fragmentation.  
 
What the
system is
capable
of doing
P
Gene
mRNA
Protein
Modified 
Protein
TRANSCRIPTION
TRANSLATION
POST-TRANSLATIONAL
MODIFICATION
ENZYME 
ACTIVITY
Metabolites
Current
state of
the
system
Figure 3.1. Depiction of what metabolomics 
actually measures. Metabolomics measures the 
actual state of the system after proteins are 
modified for their enzyme activity. Other “omics” 
measure what the system is set up to do instead 
of depicting the current state of the cell.  
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While the ability to 
separate molecules 
based on their specific 
parent m/z – fragment 
m/z is excellent for 
mass spectrometric 
identification, the 
method is time limited 
by the requirement to 
scan for each of these 
SRM pairs listed in the 
method. The scan 
time needed to detect any peak during a run is diminished when looking for a large number of 
molecules. Instrument burden can be alleviated by separating the metabolites into segments in 
which only the metabolites which elute during a range of retention times are monitored. When 
using the segmentation capability in the method and the crude LC separation to group the 
metabolites, we are able to look for close to 400 metabolites168-169 (Tables S3.1 and S3.2). 
 
This method is known as targeted metabolomics. With such techniques we tell the mass 
spectrometer exactly what molecules to look for by giving the instrument the parent m/z, 
fragment m/z, and the collision energy required to fragment the molecule. While such methods 
are useful for identification of the metabolites and quantitation, they do not allow for molecular 
discovery. Untargeted metabolomics experiments scan for everything and using the full scan 
mode and rely on retention time and exact mass to identify known metabolites. Using this 
method, potential new targets can be identified for further testing. The triple quadrupole is not 
capable of measuring exact mass therefore the following experiments were ran using SRM 
based methodology.  
 
3.2.2 Marine Microbial Metabolism and Oceanic Nutrient Cycling. Excreted metabolites 
from marine organisms make up a portion of dissolved and particulate organic matter (DOM and 
POM, respectively) within the world’s oceans (Figure 3.3). The mechanism by which DOM and 
POM effect nutrient cycling is understudied. It is known that ~50% of the primary production 
occurs in the oceans, and the release of DOM and POM from photosynthetic phytoplankton 
Q1 Q3Collision Cell Ion Detector
2nd Tier Separation:
Parent m/z
3rd Tier Separation:
Fragment m/z
1st Tier Separation:
Retention Time
Electrospray
Ion Source
TRIPLE QUADRUPOLE MASS SPECTROMETER
Figure 3.2. Triple quadrupole mass spectrometer showing the 
selected reaction monitoring reactions with three levels of 
specificity. 
125 
 
feed heterotrophic bacteria.171-172 
The overall metabolism of 
microorganisms is then affected by 
the changes in the DOM and POM 
pools of the surrounding 
community.73-74 These interactions 
then influence the redistribution of 
nutrients among species.  
 
Roseobacters are a clade of marine 
microorganisms that represent up to 
20% of species in the coastal 
marine environment and are found 
throughout the open ocean as 
well.173 These bacteria have been 
isolated from natural systems such 
as coastal environments, the open 
ocean, and marine sinking 
particles.174 They have also been shown to produce AHLs, and most organisms sequenced from 
the open ocean have shown to have LuxI homologues. The Sulfitobacter strain chosen for this 
laboratory study (NAS14-1) was isolated from the North Atlantic Ocean166  and has two 
sequenced N-acyl homoserine lactone synthetases (Figure 3.1). 
 
Components of DOM and POM can be affected by multiple avenues (Figure 3.3). Marine 
bacterial metabolism can change the uptake and/or release of small molecule metabolites. The 
changes in the surrounding DOM can also affect intracellular metabolite concentrations. 
Quorum sensing molecules, such as DPD and AHLs, might have the ability to alter metabolism 
due to their link to the activated methyl cycle (Figure S2.1). The following is a report describing 
how addition of extracellular DPD or AHLs can change the metabolism of a natural Sulfitobacter 
NAS14-1.  
 
Complementary field metabolomics were then performed on board a research cruise to the 
Sargasso Sea. Sinking particles were collected and treated with quorum sensing molecules in 
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phytoplankton
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Figure 3.3. Depiction of the microbial food web in 
the ocean. Picture adapted from Sherr and Sherr.1-2 
Solid and dashed arrows depict the pathways in 
which organic matter is consumed and released, 
respectively. The food web can be divided into two 
sets of organisms, photosynthetic and heterotrophic. 
The microbial component of the food wed is indicated 
in black.  
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order to study the potential changes in metabolism of particle associated bacteria. These 
bacteria are partially responsible for the DOM cycling in the ocean as they are found deeper in 
the ocean, and it has been shown that the bacteria associated with marine snow potentially 
have the ability to quorum sense.174 Of these isolated strains, the Roseobacter clade was well 
represented among the AHL producing bacteria observed.174 
 
3.2.3 Trichodesmium and Alkaline Phosphatase Activity. Cyanobacteria of the genus 
Trichodesmium are key members of the phytoplanktonic community in the oligotrophic regions 
of the ocean.  Nutrients are very scarce in these environments, yet Trichodesmium are highly 
successful, contributing a significant fraction of CO2 fixation in their environment.156 One of the 
key adaptations of Trichodesmium to its environment is the ability to fix N2,155 which is highly 
abundant. However, the scarcity of other nutrients can limit the rates at which Trichodesmium fix 
both N2 and CO2. 175-176  In the subtropical North Atlantic Ocean, phosphorus limitation of 
Trichodesmium has been predicted by models of ocean biogeochemistry177 and demonstrated 
in field studies employing a variety of molecular,158 microscopic,157,162 and incubation-based 
approaches.175-176   
In the open ocean Trichodesmium occur in colonies from 0.5 to 4 mm in diameter, and contain a 
diversity of other types of cells, including heterotrophic bacterial epibionts that together with 
Trichodesmium form a consortium that is highly adapted to the nutrient-poor conditions of the 
open ocean.  Cell densities of epibionts in Trichodesmium colonies can be three orders of 
magnitude greater than cell densities in surrounding waters.161  It has been shown that both 
Trichodesmium and their epibionts are capable of expressing alkaline phosphatases 
(APases),157,162 the enzymes that are used to acquire phosphate from dissolved organic 
phosphorus (DOP) molecules. However, the factors that impact the division of APase activity 
between Trichodesmium and epibionts within individual colonies are unknown.  Quorum sensing 
(QS) is a cell-density dependent signalling system used to coordinate behaviours among 
bacteria, and  Proteobacteria similar to those associated with Trichodesmium colonies are 
known to employ QS systems based on acylated homoserine lactones (AHLs; Suppl. Fig. 
1).160,178-179  Furthermore, we have recently found that AHL-based QS is sustainable at the cell 
densities typical of Trichodesmium colonies.180-181  Thus, we hypothesized that the bacterial 
epibionts on Trichodesmium use AHL-based QS to regulate the expression of APase activity. 
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3.2.4 Sampling on Board a Research Vessel. There are two main types of sampling devices 
possible aboard a research vessel (R/V) (Figure 3.4a). A CTD (conductivity, temperature, and 
depth sensor) is used to collect open ocean water at a specific depth (Figure 3.4c). This device 
allows for collection of data concerning the physical properties of the ocean at a specific location 
as well as water sampling. Bacterial counts in the ocean are much lower than those obtained in 
the lab and therefore collecting samples from CTDs that rely on high cell counts can be 
problematic. This technique, however, allows for the collection of data from different depths of 
the ocean. 
 
(a)
(b)
(c)
Figure 3.4. Sampling on board a research vessel. (a)The R/V Atlantic Explorer where the cruise 
samples  were taken. (b) Traps sent out to the ocean to collect sinking particles for 24 h at 150 m. (c) 
CTD sent out to collect samples at different depths.  
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The second type of device used to collect samples is traps (Figure 3.4b). Traps can be 
deployed from hours to weeks at a time at a specific depth and collect sinking particles (marine 
snow). Due to a membrane that allows water to escape, the traps essentially act as a 
concentration vessel. A large amount of DOM movement in the ocean can be ascribed to the 
microorganisms associated with these sinking particles. These are the ideal sampling technique 
to study the effects of quorum sensing molecules affect on marine microbial metabolism and the 
contributions this may have to DOM cycling in the ocean.  
 
Sampling from these traps on board the R/V was done by deploying the traps to 150 m in the 
open ocean. They are allowed to collect particles for 24 h before being recollected. In order to 
retrieve traps without sample loss, the collection cone is folded. This also ensures that 
unwanted microbes from higher depths are not collected. Once it is on board, the particles were 
split into eighths in order to share with all cruise participants. If the volume of sample needed to 
be increased, it was diluted with 
filter sterilized water from the same 
depth.  
 
3.3 Results and Discussion 
 
3.3.1 Trichodesmium APase 
Activity is Affected by AHL 
addition. During a cruise to the 
oligotrophic North Atlantic Ocean 
(BATS station; 31.8oN 64.1oW) we 
collected Trichodesmium colonies 
and isolated bacterial epibionts 
from these colonies on agar plates. 
In Vibrio isolates we observed the 
production of 3-oxo substituted, 
medium chain-length AHLs (e.g. 3-
oxo-octanoyl homoserine lactone 
(3-oxo-C8-HSL)), while in 
Figure 3.5. APase activity of Trichodesmium 
colonies in response to amendment with a cocktail of 
non-substituted, long-chain AHLs (C10-HSL, C12-
HSL and C14-HSL) in the North Atlantic and North 
Pacific.  Error bars indicate the magnitude of the 
range for triplicate incubations. Data are presented 
as a ratio to the no amendment control incubations. 
The horizontal dashed line represents no response to 
the amendments. 
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Erythrobacter isolates we observed non-substituted, long chain-length AHLs (e.g. tetradecane 
homoserine lactone (C14-HSL)) (Figure S3.2). The distribution of AHLs produced by the 
Erythrobacter isolates is similar to AHL distributions reported in other Alphaproteobacteria179 
and in natural cyanobacterial mats.182  As Alphaproteobacteria appear to be prevalent in 
Trichodesmium colonies of both puff and tuft morphology160, our results indicated that non-
substituted, long chain-length AHLs were most likely to be employed by QS epibionts.   
 
On a subsequent cruise to the oligotrophic North Atlantic Ocean, we conducted incubation 
experiments designed to test whether AHLs affected rates of APase activity in Trichodesmium 
colonies.  Based on the AHL distribution we observed in our isolates, we constructed a cocktail 
of non-substituted long chain-length AHLs (C10-, C12-, and C14-HSL), which was added to 
incubations containing Trichodesmium colonies.  At a number of stations across the western 
North Atlantic, we consistently found that AHLs elicited a roughly two-fold increase in APase 
activities (Kruskal-Wallis, p = 0.0064; Figure 3.5).  At the station at 28.6o N 65.1o W, 
Trichodesmium consortia were also assayed using a cell-specific APase method157 and 
microscopic inspection clearly showed that epibionts were major contributors to the total APase 
activity of the colonies (Figure 3.6), particularly in the colonies exposed to the AHL cocktail 
(although this method is qualitative and not amenable to rigorous statistical comparisons).162  
Figure 3.6. Representative photomicrographs of Trichodesmium colonies from the North Atlantic 
showing the cell-specific response to an enzyme labelled fluorescence assay of APase activity.  The 
bright white and green areas on or near the orange autofluorescent Trichodesmium trichomes 
indicate localized APase activity.  Left: Endogenous Trichodesmium APase activity from a colony 
that did not receive an AHL amendment.  Right: A colony from an incubation amended with the AHL 
cocktail, which shows the APase activity of epibiotic bacteria. 
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Given this evidence, and the fact that available genomes from cyanobacteria, including 
Trichodesmium, lack homologues of genes encoding known AHL receptors (LuxR),178 we 
speculate that the increase in APase activity primarily reflected the response of bacterial 
epibionts and not the response of Trichodesmium.  While Trichodesmium does contain genes 
that align weakly at the amino acid level to authentic LuxR homologues, the key residues in the 
AHL-binding regions183-184 are absent, indicating that these Trichodesmium genes would not 
have AHL binding functionality.   
 
3.3.2 APase Activity in Trichodesmium Colonies with DPD and AHL amendments. We 
conducted a similar experiment in the oligotrophic North Pacific, where dissolved phosphate is 
more abundant than in the North Atlantic and  the phytoplanktonic community is not thought to 
be limited by phosphorus.185-186  Yet despite this, APase activity is still frequently detected in 
Trichodesmium colonies in this region.162 Here we observed the same approximate doubling in 
APase activities in response to the long-chain AHL cocktail amendment as we observed in the 
North Atlantic (Mann-Whitney, p = 0.0042; Figure 3.5).  This result suggests that APase activity 
in Trichodesmium colonies, may also be controlled by AHL-based QS.  Furthermore, our 
observations of AHL-stimulated APase activity in both oceans suggest that this phenomenon 
could be globally distributed.  
In the North Pacific, we also conducted incubations amended with C8-HSL, 3-oxo-C8-HSL and 
(S)-2,3-dihydroxy-2,3-pentanedione (DPD) (Figure S3.2), the molecule that is abiotically 
converted to autoinducer-2 (AI-2) QS molecules in seawater.136  We found that these 
amendments had significant (Kruskal-Wallis, p = 0.0022) and unexpected effects on APase 
activity (Figure 3.7).  A C8-HSL amendment yielded nearly the same response as the non-
substituted, long-chain cocktail, while the 3-oxo-C8-HSL had little effect.  This result suggests 
that the non-substituted long-chain AHLs common in marine Alphaproteobacteria179 are 
recognized by APase wielding epibionts, but the 3-oxo AHLs are not; this result also indicates 
that the increase in APase activity we observed is a response to the signalling properties of 
specific AHL molecules, and is not a response to the potential nutritional value that would be 
common to all AHLs (e.g. dissolved organic nitrogen).  We observed that amendments of AI-2 
appeared to repress APase activity, and in incubations amended with both AI-2 and C8-HSL, 
the repression by the AI-2 amendment appeared to offset stimulation of APase activity by C8-
HSL.  Thus non-substituted AHLs and AI-2 appeared to play opposing roles in the regulation of 
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APase activity in Trichodesmium colonies. 
We speculate that one subpopulation of 
bacteria was using AHL-based QS to up-
regulate APase activity, while another 
presumably broader subpopulation was 
using AI-2 to do the opposite.  An 
alternative explanation is that a single 
subpopulation simultaneously employed 
AHLs to up-regulate APase activity when it 
benefitted their own subpopulation (i.e. 
efficiency sensing),187 but used AI-2 to 
down-regulate APase activity in situations 
overall cell abundance were greater and 
competing subpopulations could benefit.  
3.3.3 Autoinducer Concentrations in 
Trichodesmium Colonies. Using liquid 
chromatography-tandem mass spectrometry (LC/MS-MS), we analyzed  Trichodesmium 
colonies collected during our North Pacific cruise and found that both C14-HSL and AI-2 (via 
DPD derivatization)188 were present (Figure 3.8).  In natural seawater, AHLs are short-lived and 
subject to both abiotic lactonolysis and enzymatic degradation181 (i.e. quorum-quenching).  Thus 
the presence of AHLs in Trichodesmium colonies indicates that QS was active.  As mentioned 
above, C14-HSL was also observed in cultures of epibionts, lending further support to the idea 
that non-substituted, long-chain AHLs may be ubiquitous QS molecules in Trichodesmium 
colonies.  AI-2 is thought to be a universal interspecies bacterial QS signal,136 however AI-2 has 
yet to be observed in a marine environment and both its half-life and  functional role in mixed 
communities is largely unknown.  We also quantified C8-HSL and AI-2 in the aforementioned 
incubations by LC/MS/MS and found that the turnover rates of these signalling molecules varied  
(Figure 3.8).  We observed a rapid decline in C8-HSL concentration with the measured half-life 
(t½ = 7.6  ± 0.4 h) being much shorter than expected from abiotic lactonolysis alone;181 this is 
indicative of active quorum-quenching of AHLs by members of the Trichodesmium colonies 
(Figure 3.8).  This was the case whether AI-2 was added to the incubations or not, and thus 
quorum-quenching of AHLs was unaffected by AI-2.  By contrast, AI-2 was relatively stable by 
Figure 3.7. APase activity of Trichodesmium 
colonies in response to various AHL and AI-2 
amendments (shown in legend) at a station 
in the North Pacific Ocean.  Error bars 
indicate the magnitude of the range for 
triplicate incubations. Data are presented as 
a ratio to the no amendment control 
incubations. The horizontal dashed line 
represents no response to the amendments. 
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itself, but when incubations were additionally amended with C8-HSL we observed an initial 
three-fold spike in AI-2 concentrations followed by a rapid reduction (t½ = 18.6 ± 7.3 h; Figure 
3.8).  The observed initial spike in AI-2 concentrations is consistent with AHL-stimulated 
induction of AI-2 synthesis, while the subsequent decrease could be the result of AHL-
stimulated quorum quenching of AI-2 either by extracellular degradation or by uptake via a low 
affinity transporter and subsequent intracellular degradation. We know of no previous evidence 
to support either of these mechanisms, although it is recognized that some bacteria (e.g. Vibrio 
harveyi and Vibrio fischeri) utilize both AHLs and  AI-2  to synergistically regulate 
behaviour163,189 and that others (e.g. Escherichia coli and Pseudomonas aeruginosa) are able to 
degrade AI-2190 and AHLs.191  We speculate that the observed quorum quenching of both AHLs 
and AI-2 is an indication that microbes within the colonies were attempting to employ chemical 
warfare to disrupt QS-regulation of phosphate acquisition.  
Our results suggest that members of Trichodesmium consortia use QS to coordinate the 
processing and acquisition of phosphorus, a critical nutrient resource in oligotrophic open ocean 
environments.  Thus, APase activity in Trichodesmium colonies is not regulated solely by the 
availability of phosphate in the surrounding environment, but also by QS and quorum quenching 
among epibiotic bacteria.  Indeed, although APase activity in phytoplankton is canonically 
regulated by the availability of phosphate192 observations suggest that APase activity in 
Trichodesmium colonies may be detectable even when phosphate is abundant,162 and our 
finding indicates that QS could be responsible for this observation.  A recent metatranscriptomic 
study revealed the potential for a high degree of signal processing and information exchange 
amongst epibionts,158 but at this time we cannot conclude with any certainty how QS-regulated 
APase activity impacts the quantity of phosphorus available to Trichodesmium or whether rates 
of CO2 or N2 fixation are ultimately affected by QS.  Clearly, in addition to QS, the bioavailability 
of phosphate and DOP in situ will also affect APase activity.  It has been suggested that 
Trichodesmium colonies are sources of dissolved inorganic and organic nutrients to surrounding 
waters,155,159 and, if this is true, then the outcome of the QS-regulated phosphorus cycling within 
Trichodesmium consortia could have profound impacts on the productivity of the broader 
planktonic community and on the exchange of phosphorus between organic and inorganic 
reservoirs in the oligotrophic surface ocean. 
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3.3.4 Lab Studies Using Sulfitobacter NAS14-1. After learning that oceanic phosphorus 
cycling in naturally occurring communities can be regulated by quorum sensing molecules, we 
decided to study the metabolic affects of these molecules on heterotrophic bacteria in the lab. 
Cultures of NAS14-1 were treated with 500 nM DPD, DPD+C8, C8, Xylose, openC8, or no 
Figure 3.8. Concentrations of C8-HSL and AI-2 in the incubation experiments (A and B; 
amendments shown in legend), and HPLC/MS chromatograms showing their presence in 
unamended Trichodesmium colonies (C and D). A and B) Error bars indicate the magnitude of the 
range for triplicate incubations. C) The top chromatogram shows the selected reaction monitoring 
(SRM) transition from the parent ion of C14-HSL to the acyl chain ion, while the bottom panels shows 
the transition to the lactone ring ion.  D) This chromatogram shows the SRM transition from the 
parent ion of tagged DPD to a selective fragment ion.  Scheme for the derivatization of AI-2 is also 
shown. The derivatization is necessary to both stabilize the molecule and make AI-2 amenable to 
HPLC/MS/MS detection. 
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addition (NA). These were added once the cultures reached a cell density of approximately 
0.120 and this was marked as the start time. Samples from five time points were taken 
throughout their growth curve at 0, 1.25, 5.5, 8, and 24 h, post addition of treatments (Table 
S3.3). Experiments were performed in biological triplicates with each treatment being performed 
on a separate day. Triplicate NA’s were also run each day to compare to the treated cells. At 
each time point, samples were taken for cell density determination, DPD and AHL concentration 
measurements, and intracellular metabolite concentration detection.  
 
The growth kinetics showed no differences between cultures grown with DPD, C8, DPD+C8, 
Xylose, or open C8 (Figure 3.9a) from cultures grown with no added molecules. Xylose was 
chosen for a control as a carbon source for DPD while the open form of C8 was used as the 
nutritional control for the AHLs. The open form of AHLs has been shown to not be biologically 
active and therefore is a sufficient carbon and nitrogen control. Since the media is buffered at a 
pH of 7.5, there should be no chance of the AHL reclosing.193 
 
Samples taken to measure DPD concentrations in NAS14-1 showed that this strain does not 
produce any DPD (Figure 3.9b) and this is consistent with genome analysis which incates no 
luxS homologue. Cultures for which DPD was added at 500 nM showed a differential decrease 
Figure 3.9. Growth kinetics and autoinducer concentrations. (a) Growth kinetics measured for 
Sulfitobacter NAS14-1 measured by OD540. (b) DPD concentrations as measured by LC-MS/MS for 
NAS14-1 measured at times 0, 1.25, 5.5, 8, and 24 hours post addition of autoinducers or control. (c) 
C8 concentrations as measured by LC-MS/MS for NAS14-1 measured at times 0, 1.25, 5.5, 8, and 24 
hours post addition of autoinducers or control. Error bars represent standard deviations of three 
biological replicates and duplicate injections. 
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in DPD concentration over time depending on whether C8 was also added to the culture. While 
the difference in DPD concentration is significantly different after 5.5 h post addition between  
the cultures with added DPD only versus those with DPD and C8 added, 250 nM and 337 nM, 
respectively, the DPD concentration becomes near identical, 160 nM and 179 nM respectively, 
by 24 h post addition. In general, the DPD concentration decreases from ~ 400 nM to ~ 200 nM  
after 24 h of growth post addition.  
 
 The C8 concentration remains constant through 8 h at 500 nM throughout the growth curve in 
both sets of cultures containing added C8 and C8+DPD (Figure 3.9c). The cultures where no 
C8 was added showed an increase in C8 synthesis through the 8 h time point. The maximum 
C8 concentration reached was 244 nM. It is intriguing to note that when C8 was added to 
cultures no extra C8 was synthesized during the growth and while an increased C8 
concentration was seen over time from the non AHL amended cultures the C8 concentration 
was held steady for cultures amended with the AHL. However, the 24 h time point showed that 
the C8 concentration 
decreases in all cultures. 
 
When measuring the C8 
concentration in the 
cultures, the use of SRM 
based technology allowed 
us to look for other non 
identified AHLs that might 
be present. Using this 
technology, we determined that the AHLs produced by these bacteria are 3OC6, C8, 3OHC8, 
3OC8, C10, 3OHC10, and 3OC10 (structures can be found in Figure S3.2). Each was made 
throughout the growth curve, and the identity of AHLs measured at each time point is in Table 
3.1. 
 
To study the metabolism of Sulfitobacter NAS14-1, the intracellular metabolite concentrations of 
cells treated with quorum sensing molecules were measured using a targeted metabolomics 
method on a TSQ quantum max triple quadrupole mass spectrometer. The peak areas from 
each metabolite were normalized to cell density (OD540) and compared between the treated 
Table 3.1. AHLs detected from cultures of NAS14-1 
AHL 0 h 1.25 h 5.5 h 8 h 24 h 
3OC6  x x x x 
C8 x x x x x 
3OHC8 x x x x x 
3OC8 x x x x x 
C10   x x  
3OHC10 x x x x  
3OC10  x x x x 
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cultures and the untreated cultures taken on the same 
day to determine the change in concentrations of each 
metabolite at each time point. 
 
A select set of 43 metabolites were chosen from 
positive mode and processed for peak identification 
and to determine relative concentrations. As seen from 
the Trichodesmium data with APase activity, opposing 
effects were noticed when either DPD or C8 was 
added. 
 
More specifically, intracellular concentrations of the 
amino acids seemed to be affected in opposite ways 
depending on which autoinducer was added to the 
culture. This effect can be seen most dramatically 1.25 
h post addition of molecules (Figure 3.10). Metabolites 
that group together based on their similarity between 
the cultures are urea, N-acetylglutamate, glutamine, 
glutamate, N-acetylglutamine, cysteine, and S-
adenosyl methionine. Each of these metabolites show 
an approximate decrease (2 fold) in concentration from 
the control culture when DPD is added, while this same 
group shows an approximate increase (2 fold) in 
concentration from control cultures when C8 is added. 
When both DPD and C8 are added no change is seen 
from the control. Albeit to differing degrees the same trend holds true for phenylalanine, 
isoleucine, aspartate, and O-acetylserine; however, when both DPD and C8 are added these 
cultures show a decrease in concentration from the controls.  
 
As the bacteria continue to grow, the metabolic trends of each autoinducer yielding opposing 
effects slowly disappeared (5.5 h and 8 h post addition). While this trend seemingly dissipates, 
new trends start to appear. The intracellular concentrations for cultures treated with the 
individual autoinducers start to show similar effects, however when both autoinducers are added 
Figure 3.10. Heatmap showing 
intracellular metabolite 
concentrations of Sulfitobacter 
NAS14-1 treated with DPD, C8 
or both over their growth. Red 
is an increase in metabolite 
concentration while blue is a 
decrease in metabolite 
concentration. Fold changes 
are calculated from biological 
triplicates and dduplicate 
injections and compared to the 
no addition. Fold changes are 
log2 transformed. The 
heatmap with cultures treated 
with Xylose and open 3OC8 
can be found in Supplemental 
Figure S3.3. 
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the intracellular metabolite concentrations are different, whether it be an increase from no 
change, or an opposing effect. By 24 h post addition into the experiment, the majority of 
metabolites in all culture behave in a similar manner.  
 
3.3.5 Metabolic Response of Mixed Cultures from the Open Ocean to the Addition of 
Autoinducers. Samples were collected while during a cruise aboard the R/V Atlantis to the 
Sargasso Sea in order to study the metabolome of mixed communites and the effects quorum 
sensing molecules have on these populations. This was accomplished by collecting a 
population of sinking particles from a trap placed at a depth of 150 m for ~24 h. The particles 
were then incubated with 500 nM of DPD, AHLs, or a combination thereof. Four experiments 
were run with differing conditions (Table S3.4). The experiment collected from Trap 4 will be 
discussed in detail while the other three will not be discussed here. The data for the other 
experiments can be found in the Figures section (Figures S3.4-S3.8). The DPD concentration 
for each sample was also measured from these experiments, and the data can also be found 
with the corresponding metabolomics data (if available) in the figures section.  
 
For samples from Trap 4, DPD concentration was found to be ~500 nM after the 24 h incubation 
for the cultures that were amended with 500 nM DPD (Figure 3.11a). No substantial DPD was 
measured from the other cultures without added DPD (Figure 3.11b). Unfortunately we did not 
measure the DPD concentration at the time of addition, and we also did not monitor AHL 
concentration.  
 
Whole cell metabolomics data collected from a trap in the Sargasso Sea and treated with 500 
nM 3OC8, DPD and a combination thereof showed the same types of trends seen from studies 
of APase activity in Trichodesmium colonies as well as studies of Sulfitobacter NAS14-1 done in 
the lab. The data shown (Figure 3.11c) were collected after a 24 h incubation with these quorum 
sensing molecules.  
 
Approximately half of the measured metabolites showed no difference in metabolite 
concentration among the incubations, however the other half of metabolites showed differences 
between the additions. As with NAS14-1, the majority of metabolites changed were amino acids. 
Metabolites that showed a difference in concentration between DPD and C8 treated cultures 
were isoleucine, phenylalanine, tryptophan, homoserine, methionine, valine, asparagine, and 
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acetyllysine. These 
showed an increase in 
intracellular metabolite 
concentration for the 
3OC8 amended culture 
while they showed a 
decrease with the DPD 
addition. When both 
3OC8 and DPD were 
added to the culture, 
the intracellular 
concentration 
decreased similarly to 
the DPD amended 
cultures. Other 
metabolites that 
behaved in this manner 
were betaine, 
adenosine, and 
cytidine. 
 
Other amino acids 
showed similar trends 
when DPD and 3OC8 
were added separately; 
however, differed from 
that trend when DPD 
and 3OC8 were added 
together. These amino 
acids are alanine, lysine, sarcosine, glutamate, N-acetyllysine, and proline. The latter three 
showed no change between the individual quorum signal additions and the control; however 
showed a decrease in concentration from the control when both autoinducers were added 
together. Alanine, lysine, sarcosine, and the nucleotide thymine showed an increase in 
Figure 3.11. Data taken on board a research cruise. Samples 
were taken from sinking particles at 150 m and incubated for 24 h 
with either 3OC8, DPD, or a combination thereof. Open 3OC8 and 
DMSO were used as controls. (a) DPD concentration measured 
from cultures after a 24 h incubation with quorum sensing 
molecules. (b) zoomed y axis from panel (a). (c) heatmap showing 
differences in intracellular metabolite concentration for bacteria 
associated with sinking particles in the Sargasso Sea. Red is an 
increase in metabolite concentration while blue is a decrease in 
metabolite concentration. Fold changes are log2 transformed. 
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intracellular concentration compared to the control for both DPD and 3OC8 additions; however, 
when added together a decrease in concentration was seen. 
 
Other non amino acid metabolites also showed opposing changes in their concentrations upon 
quorum signal addition as compared to the control. Pipecolic acid, GABA, acadesine, palmitate, 
adenine, glycerophosphocholine, TDP, and fructose-6-phosphate all increased in concentration 
in cultures amended with 3OC8 only and decreased in concentration with DPD. The addition of 
both autoinducers led to the concentrations of these metabolites decreasing similar to DPD 
addition. 
 
Similar to the APase results found in Trichodesmium colonies, the addition of either DPD or 
AHLs can have opposing effects on the physiology of the microorganisms. Using metabolomics, 
we have shown this effect in cultures grown in the lab as well as mixed populations studied on 
board a research vessel. The ability to alter metabolism using quorum sensing molecules can 
lead to changes in the surrounding DOM and therefore change the resources available to 
surrounding organisms. 
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3.4 Appendix 
3.4.1 Supplemental Figures 
 
 
 
 
Figure S3.1. AHL quorum sensing circuit in Sulfitobacter NAS14-1. 
 
 
 
 
 
 
 
 
 
 
 
Figure S3.2. AHLs and DPD Structures. 
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Figure S3.3. Control Data (Xylose and open C8) from metabolomics experiments from 
Sulfitobacter NAS14-1  
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Figure S3.4. DPD concentration experiments from cruise CTD samples amended with C8, AHL 
cocktail and DMSO (control). 
 
 
 
 
 
 
 
 
 
Figure S3.5. DPD concentration measurements collected from Trap 2. (a) DPD shows and 
increase in concentration for this mixed culture while when 3OC8 is around the DPD 
concentration does not increase. (b) Cultures treated with no DPD showed no significant 
amounts of measurable DPD. 
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Figure S3.6. DPD (a and b) and metabolomics (c) data from Trap 6 collected from Cruise 
samples. 
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Figure S3.7. DPD (a and b) and metabolomics (c) data from Trap 7 collected from Cruise 
samples. 
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Figure S3.8. DPD (a) and metabolomics (b) data from Diatoms collected from cruise samples. 
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3.4.2 Supplemental Tables 
 
Table S3.1. SRMs in Negative Mode Method 
Po
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d 
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ID
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En
e
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y 
Ex
pe
c
te
d 
R
T 
Segment 
(min) 
0-
17
 
17
-
28
 
28
-
35
 
35
-
50
 
- Glyoxylate C00048  C2HO3- 
 
73 45 20 12.7 x 
   
- Glycolate C00160 C2H3O3- 
 
75 45 11 12.5 x 
   
- Pyruvate C00022 C3H3O3- C2H3O- 87 43 12 15 x x 
  
- Lactate C00186 C00256 C3H5O3
-
 C2H3O- 89 43 14 12.3 x 
   
- 
2(3)-Oxobutanoate 
(aka acetoacetate) 
C00109 
C00164 C4H5O3
-
 C3H5O- 101 57 11 14 x x 
  
- Glycerate C00258 C3H5O4- C2H3O3- 105 75 15 12 x 
   
- Uracil C00106 C4H3N2O2- CNO- 111 42 20 3 x 
   
- 
Fumarate, Maleate, 
and iso-
Ketovalerate 
C00122 
C01384 
C00141 
C4H3O4- C3H3O2- 115 71 11 24.6 
 
x x 
 
- Guanidoacetate C00581 C3H6N3O2- 
 
116 74 25 4 x 
   
- 
Succinate and 
Methylmalonate 
C00042 
C02170 C4H5O4
-
 C3H5O2- 117 73 10 17.4 x x 
  
- IS-Succinate 
   
119 74 10 
     
- Benzoic Acid (IS) 
   
121 77 13 27.5 
 
x x 
 
- Nicotinate C00253 C6H4NO2- C5H4N- 122 78 14 22.5 
 
x x 
 
- Taurine C00245 C2H6NO3S- SO3- 124 80 16 2.5 x 
   
- Citraconate C02226 C5H5O4- 
 
129 85 10 29 x x x 
 
- N-Acetyl-L-alanine 
   
130 88 25 14.2 x 
   
- Oxaloacetate C00036 C4H3O5- C3H3O3- 131 87 12 25.5 x 
   
- 
4,5-dihydroxy-2,3-
pentanedione(DPD
)?  
C5H7O4- C4H5O3- 131
.01 101 10 2.5 x    
- Malate C00711  C4H5O5- C4H3O4- 133 115 12 19.8 
 
x 
  
- 
133-43 
(deoxyribose?)    
133
.01 43 15 20.7  x   
- Hypoxanthine C00262 C5H3N4O- C4H2N3- 135 92 16 3 x 
   
- 
Aminobenzoate 
(pABA and oABA) 
C00108 
C00568 C7H6NO2
-
 C6H6N- 136 92 16 24.9 x x x x 
- 4-Hydroxybenzoate C00156 C7H5O3- C6H5O- 137 93 21 28.6 
 
x x 
 
- Acetyl phosphate C00227 C2H4O5P- PO3- 139 79 22 12.5 x 
   
- 
Carbamoyl 
phosphate C00169 CH3NO5P
-
 PO3- 140 79 22 25 
 
x 
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Table S3.1. Continued. 
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Ex
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te
d 
R
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Segment 
(min) 
0-
17
 
17
-
28
 
28
-
35
 
35
-
50
 
- 
Adipate and 2-
Methylglutarate C06104 C6H9O4
-
 
 
145 83 25 26.5 
 
x x 
 
- 
2-Oxoglutarate and 
Phenylpropiolate C00026 C5H5O5
-
 C4H5O3- 145 101 11 21 x x x x 
- 
2-Hydroxy-2-
methyl-
butanedioate 
C02612 C5H7O5- 
 
147 85 25 26 
 
x 
  
- 
4-Methylthio-2-
oxobutanoate C01180 C5H7O3S
-
 
 
147 99 11 30.1 
  
x 
 
- Xanthine C00385 C5H3N4O2- C4H2N3O- 151 108 21 9 x 
   
- 
2,3-
Dihydroxybenzoate C00196 C7H5O4
-
 C6H5O2- 153 109 17 30 
  
x 
 
- Orotate C00295 C5H3N2O4- C4H3N2O2- 155 111 13 15.6 x x 
  
- Dihydroorotate C00337 C5H5N2O4- C4H5N2O2- 157 113 12 13 x 
   
- Allantoin C01551 C4H5N4O3- C3H4N3O2- 157
.01 114 15 2.3 x    
- 
Aminoadipate and 
Indole-3-
carboxylate 
C00956 
C19837 
C6H10NO4-, 
C9H6NO2-  160 116 25 6 x  x  
- Phenylpyruvate C00166 C9H7O3- C7H7- 163 91 11 18.6 
 
x 
  
- Phenyllactate C05607 C9H9O3- 
 
165 103 25 34 
  
x x 
- Atrolactate 
   
165 119 25 33.5 
  
x 
 
- 
2,3-
Pyridinedicarboxyla
te 
C03722 C7H4NO4- C6H4NO2- 166 122 12 33 
  
x 
 
- 
Phosphoenolpyruv
ate C00074  C3H4O6P
-
 PO3- 167 79 20 24.7 
 
x 
  
- 
Dihydroxy-acetone-
phosphate(DHAP) C00111 C3H6O6P
-
 PO3- 169 79 38 12.5 x 
   
- 
D-glyceraldehdye-
3-phosphate C00118 C3H6O6P
-
 H2PO4- 169
.01 97 12 12.5 x    
- 
Glycerol-3-
phosphate C00093 C3H8O6P
-
 PO3- 171 79 13 13 x x 
  
- Shikimate C00493 C7H9O5- C6H5O- 173 93 18 22 
 
x 
  
- pyrophosphate C00013 H3P2O7- 
 
173 159 10 31 
  
x 
 
- 
Aconitate (cis and 
trans) 
C00417 
C02341  C6H5O6
-
 
 
173
.01 85 15 25.8   x  
- Ascorbate C00072 C6H7O6- 
 
175 87 25 14.9 
  
x 
 
- 2-Isopropylmalate C02504 C7H11O5- 
 
175 115 25 29.7 x x 
  
- 
Allantoate and 
Carbamoyl-
aspartate 
C00499 C4H7N4O4- C3H6N3O3- 175 132 12 8 x 
   
- Glucono-δ-lactone C03107  C00198 C6H9O6
-
 C5H5O4- 177 129 11 12 x 
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Table S3.1. Continued. 
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Segment 
(min) 
0-
17
 
17
-
28
 
28
-
35
 
35
-
50
 
- myo-inositol C00137 C6H11O6- C6H9O5- 179 161 15 1.5 x 
   
- 
4-
Hydroxyphenylpyru
vate 
C01179  C9H7O4- C7H7O- 179
.01 107 11 25.1  x x  
- Homocysteic acid C16511 C4H8NO5S- SO3- 182 80 21 10.6 x 
   
- 4-Pyridoxate C00847 C8H8NO4- 
 
182 138 25 32.5 
  
x 
 
- 
3-
Phosphoglycerate C00597 C3H6O7P
-
 H2PO4- 185 97 15 25.1 
 
x x 
 
- Indoleacrylate 
   
186 142 25 35 
  
x x 
- Kynurenate C01717 C10H6NO3- 
 
188 144 19 32 
  
x 
 
- 
Citrate and 
Isocitrate 
C00158 
C00311 C6H7O7
-
 C5H3O3- 191 111 13 23.7 
 
x x 
 
- Isocitrate C00311 C6H7O7- C4O4H5- 191
.01 117 17 23.7  x x  
- Citrate C00158 C6H7O7- C3O3H3- 191
.02 87 20 23.7  x x  
- 2-Keto-D-gluconate C06473 C6H9O7- C4H7O3- 193 103 12 12.5 x 
   
- Gluconate C00257 C6H11O7- C5H5O4- 195 129 15 11.4 x 
   
- 
Erythrose-4-
phosphate C00279 C4H8O7P
-
 H2PO4- 199 97 17 15.4 x 
   
- Xanthurenate C02470 C10H6NO4- 
 
204 160 25 32 
  
x 
 
- Glucarate C00767 C6H9O8- C4H5O2- 209 85 15 29 
 
x x 
 
- 
2-Deoxyribose 1-
phosphate  C5H10O7P
-
 PO3- 213 79 33 12.7 x 
   
- Pantothenate C00864 C9H16NO5- C7H16NO2- 218 146 19 19.6 x x 
  
- Prephenate C00254 C10H9O6- C6H3O- 225 91 15 31 
  
x 
 
- Deoxyuridine C00526 C9H11N2O5- C8H10NO4- 227 184 12 3.6 x 
   
- Bisphenol A (BPA) 
   
227
.01 133 24 34.5   x x 
- Bisphenol A (BPA) 
   
227
.02 212 22 34.5   x x 
- 
Pentose-phosphate 
(ribose-5P) 
C00117 
C00199 
C00231 
C5H10O8P- PO3- 229 79 40 12.2 x 
   
- 
240-179 (5-
methyldeoxycytidin
e?)    
240 179 10 1.9 x 
   
- Thymidine C00214 C10H13N2O5- C5H5N2O2- 241 125 15 12 x 
   
- Uridine C00299 C9H11N2O6- C8H10NO5- 243 200 19 3 x 
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Table S3.1. Continued. 
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0-
17
 
17
-
28
 
28
-
35
 
35
-
50
 
- Deoxyinosine C05512 C10H11N4O4- C5H3N4O- 251 135 19 10 x 
   
- 
Shikimate-3-
phosphate C03175 C7H10O8P
-
 
 
253 97 17 12.6 x 
   
- 253-152 
   
253
.01 152 10 20  x   
- 
Shikimate-3-
phosphate C03175 C7H10O8P
-
 H2PO4- 253
.1 97 17      
- Palmitate C00249 C16H31O2- 
 
255 237 25 37 
   
x 
- 
D-glucono-δ-
lactone-6-
phosphate 
C01236 C6H10O9P- H2PO4- 257 97 20 27.5 
 
x x 
 
- 
D-hexose-
phosphate 
(fructose-6P) 
C02672 C6H12O9P- PO3- 259 79 40 12.1 x 
   
- 
Glucose-1-
phosphate C00103 C6H12O9P
-
 
 
259
.01 241 14 17.8  x   
- 
Glucose-6-
phosphate C00092 C6H12O9P
-
 
 
259
.02 199 13 12.1 x   x 
- 
Fructose-6-
phosphate C00085 C6H12O9P
-
 
 
259
.03 169 14 12.1 x    
- 
259-110 (a  hexose 
phosphate?)    
259
.04 110 22 5 x    
- 
Glycerate-
diphosphate (1,3 
and 2,3) 
C00236 C3H8O10P2- PO3- 265 79 35 37 
  
x x 
- 
Glycerate-2,3-
diphosphate    
265
.01 167 12 34   x x 
- 
S-Ribosyl-
Homocysteine(SRH
) 
C03539 C9H16NO6S- 
 
266 134 18 2.3 x 
   
- Inosine C00294 C10H11N4O5- C5H3N4O- 267 135 25 10 x 
   
- 
D-Gluconate-6-
phosphate C00345 C6H12O10P
-
 H2PO4- 275 97 11 29 
 
x x 
 
- Xanthosine C01762 C10H11N4O6- C5H3N4O6- 283 151 22 14 x 
   
- Stearate C01530 C18H35O2- 
 
283
.01 265 25 38    x 
- 
Sedoheptulose-7-
phosphate C05382 C7H14O10P
-
 PO3- 289 97 25 25 
 
x 
  
- 
298-136 
(sphingosine, 
hydroxyguanosine 
or 
palmitoylethanolam
ide?) 
   
298 136 27 5 x 
   
- 
N-acetyl-
glucosamine-1-
phosphate 
C04256 C8H15NO9P- PO3- 300 79 32 13 x 
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(min) 
0-
17
 
17
-
28
 
28
-
35
 
35
-
50
 
- 
306-143 (dCMP or 
Glutathione?)    306 143 17 27.3  x x  
- dUMP C00365 C9H12N2O8P- C5H8O6P- 307 195 16 20 
 
x 
  
- 
Ribulose-1,5-
bisphosphate C01182 C5H11O11P2
-
 
 
309 211 14 25.2 
 
x 
  
- 
Geranylpyrophospha
te C00353 C10H19O7P2
-
 PO3- 313 79 18 42 
   
x 
- TMP C00364 C10H14N2O8P- 
 
321 195 20 18.1 
 
x 
  
- cyclic-AMP C00575 C10H11N5O6P- C5H4N5- 328 134
.00 31 30   x  
- 
Fructose-1,6-
bisphosphate C00354 C6H13O12P2
-
 H2PO4- 339 97 28 25 
 
x x x 
- 339-110 
   
339
.01 110 30 20  x   
- Dihexose (trehalose) C01083 C12H21O11- C6H11O6- 341 179 18 1.7 x 
   
- Orotidine-phosphate C01103 C10H12N2O11P
-
 
C9H12N2O9
P- 367 323 16 36   x x 
- 
Sedoheptulose-1,7-
bisphosphate (b) C00447 C7H15O13P2
-
 
 
369
.01 97 35 1 x x x x 
- 
Sedoheptulose-1,7-
bisphosphate (a) C00447 C7H15O13P2
-
 
 
369 271 15 1 x x x x 
- 
trans, trans-farnesyl 
diphosphate C00448 C15H27O7P2
-
 PO3- 381 79 21 42 
   
x 
- 
S-adenosyl-L-
homoCysteine(SAH) C00021 C14H19N6O5S
-
 
 
383 134 29 13 x 
   
- dCDP C00705 C9H14N3O10P2
-
 
HO6P2- 386 159 25 33.1 
  
x 
 
- 
5-Phospho-D-ribose-
1-diphosphate 
(PRPP) 
C00119 C5H12O14P3- C5H9O10P2-
 
389 291 18 35.7 
  
x x 
- Deoxycholate C11171 C24H39O4- 
 
391 345 40 42.2 
   
x 
- TDP C00363 C10H15N2O11P
2
-
  
401 159 25 30.4 
  
x 
 
- CDP C00112 C9H14N3O11P2
-
  
402 384 20 29.5 
  
x 
 
- UDP C00015 C9H13N2O12P2
-
  
403 159 26 27.5 
 
x x 
 
- Cholate C00695 C24H39O5- 
 
407 345 40 42 
   
x 
- 
Trehalose-6-
Phosphate C00689 C12H22O14P
-
 PO3- 421 79 34 12.5 x 
   
- 
Thiamine 
pyrophosphate C00068 
C12H18N4O7P2
S-  423 302 25 18  x   
- 
Adenosine 5'-
phosphosulfate 
(APS) 
C00224 C10H13N5O10PS- 
C10H13N5O
7P- 426 346 20 32   x  
- 
dGDP (SRM also for 
ADP) C00361 
C10H14N5O10P
2
-
 
HO6P2- 426
.01 159 25 31.7   x  
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0-
17
 
17
-
28
 
28
-
35
 
35
-
50
 
- IDP C00104 C10H13N4O11P
2
-
  
427 159 25 32 
  
x 
 
- GDP C00035 C10H14N5O11P
2
-
  
442 159 19 25.6 
  
x x 
- FMN C00061 C17H20N4O9P- C5H10O7P- 455 213 19 27.8 
  
x x 
- Cholesteryl sulfate C18043 C27H45O4S- 
 
465 97 40 44 
   
x 
- dCTP C00458 C9H15N3O13P3
-
 
HO6P2- 466 159 28 34 
 
x x 
 
- dUTP C00460 C9H14N2O14P3
-
 
HO6P2- 467 159 25 27.5 
 
x x 
 
- 477-417 
   
477 417 10 36.3 
   
x 
- TTP C00459 C10H16N2O14P
3
-
  
481 159 31 31.1 
  
x x 
- CTP C00063 C9H15N3O14P3
-
  
482 159 32 
     
- CTP C00063 C9H15N3O14P3
-
  
482 384 22 34 
  
x x 
- UTP C00075 C9H14N2O15P3
-
  
483 159 33 34 
 
x x x 
- 483-385 
   
483
.01 385 21 28.2  x x  
- dATP C00131 C10H15N5O12P
3 
HO6P2- 490 159 27 39 
   
x 
- TTP C00459 C10H16N2O14P
3
-
  
493 159 31 
     
- Taurodeoxycholate C05463 C26H44NO6S- 
 
498 124 25 41.5 
   
x 
- ATP and dGTP C00002 C10H15N5O13P
3
-
  
506 159 28 29 
 
x x x 
- GTP C00044 C10H15N5O14P
3
-
  
522 424 23 27.2 
 
x x x 
- UDP-D-glucose C00029 C15H21N2O18P
2
-
 
C9H12N2O9
P- 565 323 23 24.7  x   
- 
UDP-D-glucuronate 
and UDP-
galacturonate 
C00167 
C00617 
C15H21N2O18P
2
-
 
C9H13N2O1
2P2- 579 403 24 34  x x x 
- ADP-D-glucose C00498 C16H24N5O15P
2
-
 
C10H13N5O
7P- 588 346 22 26  x   
- 
Guanosine 
tetraphosphate 
(ppGpp) 
C01228 C10H16N5O17P
4
-
  
602 504 22 36 
  
x x 
- 
UDP-N-
acetylglucosamine C00043 
C17H26N3O17P
2
-
  
606 385 26 24.8 
 
x 
  
- 
611-306 (Ox. 
Glutathione or DG?)    611 306 28 23.2  x   
- 
662-540 (Ceramide 
or PE)    662 540 19 15 x    
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R
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(min) 
0-
17
 
17
-
28
 
28
-
35
 
35
-
50
 
- 
664-408 (NADH or 
DG)    664 408 31 40    x 
- Dephospho-CoA C00882 C21H34N7O13P
2S-  
686
.2 339 35 38    x 
- Cyclic-diGMP C16463 C20H23N10O14P2-  689 344 32 26.6  x x  
- 709-354 
   
709 354 32 
  
x x 
 
- 
742-620 (PC or 
PE?)    742 620 18 25  x   
- 
744-408 (NADPH, 
PC or PE?)    744 408 34 35   x x 
- CoA C00010 C21H35N7O16P
3S-  766 408 40 35    x 
- acetyl-CoA C00024 C23H37N7O17P
3S-  808 408 31 31.1    x 
- Propanoyl-CoA C00100 C24H39N7O17P
3S- 
ADP - 
H2O 822 408 31 38    x 
- Acetoacetyl-CoA C00332 C25H39N7O18P
3S- -C4H4O2 850 766 30 36.6    x 
- Malonyl-CoA C00083 C24H37N7O19P
3S- -CO2 852 808 24 36.5    x 
- 
Succinyl-CoA and 
Methylmalonyl-CoA C00091 
C25H39N7O19P
3S- 
C24H39N7O
17P3S- 866 822 20 37    x 
- 
3-hydroxy-3-
methylglutaryl-CoA C00356 
C27H43N7O20P
3S- 
C10H12N5O
9P2- 910 408 43 37    x 
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Table S3.2. SRMs in Positive Mode Method 
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R
T 
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0-
11
 
11
-
15
 
15
-
19
 
19
-
40
 
+ Urea C00086 CH5N2O+ 
 
61 44 23 9.2 x 
   
+ Imidazole C01589 C3H5N2+ 
 
69 42 21 6.9 x 
   
+ Glycine C00037 C2H6NO2+ CH4N+ 76 30 16 14.4 
 
x x 
 
+ 
Alanine and 
Sarcosine 
C00041 
C00213 C3H8NO2
+
 C2H8N+ 90 44 11 13.6 
 
x x 
 
+ 93-57 
   
93 57 10 
 
x x x x 
+ Betaine Aldehyde C00576 C5H12NO+ C3H8N+? 102 58 25 14.5 
 
x x 
 
+ Dimethylglycine C01026 C4H10NO2+ C3H8N+? 104 58 25 8.3 x x 
  
+ Choline C00114 C5H14NO+ C3H10N+ 104
.01 60 19 13.8  x x  
+ GABA C00334 C4H10NO2+ 
 
104
.02 69 20 13.5  x   
+ Serine C00065 C3H8NO3+ C2H6NO+ 106 60 13 14.7 
 
x x 
 
+ Cytosine C00380 C4H6N3O+ C4H3N2O+ 112 95 17 11.5 x x 
  
+ Creatinine C00791 C4H8N3O+ 
 
114 44 17 10 x x 
  
+ Proline C00148 C5H10NO2+ C4H8N+ 116 70 11 13.3 
 
x x 
 
+ Valine C00183 C5H12NO2+ C4H7+ 118 55 11 13.1 
 
x x 
 
+ Indole C00463 C8H8N+ C7H7+ 118 91 24 3.2 
    
+ Betaine C00719 C5H11NO2+ C3H8N+? 118
.01 58 34 11.7 x x   
+ Homoserine C00263 C4H10NO3+ C2H6N+ 120 44 30 14 
 
x x 
 
+ Threonine C00188 C4H10NO3+ C3H8NO+ 120 74 11 14.4 
 
x x 
 
+ Tris 
   
122 57 19 11.9 x x x x 
+ Cysteine C00097 C3H8NO2S+ C2H3S+ 122
.01 59 27 17.5  x x  
+ Nicotinamide C00153 C6H7N2O+ C5H6N+ 123 80 20 7 x 
 
x x 
+ 
Imidazoleacetic 
acid C02835 C5H7N2O2
+
 
 
127 81 13 16 
  
x 
 
+ Thymine C00178 C5H7N2O2+ C5H4NO2+ 127
.01 110 17 7.3 x x   
+ 130-84 
   
130 84 16 13.3 
 
x 
  
+ DL-Pipecolic acid 
   
131 114 10 16 
 
x 
  
+ N-acetylputrescine C02714 C6H15N2O+ 
 
131
.01 114 25 12.6  x x  
+ (Iso)Leucine C00407 C6H14NO2+ C5H12N+ 132 86 11 12.4 x x 
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0-
11
 
11
-
15
 
15
-
19
 
19
-
40
 
+ creatine C00300 C4H10N3O2+ 
 
132
.01 90 13 13  x   
+ 
4,5-dihydroxy-2,3-
pentanedione(DPD
+)    
133
.02 43 15 3.5 x    
+ Ornithine C00077 C5H13N2O2+ C4H8N+ 133
.01 70 12 15.3  x x  
+ Asparagine C00152 C4H9N2O3+ C2H4NO2+ 133
.02 74 17 14.7  x x  
+ Aspartate C00049 C4H8NO4+ C2H4NO2+ 134 74 15 18.2 
  
x x 
+ Homocysteine C00155 C4H10NO2S+ C3H8NS+ 136 90 15 12 
 
x 
  
+ Adenine C00147 C5H6N5+ C5H3N4+ 136
.02 119 24 12 x x   
+ Methylcysteine 
   
136
.01 119 10 12.5  x   
+ Histidinol C00860 C6H12N3O+ C5H7N2+ 142 95 18 12 x x 
  
+ Lysine-b C00047 C6H15N2O2+ C5H7+ 147 67 30 15 
 
x x 
 
+ 
Glutamine and 
Lysine(-a) 
C00047 
C00064 
C6H15N2O2+, 
C5H11N2O3+  
147
.01 84 15 15  x x  
+ Glutamate C00025 C5H10NO4+ C4H6NO+ 148 84 15 18.4 
  
x x 
+ O-acetyl-L-serine C00979 C5H10NO4+ C3H8NO3+ 148
.01 106 12 15.7  x x  
+ Methionine C00073 C5H12NO2S+ C5H9O2S+ 150 133 10 13.3 
 
x x 
 
+ Guanine C00242 C5H6N5O+ C4H4N3O+ 152 110 18 12.6 
 
x x 
 
+ Histidine C00135 C6H10N3O2+ C5H8N3+ 156 110 12 14.8 
 
x x 
 
+ Carnitine C00318 C7H16NO3+ C4H7O3+ 162 103 18 12.3 
 
x 
  
+ Phenylalanine C00079 C9H12NO2+ C8H7+ 166 103 28 11.7 x x x 
 
+ Pyridoxamine C00534 C8H13N2O2+ 
 
169 134 23 13 
 
x 
  
+ 3-methylhistidine C01152 C7H12N3O2+ 
 
170 96 21 15 
 
x x 
 
+ Pyridoxine C00314 C8H12NO3+ C8H8NO+ 170
.02 134 22 12     
+ 1-methylhistidine C01152 C7H12N3O2+ 
 
170
.01 124 18 13.7  x   
+ 
Butyryl-homoserine 
lactone (C4-HSL) C11837 C8H14NO3
+
 C4H8NO2+ 172 102 10 3.7 x 
   
+ Arginine C00062 C6H15N4O2+ CH6N3+ 175
.02 60 14 14.4  x x  
+ N-acetyl-Ornithine C00437 C7H15N2O3+ C5H9NO2+ 175
.01 115 14 13.4  x x  
+ Citrulline C00327 C6H14N3O3+ C6H11N2O3+
 
176 159 12 13 
 
x x 
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0-
11
 
11
-
15
 
15
-
19
 
19
-
40
 
+ 
N-Carbamoyl-L-
aspartate C00438 C5H9N2O5
+
 C2H4NO2+ 177 74 17 21 
  
x x 
+ Glucosamine C00329 C6H14NO5+ C6H12NO4+
 
180 162 10 12.9 
 
x x 
 
+ Tyrosine C00082 C9H12NO3+ C6H5+ 182 77 37 14.2 
 
x x 
 
+ Epinephrine C00788 C9H14NO3+ 
 
184 166 11 23 x x x x 
+ 3-phospho-serine C01005 C3H9NO6P+ C3H6NO2+ 186 88 10 23.5 
   
x 
+ Tributylamine 
   
186
.01 130 18 1     
+ 
N-acetyl-L-Lysine 
and Acetyllysine 
C02727 
C12989 C8H17N2O3
+
 
 
189 84 24 6 x x x x 
+ N-acetyl-glutamine 
 
C7H13N2O4+ C5H8NO3+ 189
.01 130 15 14.6  x x x 
+ N-acetyl-glutamate  C00624 C7H12NO5+ C4H6NO+ 190 84 22 19.6 
  
x x 
+ Acetylcarnitine C02571 C9H19NO4+ 
 
204 85 17 11 x x 
  
+ Tryptophan C00078 C11H13N2O2+ C9H8NO+ 205 146 16 13.1 
 
x x 
 
+ Kynurenine C00328 C10H13N2O3+ 
 
209 146 23 12 
 
x 
  
+ 
N-(3-
Oxohexanoyl)homo
serine lactone 
C11839 C10H16NO4+ C4H8NO2+ 214 102 13 3.7 x 
   
+ 222-138 
   
222 138 16 12.4 x x 
  
+ Flavone C15608 C15H11O2+ 
 
223 121 27 5 x 
   
+ Cystathionine C02291 C7H15N2O4S+ C4H8NO2S+
 
223
.01 134 11 16.5  x x  
+ 
Octanoyl-
homoserine lactone  C12H22NO3
+
 C4H8NO2+ 228 102 11 3.7 x 
   
+ Cytidine C00475 C9H14N3O5+ C4H6N3O+ 244 112 12 12.1 x x 
  
+ Biotin (Vitamin H) C00120 C10H17N2O3S+ C10H15N2O
2S+ 245 227 18 15.6  x x  
+ Deoxyadenosine C00559 C10H14N5O3+ C5H6N5+ 252 136 20 9.7 x x 
  
+ 
Glycerophosphoch
oline C00670 C8H22NO6P
+
 
 
258 104 14 12.6 
 
x x 
 
+ 
Acadesine (AICAR 
without phosphate)  C9H15N4O5
+
 C4H4N3O+ 259 110 22 6.6 x x 
  
+ AICAR (+) C04677 C9H14N4O5+ 
 
259 110 22 
     
+ 
Glucosamine-6-
phosphate C00352 C6H15NO8P
+
 C6H8NO2+ 260 126 15 19.5 
  
x x 
+ Glucosamine-1P C06156 C6H15NO8P+ C6H12NO4+
 
260
.01 162 15 23   x x 
+ 
Thiamine (Vitamin 
B1) C00378 C12H17N4OS
+
 C6H8N3+ 265 122 17 3 x x 
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0-
11
 
11
-
15
 
15
-
19
 
19
-
40
 
+ Deoxyadenosine C00559 C05198 C10H14N5O3
+
 
 
267
.1 146 20      
+ 
S-Ribosyl-
Homocysteine 
(SRH) 
C03539 C9H18NO6S+ 
 
268 88 29 14 
 
x x 
 
+ Adenosine C00212 C10H14N5O4+ C5H6N5+ 268
.01 136 27 10.5 x x   
+ Deoxyguanosine C00330 C10H14N5O4+ C5H6N5O+ 268
.02 152 15 12  x   
+ 1-methyladenosine C02494 C11H16N5O4+ 
 
282 150 25 11 x x 
  
+ Guanosine C00387 C10H14N5O5+ C5H3N4O+ 284 135 33 13.1 
 
x 
  
+ 
N-(L-
Arginino)succinate C03406 C10H19N4O6
+
 C4H8N+ 291 70 35 17.5 
  
x 
 
+ 
5'-
methylthioadenosin
e 
C00170 C11H16N5O3S+ C5H6N5+ 298 136 27 8.1 x x 
  
+ dCMP C00239 C9H15N3O7P+ C4H6N3O+ 308 112 16 20 
  
x x 
+ 
Reduced 
glutathione  C00051 C10H18N3O6S
+
 
C5H8NO3S
+
 
308
.01 162 19 20.5   x x 
+ TMP C00364 C10H16N2O8P+ C5H5O+ 323 81 17 20.7 
   
x 
+ CMP C00055 C9H15N3O8P+ C4H6N3O+ 324 112 16 22.8 
  
x x 
+ UMP C00105 C9H14N2O9P+ C5H5O2+ 325 97 12 22 
  
x x 
+ dAMP C00360 C10H15N5O6P+ C5H6N5+ 332 136 21 25 
 
x x x 
+ 
Nicotinamide 
ribotide C00455 C11H16N2O8P
+
 
 
335 123 28 17 
  
x 
 
+ UMP C00105 C9H14N2O9P+ 
 
336 102 25 20.2 
  
x x 
+ 
AICAR-
MonoPhosphate  C9H16N4O8P
+
 C4H4N3O+ 339 110 30 19.5 
  
x x 
+ 
Thiamine-
phosphate C01081 
C12H19N4O4P
S+ C6H8N3
+
 345 122 13 17 
  
x 
 
+ dGMP C00362 C10H15N5O7P+ C5H3N4O+ 348 135 36 20 
   
x 
+ AMP C00020 C10H15N5O7P+ C5H6N5+ 348
.01 136 21 14.2  x x x 
+ IMP C00130 C10H14N4O8P+ C5H5N4O+ 349 137 19 25.1 
  
x x 
+ IS AMP 
   
363
.1 146 21      
+ GMP C00144 C10H15N5O8P+ C5H6N5O+ 364 152 19 25 
  
x x 
+ 
Xanthosine 5'-
phosphate C00655 C10H14N4O9P
+
 C5H5O2+ 365 97 11 25 
   
x 
+ 
Riboflavin (Vitamin 
B2) C00255 C17H21N4O6
+
 
C12H12N4O
2
+
 
377 243 24 10.6 x x 
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Segment 
(min) 
0-
11
 
11
-
15
 
15
-
19
 
19
-
40
 
+ 
S-adenosyl-L-
homoCysteine 
(SAH) 
C00021 C14H21N6O5S+ C5H6N5+ 385 136 19 14.3 
 
x x 
 
+ dCDP C00705 C9H16N3O10P2+
 
C4H6N3O+ 388 112 25 20 
  
x x 
+ 
S-adenosyl-L-
methionine (SAM) C00019 C15H24N6O5S
+
 
C10H12N5O
3
+
 
399 250 13 13.3 
 
x x 
 
+ TDP C00363 C10H17N2O11P
2
+
 
C5H5O+ 403 81 25 21 
  
x x 
+ CDP C00112 C9H16N3O11P2+
 
C4H6N3O+ 404 112 25 21 
  
x x 
+ UDP C00015 C9H15N2O12P2+
 
C5H5O2+ 405 97 25 21 
  
x x 
+ ADP C00008 C10H16N5O10P
2
+
 
C5H6N5+ 428 136 31 21.5 
  
x x 
+ IDP C00104 C10H15N4O11P
2
+
 
C5H5N4O+ 429 137 25 23 
   
x 
+ Folate C00504 C19H20N7O6+ C14H11N6O
2
+
 
442 295 16 23 
   
x 
+ GDP C00035 C10H16N5O11P
2
+
 
C5H6N5O+ 444 152 30 22.5 
   
x 
+ 7,8-dihydrofolate C00415 C19H22N7O6+ C7H8N5O+ 444
.01 178 30 23    x 
+ 
5-methyl-
tetrahydrofolate C00440 C20H26N7O6
+
 
C15H17N6O
2
+
 
460 313
.1 19 23    x 
+ dCTP C00458 C9H17N3O13P3+
 
C4H6N3O+ 468 112 31 24 
   
x 
+ dUTP C00460 C9H16N2O14P3+
 
C5H5O+ 469 81 18 24 
   
x 
+ TTP C00459 C10H18N2O14P
3
+
 
C5H5O+ 483 81 25 23 
   
x 
+ CTP C00063 C9H17N3O14P3+
 
C4H6N3O+ 484 112 21 23 
   
x 
+ UTP C00075 C9H16N2O15P3+
 
C5H5O2+ 485 97 30 23 
   
x 
+ dATP C00131 C10H17N5O12P
3
+
 
C5H6N5+ 492 136 35 24 
   
x 
+ ATP C00002 C10H17N5O13P
3
+
 
C5H6N5+ 508 136 30 25 
   
x 
+ dGTP C00286 C10H17N5O13P
3
+
 
C5H6N5O+ 508
.01 152 30 25.5    x 
+ ITP C00081 C10H16N4O14P
3
+
 
C5H5N4O+ 509 137 25 24 
   
x 
+ ATP-gamma-S C13742 C10H17N5O12P
3S+ C5H6N5
+
 524 136 35 25 
   
x 
+ GTP C00044 C10H17N5O14P
3
+
 
C5H6N5O+ 524
.01 152 37 25.5    x 
+ Diiodothyronine 
   
526 353 29 11 x x 
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(min) 
0-
11
 
11
-
15
 
15
-
19
 
19
-
40
 
+ 
Oxidized 
glutathione C00127 
C20H33N6O12S
2
+
 
C8H11N2O2
S2+ 613 231 33 21    x 
+ NAD C00003 C21H28N7O14P
2
+
 
C10H16N5O
10P2 664 428 30 17   x  
+ NADH C00004 C21H30N7O14P
2
+
 
C16H24N2O
13P2+ 666 514 26 19.5  x x x 
+ Dephospho-CoA C00882 C21H36N7O13P
2S+ 
C10H15N5O
7P+ 688 348 25 23.5    x 
+ Cyclic-diGMP C16463 C20H25N10O14P2+ C5H6N5O
+
 691 152 35 23 
   
x 
+ NADP C00006 C21H29N7O17P
3
+
 
C5H6N5+ 744 136 48 22 
   
x 
+ NADPH C00005 C21H31N7O17P
3
+
 
C21H28N6O
17P3+ 746 729 16 23.5 x   x 
+ CoA C00010 C21H37N7O16P
3S+ 
C11H21N2O
3S+ 768 261 37 24    x 
+ FAD C00016 C27H34N9O15P
2
+
 
C10H15N5O
7P+ 786 348 24 25  x x x 
+ Acetyl-CoA C00024 C23H39N7O17P
3S+ 
C13H23N2O
4S+ 810 303 28 23    x 
+ Propanoyl-CoA C00100 C24H41N7O17P
3S+ 
C14H25N2O
4S+ 824 317 33 25    x 
+ Acetoacetyl-CoA C00332 C25H41N7O18P
3S+ 
C15H15N2
O5S+ 852 345 34 26    x 
+ Malonyl-CoA C00083 C24H39N7O19P
3S+ 
C14H23N2O
6S+ 854 347 34 26    x 
+ Succinyl-CoA C00091 C25H41N7O19P
3S+ 
C15H25N2O
6S+ 868 361 38 26    x 
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Table S3.3. Experimental Outline for Lab Studies using Sulfitobacter NAS14-1 
Day Experiment Control Replicates Total Cultures 
1 + 500 nM DPD No Addition 3 6 
2 + 500 nM C8 No Addition 3 6 
3 + 500 nM DPD + C8 No Addition 3 6 
4 + 500 nM Xylose No Addition 3 6 
5 + 500 nM openC8 No Addition 3 6 
 
 
 
Table S3.4. Experimental Outline for Cruise 
Experiment Treatment 1 Treatment 2 Treatment 3 Treatment 4 Treatment 5 
Diatoms AHL Cocktail AHL + DPD DPD Open AHL Control 
Trap 4 3OC8 3OC8 + DPD DPD Open AHL Control 
Trap 6 3OC8 3OC8 + DPD DPD Open AHL Control 
Trap 7 C8 3OC8 AHL Cocktail Open AHL Control 
 
 
 
 
 
Table S3.5. Roseobacter Minimal Media 
Recipe (RMM) 
750 mL almost saturated Sea Salts (15g) 
250 mL Basal Medium 
150 mL Tris HCl Buffer (pH 7.5) 
375 mL Water 
1 mL Metals 
2 mL Vitamins and Minerals 
10 mL 1 M Acetate (final concetration of 10 mM) 
1 mL 68 mM FeEDTA 
 
Basal Medium 
 
87 mg K
2
HPO
4
 
 
1.5 g NH
4
Cl 
 
525 mL Water 
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3.4.3 Detailed Methods 
 
General Methods. The liquid chromatography-tandem mass spectrometer (LC-MS/MS) used 
for these studies consisted of a Finnigan Surveyor Autosampler Plus, Surveyor MS Pump Plus, 
and TSQ Quantum Discovery Max triple quadrupole MS (Thermo Electron Corporation, 
Waltham, Massachusetts). All MS spectra were collected and analyzed using the Xcalibur MS 
software package (Thermo Electron Corporation). All other reagents listed below were ordered 
from Fisher Scientific: water (HPLC), methanol (HPLC), acetonitrile (HPLC), ammonium 
acetate, ammonium hydroxide, tributylamine (99%), and glacial acetic acid. 
 
Culture Growing Conditions and Media Components.Sulfitobacter NAS14-1, from freezer 
stocks, was grown on half strength YTSS agar plates at 30 °C. A single colony from this plate 
was then transferred to 7 mL of half strength YTSS broth and allowed to grow overnight at 30 °C 
with agitation at 200 rpm. From this culture, 100 µL was transferred to 7 mL Roseobacter 
Minimal Media (RMM) and grown at 30 °C with agitation at 200 rpm. RMM recipe is found in 
Table S3.5. 
 
Experimental Setup for Lab Studies. Six fresh cultures of NAS14-1 grown in RMM were set 
up using a 1:1000 dilution and the cell density was monitored. These cultures were split up and 
offset by 45 min. Once an OD540 of ~ 0.120 was reached, half the cultures were treated with 500 
nM of DPD, C8, DPD+C8, Xylose, or Open C8, while the other half were untreated (Table S3.3). 
Each of these treatments was done on a different day. The untreated cultures were repeated on 
each day. Samples were taken at times of 0 h, 1.25 h, 5.5 h, 8 h, and 24 h. 
 
Experimental Setup On Cruise. While on a cruise to the Sargasso Sea, experiments were ran 
to test the affects of quorum sensing molecules on samples collected from four different 
sediment traps. Each of the experiments was set up with fifteen total cultures that contained 
triplicates for each treatment. The conditions for each of the experiments can be found in Table 
S3.4. All additions were done with 500 nM of each compound. These cultures were incubated 
for 24 h, at which point samples were taken for DPD and metabolomics analysis.  
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Sampling for DPD concentration.  
See previous Chapters. 
 
Sampling for AHL concentration.  
See previous Chapters. 
 
Metabolite Extraction 
 
Lab Studies. At each time point, 10 mL of each culture is filtered onto a Magna Nylon Filter 
(Millipore, Billerica, MA). The filters are then placed upside down into a petri dish containing 1.3  
mL of a 40:40:20 solution of ACN:MeOH:H2O with 1 M formic acid which was pre-cooled to -20 
°C. The cells were then allowed to extract at this temperature for 20 min. At this time, the cells 
were washed off the filter and placed in a 1.5 mL centrifuge tube and centrifuged (5 min, 13.6 
rpm, 16.1 rcf, 4 °C). The supernatants were then transferred to two 300 µL autosampler vials 
labeled for positive and negative mode and a 1.5 mL centrifuge tube for storage. These samples 
were then stored at -80 °C until mass spectrometric analysis. 
 
Cruise Studies Modified Sample Extraction. Samples taken while on board a research vessel 
were kept on filters and extracted once back in the lab. The details of this technique are as 
follows, At each time point 15 mLs of each culture were filtered onto a Magna Nylon Filter 
(Millipore, Bellerica, MA). The filters were then folded and placed in a pre-sterilized cryogenic 
vial (2 mL) and immediately flash frozen with liquid nitrogen (-196 °C) and kept at this 
temperature or -80 °C until extraction on land. Once on land, in a 4 °C room, the samples filters 
were placed in a petri dish and the extraction solvent, 40:40:20 solution of ACN:MeOH:H2O with 
1 M formic acid (1.3 mL), was used to help thaw and unfold the filters. The filters were then kept 
upside down in the extraction solvent and the extraction process was continued as previously 
described.  
 
Metabolomics Chromatographic Details. High performance liquid chromatography (HPLC) 
was performed utilizing a quaternary pump to generate a gradient for the elution of compounds 
from the stationary phase and were separated by modification of methods of the Rabinowitz 
lab.194-195. For all samples, 10 µL was injected onto the column via a cooled autosampler at 4 
°C. Using two chromatographic runs the full analysis of the metabolome was accomplished as 
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separate detection is required for positively and negatively ionizing molecules. The eluent from 
the separation was introduced directly into the mass spectrometer. For positive mode analyses, 
a flow rate of 150 µL / min was used and the stationary phase was aminopropyl functionalized 
particles (5 µm pore size, 100 Å particle size) packed into a 250 × 2 mm column (Luna NH2, 
Phenomenex, Torrance CA) kept at 10 oC during the run. The mobile phases were 95% 20mM 
ammonium acetate, 20mM ammonium hydroxide buffered at pH= 9.4 in HPLC grade water and  
5% HPLC grade acetonitrile (solvent A) and HPLC grade acetonitrile (solvent B). These were 
used to construct the following 40 min gradient elution profile: 
t ) 0 min, 15% solvent A, 85% solvent B; t ) 15 min, 100% solvent A, 0% solvent B; t ) 28 min, 
100% solvent A, 0% solvent B; t ) 30, 15% solvent A, 85% solvent B; t ) 40, 15% solvent A, 85% 
solvent B.  
For negative mode analyses, a flow rate of 200 µL / min was used. The stationary phase was a 
Synergi Hydro-RP C18 (4 µm pore size, 80 Å particle size) packed into a 150 × 2 mm column 
(Phenomenex, Torrance CA) kept at 25 oC during the run. The mobile phases were 11mM  
tributylamine and 15mM acetic acid in 97% HPLC grade water and  3% HPLC grade methanol 
(solvent A) and HPLC grade methanol (solvent B). These were used to construct the following 
50 min gradient elution profile:  
t ) 0 min, 100% solvent A, 0% solvent B; t ) 5 min, 100% solvent A, 0% solvent B; t ) 10 min, 
80% solvent A, 20% solvent B; t ) 15, 80% solvent A, 20% solvent B; t ) 30, 35% solvent A, 65% 
solvent B; t ) 33, 5% solvent A, 95% solvent B t ) 37, 5% solvent A, 95% solvent B; t ) 38, 100% 
solvent A, 0% solvent B; t ) 50, 100% solvent A, 0% solvent B.  
 
Metabolomics Mass Spectrometric Detection Parameters. Samples were introduced into the 
electrospray ionization (ESI) chamber of the triple quadrupole MS  through a 0.1 mm internal 
diameter fused silica capillary after delivery by HPLC as described previously. The spray 
voltage for the ESI source was set to 4500 V for detection in positive ion mode and 3000 V for 
detection in negative ion mode. Nitrogen was used as the sheath gas (40 psi). The inlet capillary 
temperature was 290 °C and the argon used as the collision gas was set at 1.5 mTorr. Samples 
were analyzed using selected reaction monitoring (SRM) technology, and the scan time for each 
SRM was 0.05 s with a scan width of 1 m/z. See Tables S3.1 and S3.2 for a list of SRMs. Full 
selected reaction monitoring (SRM) detection parameters for the majority of compounds have 
been previously reported by Rabinowitz and coworkers. 
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Metabolomics Data Handling. Xcalibur Quan Browser (Thermo Electron, Waltham MA) was 
used to visualize and manually integrate metabolite peaks over a set time window. The 
integration values were then entered in an excel spreadsheet. Fold changes were calculated 
from the average of the three replicates for the cruise samples compared to the culture treated 
with DMSO as the control. The fold changes for the lab studies were calculated from the 
averages of the middle four replicates compared to the no addition cultures. Fold changes were 
analyzed by Cluster and visualized by Java Treeview. 
 
  
164 
 
CONCLUSION 
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Gaining a greater insight into quorum sensing could lead to a better understanding of larger 
systems of inter-organism interactaction as well as potentially lead to novel therapeutics. With 
the tools presented herein, the quorum sensing signals DPD ((S)-4,5-dihydroxy-2,3-
pentanedione) and AHLs (acylhomoserine lactones) can now be detected and quantitated 
(Chapter I). By exploiting the reactivity of the 1,2-diketo moiety of DPD with o-diaminobenzene, 
a tag was developed to circumvent to difficulties in detecting this molecule. Using a previously 
developed synthesis of DPD and 13C-DPD, both detection and quatitation was accomplished 
with isotope dilution mass spectrometry using SRM based technology. This method was also 
used to quantitate AHLs after a successful development of a stable isotope AHL internal 
standard. Since AHLs are a broad class of signals with a conserved homoserine lactone portion 
and a differentiated acyl chain, the isotope was placed on the conserved portion in order to 
allow differentiation of the internal standard to generate standards for any naturally occurring 
molecule. A set of eight (D2)AHLs were synthesized and used to develop a short LC-MS/MS 
method for detection of these molecules.  
 
Using this technology, measurement of quorum sensing signals from cultures was 
accomplished to answer questions as to the function of these molecules (Chapter II). It was 
determined that bacteria that biosynthesize DPD through the activated methyl cycle do not 
necessary use the molecule as a cell density signal. To determine whether these molecules are 
used to monitor cell density the signal concentration to cell number (as measured by optical 
density) over time under increasing nutrient conditions was monitored. This number should 
remain constant for all conditions if, indeed, the molecule is used to monitor cell density. Using 
this method, it was determined that DPD is not a cell density signal for E. coli, however it is a 
cell density signal for V. harveyi as the DPD concentration/cell density number remained 
constant over time and nutrient conditions. V. harveyi also synthesizes an AHL, HAI-1, and the 
concentration of this molecule/cell density is not maintained over all conditions. After further 
investigation, it was determined that the rate of synthesis for this molecule remains constant 
over the growth curve indicating that this is a signal potentially metabolic in nature. A study 
using V. fischeri was then conducted to determine multiple AHL signals, and the detection of 
these molecules showed a temporal pattern in these bacteria showing that the timing of the 
synthesis of individual molecules may signal different points in their growth cycle. By using the 
techniques to detect and quantitate quorum sensing molecules, we were able to determine that 
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these signals may contain information content not necessarily related to cell density as originally 
thought. 
 
After gaining a further understanding of the biosynthesis of these molecules, we then sought to 
determine if they could affect microorganisms, even if the bacteria did not synthesize these 
molecules themselves. Due to the interest in quorum sensing in the ocean, the effect that these 
molecules have on nutrient cycling was investigated. Since quorum sensing is the link between 
signaling and metabolism, metabolomics was used to study the changes of intracellular 
metabolite concentrations of marine microbes and naturally occurring populations (Chapter III). 
Initial work was done in collaboration with the Van Mooy lab at Woods Hole Oceanographic 
Institute to determine that DPD and AHLs have an effect on alkaline phosphatase (APase) 
activity in Trichodesimium consortia. Not only was APase activity altered, but DPD or AHLs had 
opposing effects. This led to the hypothesis that DPD may actually act through quorum 
quenching. The idea that the two quorum sensing signals could lead to opposing trends in 
metabolism was intriguing and Sulfitobacter NAS14-1 cultures were grown in lab and incubated 
with either of these molecules (DPD or C8). The previous measurement technology to 
quantitate DPD and C8 concentrations was used to monitor both signals over the course of the 
experiment. DPD concentrations were shown to slowing decrease over time; however, in the 
presence of C8 the rate was slightly slower. The C8 concentration was however maintained 
through exponential phase when only C8 was added as well as in the presence of DPD. 
NAS14-1 synthesizes C8 on its own, and due to the fact that no extra C8 was detected in 
cultures with added C8 this bacteria was determined to have a mechanism to monitor the 
extracellular C8 concentration and turn off the synthesis of this signal when a certain 
concentration is reached.  The intracellular metabolite changes from these experiments showed 
similar trends to the changes observed with APase activity in Trichodesmium. The most drastic 
changes were seen at 1.25 and 5.5 h post addition of the molecules. The changes observed in 
the extracellular DPD concentration versus C8 concentrations could explain differences seen in 
the intracellular metabolite concentrations. Care was taken to ensure changes were not due to 
DPD being used as a carbon source, and that the effects measured are due to DPD “signaling”. 
Studies were also performed using mixed species collected from the open ocean. The 
intracellular metabolite concentration was measured using the same conditions as the lab 
cultures showed similar changes after a 24 h incubation. DPD was the only quorum sensing 
molecule monitored during the experiment.  The DPD concentration was only measured at 24 h 
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and found to be equal to what was initially added to the cultures. The hypothesis that 
extracellular signals are able to alter intracellular metabolite concentrations is of interest when 
studying carbon and nitrogen cycling in the ocean and will provide insight into the interactions 
among organisms. Species synthesizing DPD or an AHL potentially have the ability to alter the 
metabolism of other species in order to control nutrient availability to enhance their own survival.  
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